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General Introduction 
“Cluster One”
The Division Bell, Pink Floyd
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Carbohydrates 
Carbohydrates are all around us. Besides buying them in the candy shop, carbohydrates, also called 
sugars or glycans, are also present everywhere in Nature. Carbohydrates are the most abundant class 
of naturally occurring organic compounds, making up approximately 75% of Earths’ biomass.1 Carbo 
hydrates are structurally very diverse and can vary a lot in their size and complexity, e.g. from 5 to 
literally thousands of carbon atoms. The name carbohydrate is derived from the empirical formula first 
postulated for this class of compounds: C·H2O, a hydrate of carbon.
1 This original empirical formula 
actually no longer suffices for the whole field of carbohydrates. For example, nitrogen-containing 
carbohydrates (e.g. sialic acid) cannot be described using this empirical formula. The complexity and 
many rules related to their names and structure are, however, out of scope of this thesis, but are 
discussed in several excellent books and reviews.1-2 Carbohydrates are built from smaller chemical units 
called monosaccharides. The multitude of different monosaccharides and the endless combinations 
thereof in complex carbohydrates result in the huge functional diversity of carbohydrates. Single 
differences in a monosaccharide of a complex carbohydrate on red blood cells, for example, determine 
our blood type. On the other hand, a polymeric glucose carbohydrate, called cellulose, is important 
for the structure of all plants on earth.3 In the human body we find a great number of carbohydrates 
with varying complexity. A simple but abundant one is glycogen a glucose polymer, which is our body’s 
reserve energy supply. The monosaccharide N-acetylglucosamine is, however, a major component 
of the cell wall. The monosaccharide, sialic acid,4 is found as a terminal unit on many complex 
carbohydrates on the outer surface of human cells and plays important roles in cell recognition and 
communication. In general, complex carbohydrates can be found on the outer surface of almost all 
living cells. This dense sugar coating, unique to each type of cell or organism, is essential for cell 
recognition and communication processes between our own cells, but also for example between our 
cells and bacterial cells in the gut. In short, carbohydrates are essential molecules of life and can be 
viewed as the social messengers of a cell (Figure 1). 
Figure 1. Carbohydrates are the social messengers of a cell.
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The molecular mechanism behind the biosynthesis of complex carbohydrates and how their structure 
directs biological processes in health and disease is, however, poorly understood. Using (organic) 
chemistry to design and synthesise these carbohydrates is a powerful approach to investigate this 
biological role at the molecular-level. 
Carbohydrate chemistry, the sub-discipline in chemistry mainly focussing on carbohydrates, has 
always been of high interest since the pioneering work by Nobel laureate Emil Fischer (Figure 2) in 
the early 20th century.1,5 Nowadays, carbohydrates are used in a wide variety of applications ranging 
from pharmaceuticals,6 food,7 vaccines,8 and bio-sensors.9 Carbohydrates also have a major influence 
on our health and are often implicated in diseases.10-11 Every cell – for example, a mammalian cell or a 
bacterial cell – has a unique carbohydrate layer, which is typically related to their (dys)functioning. For 
example, surface-bound carbohydrates, such as sialic acids, on cancer cells are often over-expressed 
or have unusual terminal glycans.12 The unique cell-surface carbohydrate layer is not encoded in the 
genes of an organism and the biosynthesis of their complex structures is not template-driven. The tools 
to study DNA or proteins at the molecular level can therefore not be applied on carbohydrates. The 
design and chemical synthesis of carbohydrates and enhanced unnatural versions thereof as “molecular 
tools” can be used to unravel carbohydrate-related biological processes. This chemistry-based 
approach using molecular tools in combination with analytical techniques such as mass spectrometry 
and fluorescence microscopy to study biological phenomena is called “chemical biology” and has 
accelerated the study of carbohydrates.13-14 This thesis presents a study that uses such a chemistry-
based approach to investigate the role of bacterial carbohydrates in the human gut. The subsequent 
sections will provide a general introduction on the various scientific disciplines and research subjects 
involved in this study.
Chemical microbiology
Although an all-encompassing definition of chemical biology is challenging,15 in the context of this 
study it is defined as a research discipline where chemists develop tailor-made molecular tools to study 
and modify biological processes at the molecular level, often in close collaboration with biologists. It is 
closely related to cell biology and biochemistry, but in chemical biology molecules and their tuning and 
monitoring abilities are central rather than biochemical pathways. Sub-disciplines within this field are 
chemical glycobiology, focussing on the carbohydrates involved in biological pathways, or proteomics 
using molecular tools, mass spectrometry and advanced computer programs to unravel the proteome. 
Chemical biology, initially, was mainly applied to numerous mammalian cell lines. In recent years, 
however, chemist started to also use this approach to look in more detail at other organisms such 
as plants and microbes.16-18 Chemical biology is a nice example of how our modern interdisciplinary 
approach to science can bring new insight and techniques to the study of biology. This is, however, 
far from a new phenomenon. Actually, the first chemist working in the field of microbiology was Louis 
Pasteur (Figure 2). His early work on isomers of d-tartrate illustrated that microorganisms can catalyse 
specific chemical reactions.19 Another pioneer was the Dutch scientist Martinus Beijerinck, whom 
was originally trained as a botanical expert but changed his research interest towards microbiology 
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(Figure 2).19 He formulated the enrichment culture technique. In this technique microorganisms are 
isolated from their natural habitat and enriched with optimal nutrients and incubation conditions to 
favour one microorganism over the other. 
The overall aim of the study presented in this thesis was to gain new insights in the role of bacterial 
carbohydrates in the human gut. Chemical biology tools are well suited for this aim. The study of 
microbes at the molecular level with chemical tools can therefore be seen as a forgotten sub-discipline 
in chemical biology that only recently received new attention: chemical microbiology.
Gut microbiome
All the various microbes found in and on our body, collectively called the human microbiome, play 
an essential role in keeping us alive, especially the gut microbiome is important for our well-being. 
The complexity of the gut microbiome, however, is high, with millions of genes that vastly exceed the 
coding capacity of our own genome.20 In other words, many diseases can be related to an imbalance 
in the bacterial composition within the gut. Specific diseases such as Crohn disease, are often directly 
linked to bacteria in our gut.21 Such a direct link is, however, only in specific cases such as C. difficile 
infections applicable.23 In order to understand the role of our microbiome in even more detail important 
questions such as “do individuals share a core human microbiome”; “is there a correlation between 
microbial population structure and host genotype”; “Do differences in the human microbiome 
correlate with differences in human health”; and “are differences in the relative abundance of bacteria 
important” have to be answered.24 Currently, the gut microbiome is being mapped in great detail to 
fully understand how bacteria interact among themselves and with our cells in the human gut.25 In 
the future a better understanding of the function of our gut microbiome and its systemic impact will 
result in better diagnostics or therapies to improve the quality of life. The presence of carbohydrates 
on both the outer surface of gut bacteria and our own cells suggest they play a role on the effect of the 
microbiome on human health. Besides the common eukaryotic carbohydrate monomers, bacteria 
Figure 2. Emil Fischer, 1852 –1919 (left), Louis Pasteur, 1822 –1895  (center) and Martinus Beijerinck, 1851 –1931  (right).
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have an extended additional set of unique bacterial monosaccharides.17 The role of these bacterial 
monosaccharides is often not fully understood. Especially those human gut bacterial sugars present 
on their outer surface which are in close contact with humans are of special interest. Our aim is to use 
chemical microbiology to study carbohydrates in the cell wall of human-gut bacteria at the molecular 
level. 
Peptidoglycan and the bacterial cell envelope
A variety of carbohydrates is present in the bacterial cell envelope and may provide rigidity and shape 
to the cell, serve as a barrier for nutrients and endogenous molecules, and interact with other bacteria 
and host cells. Bacteria can be divided into two major classes, the Gram-positive and Gram-negative. 
The difference between these two classes can be seen in Figure 3 and is caused by a carbohydrate-
containing cell wall component, called peptidoglycan, and the presence of an outer membrane in 
Gram-negative bacteria that is decorated with a variety of carbohydrate-containing molecules.
The Gram-positive cell-envelope (figure 3, left panel) consists of an inner membrane and a large cell 
wall made up of peptidoglycan that is often covered by glycosylated molecules, such as fimbriae (also 
termed pili), S-layers or other glycoproteins, and capsular polysaccharides (CPS).
The Gram-negative cell-envelope (figure 3, right panel) includes two membrane, outer and inner 
membrane that includes the relatively small peptidoglycan layer. The outer membrane is covered 
with a dense layer of (lipo)proteins, glycans and lipids. These include a lipopolysaccharide layer or 
simply LPS (Figure 4). The LPS layer can contain a variety of glycans, such as ketodeoxyoctonate (KDO), 
glucose (Glc), galactose (Gal), and N-acetylglucosamine (GlcNAc).
Peptidoglycans are part of both Gram-positive and -negative bacteria and consist of a mesh-like 
structure of polymeric chains of a repeating disaccharide-penta-peptide unit. The disaccharide 
Figure 3. Schematic view of the architecture of the cell envelope in Gram-positive and Gram-negative bacteria.
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consist of the two monosaccharides, N-acetylglucosamine and N-acetylmuramic acid (MurNAc), 
that are  β-(1,4) linked. The penta-peptide consist in most cases of l-alanine (l-Ala), d-glutamic acid 
(d-Glu), meso-diaminopimelic acid (DAP), and two d-alanines (d-Ala). Crosslinking is often seen 
between the meso-diaminopimelic acid residue and d-alanine, and gives extra rigidity and strength 
to the cell wall. The full penta-peptide chain is synthesised sequentially by ligases inside the bacteria 
and subsequently exported over the inner membrane and further polymerised. The biosynthesis of 
peptidoglycan is a complex multistep process where a variety of genes are involved. Recent reviews 
discuss the biosynthesis in full detail.26-27 The presence of d-amino acids in PG is of specific interest 
since it is absent in mammals. This resulted over the years in antibiotics that specifically target the 
biosynthesis of these amino acids such as the β-lactams and d-cycloserine. To improve the current 
antibiotics and develop new, more information is needed to understand PG dynamics in full detail. 
Furthermore, in a variety of bacteria it is still not known whether PGs are present. Some are 
completely devoid of PG, such as Mycoplasma spp., while for others belonging to the syperphylum 
Planctomycetes-Verrucomicrobia-Chlamydia cluster, the PG presence has been enigmatic. One of 
these, belonging to the Verrucomicrobia, is Akkermansia muciniphila. In chapter 3 and 4 we describe 
studies performed on various bacteria, including A. muciniphila, in order to investigate their surface 
glycan structures and for whether they can produce PG. One of the methods to study PG is metabolic 
labelling, the incorporation of chemical probes in biological systems using the metabolic pathways 
provided by the organism [see chapter 2 for a review on metabolic oligosaccharide engineering, 
chapter 3 for studies on peptidoglycan labelling, and chapter 4 for experimental work on metabolic 
oligosaccharide engineering in human-gut microbes]. Metabolic labelling has proven to be a powerful 
technique to study PG synthesis and dynamics in more detail. In 2014, Maurelli and co-workers 
were among the first to use metabolic labelling to replace the natural d-Ala–d-Ala dipeptide for a 
d-Ala–d-Ala alkyne probe.32 This probe was incorporated directly by the endogenous enzymes in 
Chlamydiae, demonstrating the presence of PG in bacteria belonging to this phylum. Side-chain 
modifications on the α-position were already known to not interfere with the biosynthesis of PG. 
In the biosynthesis of PG a dipeptide intermediate is involved, and for that reason most probes are 
also based on this dipeptide intermediate. Over the last years several PG dipeptide probes were 
synthesised (Figure 5). 
Figure 4. Schematic view of LPS layer of bacteria. GlcNAc: N-acetylglucosamine, Glc: glucose, 
Gal: galactose, Hep: heptose, Kdo: ketodeoxyoctonate.
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The molecular mechanism behind the visualisation of most of these PG dipeptide probes relies on a 
two-step bioconjugation reaction using the copper-catalysed azide alkyne cycloaddition (CuAAC) or 
Strain-Promoted Azide Alkyne Cycloaddition (SPAAC).33-35 In the first step the unnatural PG dipeptide is 
taken up by the cell and incorporated into the peptidoglycan layer. In the second step a bioconjugation, 
for example click chemistry, is performed to visualise the PG dipeptide probe with a fluorescent dye 
or antibody. A variety of combinations are known nowadays, with azide-alkyne click chemistry to 
be the most popular choice. The current method developed by Maurelli and co-workers has a few 
drawbacks.32 The alkyne dipeptide is not commercially available and the click chemistry uses copper, 
a known toxic in many biological pathways. Other bioconjugation reactions such as SPAAC, tetrazine 
ligation or Strain-Promoted Alkyne-Nitrone Cycloaddition (SPANC) do not need copper.36-39 Chemical 
PG probes using these bioconjugation reactions have also been developed (Figure 5). Bioconjugation 
without the use of copper has find applications in many organisms such as mammalian cell lines, plants, 
and bacteria.14 New bioconjugation techniques such as SPANC or tetrazine ligation are compatible with 
the CuAAC or SPAAC and thereby enable dual labelling using both techniques.40 This dual labelling has 
successfully been applied in bacteria to study PG dynamics (vide infra).
 
 
 
 
Figure 5. d-Ala and d-Ala-d-Ala peptidoglycan probes.
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O-glycans in the Human Gut
Although peptidoglycan forms the largest glycan-polymer in bacteria a variety of other glycans can be 
found on the human cell membrane. Two distinct types of glycans are: O-linked glycans and N-linked 
glycans. A glycan connected to an oxygen of an amino acid such as serine, threonine, or tyrosine via 
a glycosidic linkage is called a O-linked glycan. When glycans are linked to an amine in for example 
asparagine it is called N-linked. The most abundant type of O-linked glycans in eukaryotes and 
bacteria is the mucin-type which is characterised by the presence of N-acetyl-α-d-galactosamine.25 
Mucin-type O-linked glycosylation is an important post-translational modification and involved in a 
variety of physiological responses and diseases.41 Mucin-type O-glycans dominate the inner surface 
of the intestinal tract and thereby are suspected to have a significant role in regulating the microbial 
composition of the gut microbiome. Some bacteria can also degrade the mucin type O-glycans 
themselves. One of this mucin-degrading bacteria is Akkermansia muciniphila. A. muciniphila, a 
species from the phylum Verrucomicrobia, was recently discovered in the human intestinal tract.28 A. 
muciniphila is a mucin-degrading human-gut bacterium, and has been implicated in the regulation of 
body weight and metabolism, is present since early childhood in our gut, and can easily rise to 3% of 
the total bacterial count in human feces during adulthood.28-31, 42-44 
A more detailed study of this species, among others, is important to understand our human 
microbiome. Metabolic labelling also provides a tool to study these glycans in more detail. A 
combination of PG and glycan labelling called dual labelling would even make it possible to target 
and track selectively different glycans under the same physiological conditions. The labelling of 
other cell glycoconjugates is, of course, not possible with the PG dipeptide probes. For the labelling 
of these species other probes have, however, been developed. Among the well-studied probes are 
azido variants of N-acetylglucosamine (GlcNAz), N-acetylgalactosamine (GalNAz), azido-fucose, and 
5-acetylneuraminic acid (Neu5Az).14, 45 Almost all monosaccharide within the mucin-type O-glycans 
can be studied with these azido-probes. More recent probes with cyclopropene and isonitrile 
bioconjugation handles have also been developed and successfully used for metabolic labelling.38, 
46-48 Other glycans such as glucose or N-acetylmannosamine (ManNAc) are, in general, not suitable 
for metabolic labelling in bacteria, since their biosynthetic pathways are absent in most bacteria. 
A few examples where Ac
4
ManNAz showed metabolic labelling are, however, known.49 The role of 
carbohydrates that are present in gut bacteria is of high interest. Unfortunately selectivity in labelling 
of these carbohydrates is often the limiting factor. For example, Bacteroides thetaiotaomicron, 
a human gut symbiont is known to degrade more than a dozen types of glycans while species like 
Anaerostipes rhamnosivorans or Faeacalibacterium prausnitzii (both well-studied butyrate-producing 
gut bacteria) can only degrade a limited amount of glycans.50-52 Additionally, as mentioned, bacteria 
also use many monosaccharides and complex carbohydrates that are unique to their domain. If this 
bacterial carbohydrate composition can be mapped in more detail, a better understanding of these 
glycoconjugates and the bacteria themselves will be obtained.
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Microbial sialic acids
One class of carbohydrates that only occurs in bacteria that interact with humans are microbial sialic 
acids (MSA). Sialic acids are the most abundant natural family of nonulosonic acids.53 Nonulosonic acids 
are nine-carbon α-ketoacid sugars typically found on the surfaces of glycoconjugates in mammalian 
cells. Sialic acids were first identified in vertebrates over 80 years ago by Ernst Klenk and Gunnar Blix.54 
More than 50 natural occurring sialic acid derivatives are known nowadays in a variety of cellular 
organisms such as insects and fish eggs.4, 55 All sialic acids are characterised by their 3-deoxy-d-glycero-
d-galacto-2-nonulosonic acid skeleton. At C1 they have a carboxylic acid group which at physiological 
pH is deprotonated. Three major classes of sialic acid are known: N-acetylneuraminic acid (Neu5Ac), 
N-glycolylneuraminic acid (Neu5Gc) and 3-deoxy-d-glycero-d-galacto-2-nonulosonic acid (KDN). 
Especially Neu5Ac gained a lot or interest over the years due to the connection in mammalian 
tumours.56 Sialic acids are always found as α-linked carbohydrates on glycoconjugates.
Like other sialic acids, MSAs can be found on N- and O-linked glycans, glycosphingolipids, 
glycosaminoglycans, glycophospholipid anchors, and lipo-oligo/polysaccharides. Sialic acids have been 
implicated in vital neurological and immunological processes and various diseases such as cancer, the 
common flu, and cholera (see for excellent reviews Varki and Crockers56-58). As a matter of fact, many 
pathogenic bacteria have decorated their cell (wall) surfaces with sialic acid residues or derivatives 
thereof in order to mask their presence for the human immune response.59 
Figure 6. Fischer projection and chemical structure of the microbial sialic acids, legionaminic acid and pseudaminic acid, 
and the most abundant human sialic acid, N-acetylneuraminic acid.
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Some bacterial species can express sialic acid themselves, while other bacteria have developed a 
unique class of sialic acids which are only present in those microbes of the species that are in close 
contact with humans. The best studied MSA are legionaminic (Leg) and pseudaminic acid (Pse) (Figure 
6).60 In the O-chain polysaccharide of the LPS of Pseudomonas aeruginosa O7 and O9 and Shigella 
boydii Pse was isolated. In the O-chain of LPS in Legionella pneumophila serotype 1 Leg was isolated in 
1994.61 Legionaminic acid greatly resembles N-acetylneuraminic acid. At the C9-position legionaminic 
acid has a methyl group compared to the C9-hydroxy group in N-acetylneuraminic acid and the 7-OH 
in Neu5Ac is changed to 7-NHAc in Leg (Figure 6). Pseudaminic acid has a different stereochemistry at 
the C5, C7, and C8 position compared to legionaminic acid. Thus, legionaminic acid has a d-Gal d-Gly 
configuration and pseudaminic acid a l-Man l-Gly configuration. Two natural epimers of legionaminic 
acid are known 4-epi-legionaminic acid and 8-epi-legionaminic acid with d-glycero-d-talo and 
l-glycero-d-galacto configuration, respectively. The discovery of pseudaminic acid was relevant, since 
it was long thought that all nonulosonic acids were direct regio- and stereochemical derivatives of 
neuraminic acid.62 Pseudaminic acid are found both as α- and β-linked carbohydrates, on the terminal 
end of glycans or internally linked. Most of these linkages are nitrogen-based on either the C-5 or 
C-7 position.63 Campylobacter, Helicobacter, Escherichia, and Legionella pneumophila are among 
the most interesting species to study pseudaminic and legionaminic acid in more detail, because all 
these species are major players in diseases related to the human gut. An interesting detail is that all 
these bacterial species are Gram-negative bacteria. This is mainly because their flagella are heavily 
glycosylated with pseudaminic acid residues.64 It does not, however, mean that other glycoconjugates 
are absent in Pse, or that Pse is only present in Gram-negative bacteria. 
In recent years, microbial sialic acids have been discovered in both non-pathogenic and pathogenic 
bacteria. Many bacterial species have Pse and/or Leg or epimers thereof in their glycans. A complete 
overview of species with Pse or Leg was given in 2014 by Zunk and Kiefel.60 Derivatives and epimers 
of these two classes are known and found in a variety of bacterial species such as acinetaminic acid in 
the capsule of Acinetobacter baumannii.65 An overview of known natural epimers and derivatives of 
pseudaminic acid is shown in Figure 7.
Figure 7. Natural occurring pseudaminic acid derivatives.
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Biological significance of pseudaminic acid
In order to unravel the biological role of MSAs we have to identify the classes of proteins involved 
in their lifecycle. Three distinct classes of proteins are involved in the lifecycle of a MSAs. The first 
class are the glycosyltransferase enzymes, known as sialyltransferases. Glycosyltransferases can place 
(hence transfer) the (microbial) sialic acid onto proteins or present glycoconjugates. The second 
class of proteins, the so-called lectins, has interaction with the MSA on the outer surface. Lectins, 
carbohydrate-binding proteins, and sometimes also antibodies interact with the sialic acid to trigger 
a biological response through binding. The last class are the glycosylhydrolases that can hydrolyse 
the glycosidic bond of the sialic acid with its aglycone, also called sialidases. After this hydrolysis the 
lifecycle of (microbial) sialic acids ends, it can be recycled or degraded. Nearly nothing is known about 
these three classes of proteins for MSAs. Improved knowledge about the enzymes involved with MSAs 
and how the interaction takes place could lead to further understanding of the role of MSAs in bacteria 
and perhaps also of interactions with their host.66
Aim of this thesis
Bacterial carbohydrates form a large group of very diverse carbohydrates which play a major but as 
of yet poorly understood role in the human body, especially in the gut. Synthetic organic chemistry 
enables the synthesis of these (complex) bacterial carbohydrates, and the design of tailor-made 
enhanced versions that can function as molecular tools to study the biology. This thesis presents a 
study in which we aim to investigate the role of bacterial carbohydrates in the human gut. We aim 
to contribute to unravelling the role of these bacterial carbohydrates in the human gut using a 
combination of synthetic organic chemistry and microbiology: chemical microbiology.
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Outline of this thesis
In this thesis we have made a start to explore the role of bacterial sugars in the human gut. For the study 
of peptidoglycan we designed and synthesised two new peptidoglycan probes. This work is described 
in chapter 3. Labelling was performed in both E. coli and A. muciniphila with these novel probes. The 
newly developed PG probes were non-toxic as showed by viable count analysis. Other glycoconjugates 
in E. coli and A. muciniphila were also targeted with azido-variants of Ac
4
GlcNAc, Ac
4
GalNAc, and 
Ac
4
FucAc. This technique is called metabolic oligosaccharide engineering and is described in a review 
in chapter 2. For visualisation of the labelling we performed confocal microscopy with all samples. To 
quantify this labelling flow cytometry was used. The orthogonal isonitrile PG and azido glycan probes 
were also used in a dual labelling experiment to label PG and fucose-glycans simultaneously.
Experimental work with MOE in human gut related bacteria is described in chapter 4. A small 
collection of azido-glycans, Ac
4
GlcNAz, Ac
4
GalNAz, Ac
4
FucAz, Ac
4
RhamAz, and Neu5Az were used in 
relevant human-gut bacteria such as A. muciniphila, A. rhamnosivorans, and other butyrate-producing 
bacteria. As a proof of principle MOE was tested in a co-culture of a combination of these gut bacteria. 
Confocal microscopy and flow cytometry were used to visualise and quantify the labelling.
In order to label more complex carbohydrates in the human gut or man-related bacteria we aimed 
for the total synthesis of pseudaminic acid. This microbial sialic acid is found on the outer surface 
of bacteria. Chemical synthesis towards Pse was known at the start of this work, but no extensive 
chemical biology experiments had been performed. First, a literature overview of known syntheses 
towards Pse and Leg is discussed. Next, we describe our efforts towards these chemical probes of Pse 
in chapter 5. Key reactions to obtain Pse chemical probes, such as the Henry reaction and tethered 
aminohydroxylation, were performed and optimised where possible. The Garner aldehyde derivative, 
derived from l-threonine, proved to be a versatile important building block towards Pse.
Finally, chapter 6 provides a general discussion about all previous chapters. Furthermore it discusses 
unpublished work and looks into the future of this exciting and only new-born field, chemical 
microbiology.
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Getting a Grip on Glycans: 
a Current Overview of the Metabolic Oligosaccharide Engineering Toolbox
“Wot’s… Uh The Deal”
Obscured by Clouds, Pink Floyd
Abstract
This review discusses the advances in metabolic oligosaccharide engineering (MOE) from 2010-2016 
with a focus on the structure, preparation, and reactivity of its chemical probes. A brief historical 
overview of MOE is followed by a comprehensive overview of the chemical probes currently 
available in the MOE molecular toolbox and the bioconjugation techniques they enable. The final 
part of the review focusses on the synthesis of a selection of probes and finishes with an outlook on 
recent and potential upcoming advances in the field of MOE.
This work was published in
T. J. Sminia, H. Zuilhof, T. Wennekes, Carbohydrate Research, 2016, 435, 121
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1. Introduction
The field that studies glycobiology has been in existence for well over a century and was first properly 
defined over 25 years ago.1 Since then the intimate and complex involvement of carbohydrates, 
also called glycans, in a vast number of health- and disease-associated biological communication 
processes has been further substantiated and many new connections have been discovered. One 
can even consider them a companion to nucleic acids and proteins as key players in the storage 
and transfer of information in virtually all organisms. In stark contrast to these established ‘central 
dogma’ biomolecules, however, stands our understanding of the relationship between glycan 
molecular structure and their biology activity. The reason we are still almost literally in the dark is 
that studying glycans poses unique challenges when compared with proteins and nucleotides, related 
to their highly complex, often branched structures. An additional challenge is that the assembly 
of glycans – their structure – is not template-driven (encoded in genes), and instead occurs via 
complex and dynamic processing and trimming of the glycan chain under the action of a series of 
competitive glycosyltransferase and glycosidase enzymes. The study of how glycans are assembled 
by glycosyltransferases, catabolised by glycosidases, recognised by lectins, and how or when taken 
together this enables the dynamic storage and transfer of information via their molecular structure is 
therefore at the frontier of science. The field that uses a chemistry-based approach to answers these 
largely unanswered questions about glycobiology has been coined ‘Chemical Glycobiology’. The 15 
years that have passed since it was first defined as such by Bertozzi have seen it blossoming and many 
excellent reviews cover all these advances.2-4 
The current review focusses on a chemical glycobiology strategy that uses the glycan salvage pathways 
that most organisms possess. These pathways allow a cell to convert monosaccharides, liberated 
from complex glycans or originating from the extracellular space, into their nucleotide-activated 
counterparts that are substrates for glycosyltransferases located in the endoplasmic reticulum and 
Golgi apparatus. This eventually results in the monosaccharide becoming part of complex cellular 
Figure 1. Schematic overview of metabolic oligosaccharide engineering.
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glycan structures, e.g. N-glycans and O-glycans on proteins and glycolipids (Figure 1). In the 1990’s it 
was discovered that the enzymes that participate in these glycan salvage pathways sometimes allow for 
unnatural modifications in the structure of their monosaccharide-based substrate.5, 6 This enabled the 
design of tailor-made monosaccharide-based chemical probes that are labelled with a small unnatural 
chemical handle that can be addressed after incorporation under specific conditions at a predefined 
moment. Processing of these probes via the glycan salvage pathways allows for direct profiling of 
cellular glycans. This technique is nowadays often called metabolic oligosaccharide engineering (MOE) 
and it complements other approaches to profile cellular glycans, like tracing incorporation of isotope 
(radio)labeled glycans, indirect profiling using (chemical) lectins or direct chemical tagging of native 
glycans, e.g. the use of sodium periodate-mediated generation of taggable aldehydes from neuraminic 
acid. For a comprehensive overview of all the applications developed thus far with MOE we direct the 
reader to various recent reviews.7-18 This review focusses on another integral part of MOE, namely 
the fact that all chemical probes evaluated for MOE have to be designed and synthesised. We here 
provide an up-to-date comprehensive overview of the current toolbox of chemical probe structures 
implemented in MOE, i.e. the chemical handles employed to enable (bioorthogonal) bioconjugation 
reactions for profiling labeled glycans. We illustrate their use with selected recent examples of 
applications in various organisms. Additionally we provide a selected overview of various synthetic 
routes that are nowadays used to obtain these probes. The review finishes with an outlook that 
highlights some recent and prospective advances in the application of MOE.
2. Historical overview of MOE and bioconjugation reactions
Key to the success of any metabolic oligosaccharide engineering approach is the ability of the labelled 
glycans to be selectively tagged after incorporation via a bioconjugation reaction. The requirements 
for bioconjugate reactions suitable for use with MOE are largely known, such as compatibility 
with complex biological mixtures, stability of the bioconjugate, high reaction rates, and ideally no 
interference with native biochemical processes (known as bio-orthogonality).17 Many of the currently 
available bioconjugation reactions have already been applied in MOE (see Table 1), and many efforts to 
further extend and improve the application and capabilities of bioconjugation reactions are ongoing. 
In this section we limit ourselves to a brief summary; the development, reaction kinetics, and general 
handling of these reactions are highlighted in several recent reviews.13, 16, 17, 19-21 
Among the first bioconjugation reactions to be applied for MOE were aldehyde/ketone condensation 
reactions with hydrazides and aminooxy groups to give hydrazones and oximes, respectively (Figure 
2).22 With the discovery of azide and alkyne conjugations, the field of metabolic labelling exploded.23 
Azides are reduced under Staudinger conditions and trapped intramolecularly with a biocompatible 
phosphine reagent as discovered by the Bertozzi group.23 In addition, azides are easily used in the 
Copper-catalysed Azide Alkyne Cycloaddition (CuAAC) reaction.24 In the presence of copper(I) ions, azide 
and alkyne substrates react rapidly to form stable triazoles. This hallmark reaction in click chemistry is 
nowadays still the most used technique. In order to exclude toxic copper from biological systems two 
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methods were developed. The first method uses amine-triazole based ligands to accelerate the CuAAC 
reaction and limit the required amount of copper, while the other method uses strained alkynes to 
improve the reaction kinetics in a copper-free manner.7 The use of strained alkynes in biological 
systems is known as the Strain-Promoted Azide Alkyne Cycloaddition (SPAAC) reaction.25 Despite the 
exclusion of copper, the SPAAC reaction is not always superior over the CuAAC reaction, since some 
strained alkyne reagents are known to have a higher background labelling due to side reactions with 
cellular thiols.26 Several recent advances in the field have introduced photoactivation to provide spatial 
and temporal control in bioconjugation reactions. The Boons laboratory introduced a photochemically 
triggered SPAAC click reaction with a dibenzocyclooctyne derivative.27 A photocontrolled version of 
the Staudinger-Bertozzi ligation has also been reported and successfully applied in living organisms 
such as zebrafish.28 A recent reinvestigation of the photo-induced 1,3-dipolar cycloaddition between 
an alkene and tetrazole has questioned its bio-orthogonality and alkene selectivity of the reactive 
intermediate nitrile imine.29 This bioconjugation reaction has to the best of our knowledge not yet 
been applied in MOE. 
32
Figure 2. Timeline of the history of metabolic oligosaccharide engineering probes.
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Table 1. Overview of bioconjugation reactions.
Name Reactant 1 Reactant 2 Remarks Average reaction 
rate30
REF
Staudinger-
Bertozzi ligation
azide phosphine phospazene trapped 
intramolecularly as amide
k ~10-3 M-1 s-1 23
CuAAC alkyne azide Cu-catalysed with ascorbic acid 
Cu(I)-regeneration
k ~10-200 M-1 s-1 31, 32
SPAAC strained alkyne azide Ring strain is driving force of 
the reaction
k ~10-2-1 M-1 s-1 25
Hydrazide ketone 
ligation
ketone hydrazide product is hydrazone k ~10-3 M-1 s-1 5, 6
Oxime ligation ketone amino-oxy product is oxime unknown 33
invDA (strained/ 
terminal) alkene
tetrazine dihydropyrazine product k ~1-104 M-1 s-1 34
1,3-dipolar 
cycloaddition
(strained/ 
terminal) alkene
nitrile imine nitrile imines are formed in situ 
after UV activation of tetrazoles
k ~890 M-1 s-1 35
Photo-activated 
1,3-cycloaddition
terminal alkene tetrazole product is pyrazole k ~4.41 ± 0.34 × 
10-2 M-1 s-1
27
Photo-activated 
diazirines
diazirine UV activation needed unknown 36
Isonitrile ligation isonitrile tetrazine stable product for tertiary 
isonitrile
k ~57.5 ± 1.5 × 10-2 
M-1 s-1
37
Hetero Diels Alder vinyl sulfide diol product is thioacetal k ~1.5 ± 0.1 × 10-3 
M-1 s-1
38
Diazo ligation diazo strained alkyne product is pyrazole k ~0.04 M-1 s-1 39
SPOQC strained alkyne quinone among fastest known 
bioconjugation reactions
k ~496 ± 70 M-1 s-1 40
SPANC alkyne nitrone k ~39 M-1 s-1 41
Other photochemical activation reactions have also been used in combination with MOE. 
Photoactivation by UV irradiation of aryl azides, diazirines, and benzophenone results in the formation 
of reactive nitrene, carbene and radical intermediates, respectively, that react with almost any 
structure in close proximity, even aliphatic C-H bonds.42 These photo-active probes can be taken up by 
the cell without significant toxic effects; however, UV irradiation can of course damage the cells. The 
generated reactive intermediate will react with proteins in the near vicinity of the labelled glycan, and 
thereby provide fruitful insights in protein-glycan interactions in biological pathways.
A recently discovered bioconjugation reaction is the inverse electron demand Diels Alder reaction 
(invDA).34, 43 The reaction is fast and irreversible, and most tetrazines are easy to make and stable in 
aqueous media. For MOE, the dienophile can be a terminal alkene, cyclopropene, diazo, or isonitrile 
moiety. The invDA reactions are superior over the CuAAC or SPAAC reaction in terms of reaction kinetics 
and biocompatibility. A photoactivatable tetrazine for use in invDA was recently reported by Fox and 
co-workers.44 Dihydrotetrazines were oxidised to tetrazines upon irradiation by red light (660 nm) in 
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the presence of methylene blue. Upon addition of strained alkenes (e.g. trans-cyclooctene (TCO)), 
the generated tetrazine reacts rapidly with these. The same dihydrotetrazine precursors could also be 
chemo-enzymatically activated using a peroxidase. Beside the three main classes of bioconjugation, 
azide-alkyne, tetrazine invDA ligation and photo-chemical activation, other methods are also being 
explored for use in MOE, but not widely applied. Several recent developments are discussed in the 
outlook.
3. Overview of chemical probes their applications and tagging-mechanism
The tagging of labelled glycans after a MOE experiment can be performed with a wide variety of different 
chemical handles. Azides, alkynes, and cyclopropenes are among the most popular nowadays. Other 
frequently used chemical handles are diazirines, diazo, isonitriles, thiols, and nitrones. The chemical 
synthesis of these chemical handles varies from basic amide couplings to more complex synthetic 
strategies. In most routes the endpoint of the chemical synthesis is a fully acetylated monosaccharide-
based chemical probe. The overall modus operandi of MOE is that acetylated monosaccharide-based 
chemical probes are fed to target cells or an organism, as the acetyl esters facilitate the passive uptake 
of the probe.5, 6 An additional beneficial result of acetylated probes is the easier purification thereof 
by standard procedures such as flash column chromatography. Once inside the cell, the acetyl groups 
are hydrolysed by nonspecific cytosolic esterases and the probe is processed by the glycan salvage 
pathway and transformed into nucleotide-activated donor substrates for glycosyltransferase enzymes 
in the glycosylation pathways. These glycosylation pathways take place in the endoplasmic reticulum 
and Golgi apparatus of the cell. There, the labelled-donors are incorporated into the many complex 
cellular glycan structures, e.g. N-glycans and O-glycans on proteins and glycolipids. Finally, the small 
chemical handle can be addressed to directly profile the targeted monosaccharide in the cells complex 
glycans. 
Since its inception in 1997 an extensive toolbox of chemical probes has been developed for use in 
MOE. Table 2 provides a comprehensive overview of the glycan-based chemical probes that have thus 
far been used in MOE and tested in a variety of organisms from mammalian cell lines to zebrafish 
and bacteria, and more recently also in plants. The table is organised per glycan and functional 
group. In general, the ManNAc, GlcNAc, and GalNAc salvage pathways are most tolerant towards 
unnatural glycans with small or sometimes even substantial chemical handles, as can be seen by their 
overwhelming presence in Table 2. Especially acyl substituents on the 2-position of these 2-deoxy 
amino glycans are well tolerated. In early work by the Bertozzi group, 2-deoxy 2-azido glycans were 
found to be either toxic or not converted to cell-surface glycans, indicating that the N-acyl group itself 
is essential for enzymatic recognition and conversion of ManNAc analogues.45 The overview of Table 2 
is followed by sections, subdivided on the basis of the chemical handles in these probes, that discuss 
their development, mode of action and selected applications.
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Table 2. Overview of glycan-based chemical probes for metabolic oligosaccharide engineering.
Label N-acetylmannosamine REF N-acetylglucosamine REF N-acetylgalactosamine REF
Natural 
glycans
ManNAc
R1= CH3
R2= O
R3= H
6 GlcNAc
R1= CH3
R2= H
4 GalNAc
R1= CH3
R2= H
6
Aliphatic 
analogues
ManNPro
R1= CH2CH3
R2= O
R3= H
6 GlcNPro
R1= CH2CH3
R2= H
6 GalNPro
R1= CH2CH3
R2= H
6
Ketones ManNLev
R1= (CH2)2COCH3
R2= O
R3= H
22 GlcNLev
R1= (CH2)2COCH3
R2= H
22 GalNLev
R1= (CH2)2COCH3
R2= H
22
Azides Ac4ManNAz 
R1= CH2N3
R2= O
R3= Ac
23 Ac4GlcNAz
R1= CH2N3
R2= Ac
23 Ac4GalNAz
R1= CH2N3
R2= Ac
23
ManNAz 
R1= CH2N3
R2= O
R3= H
23 GlcNAz
R1= CH2N3
R2= H
23 GalNAz
R1= CH2N3
R2= H
23
1,3,4-O-Bu3ManNAz
R1= CH2N3
R2= R3= Bu
46
Ac4ManN2Azaryl
R1= CH2PhN3
R2= O
R3= Ac
47
Ac3-4-Az-ManNAc
R1= OAc
R2= Ac
R3= N3
48
Alkynes Ac4ManNAlk
R1= (CH2)2C≡CH
R2= O
R3= Ac
49, 50 Ac4GlcNAlk
R1= (CH2)2C≡CH
R2= Ac
51 Ac4GalNAlk
R1= (CH2)2C≡CH
R2= Ac
52
Ac4ManPoc
R1= OCH2C≡CH
R2=O
R3= Ac
53 Ac4GlcPoc
R1= OCH2C≡CH
R2= Ac
53 Ac4GalPoc
R1= OCH2C≡CH
R2= Ac
53
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Thiols Ac4ManNTGc
R1= CH2SAc
R2= O
R3= Ac
54 Ac4GlcNTGc
R1= CH2SAc
R2= Ac
54 Ac4GalNTGc
R1= CH2SAc
R2= Ac
54
Cyclopro
pene
Ac4ManNCyc
R1=  
R2= O
R3= Ac
55
Ac4ManNCyoc
R1=  
R2= O
R3= Ac
56 Ac4GlcNCyoc 
R1=  
R2= Ac
57 Ac4GalNCyoc
R1=  
R2= Ac
57
Terminal 
alkenes
Ac4ManNPtl
R1= (CH2)2 –CH=CH2
R2= O
R3= Ac
58
Ac4ManNHxl
R1= (CH2)3 –CH=CH2
R2= O
R3= Ac
58
Ac4ManNAloc
R1= OCH2–CH=CH2
R2= O
R3= Ac
59 Ac4GlcNAloc
R1= OCH2–CH=CH2
R2= Ac
59
Ac4ManNBeoc
R1= O(CH2)2–CH=CH2
R2= O
R3= Ac
59 Ac4GlcNBeoc
R1= O(CH2)2–CH=CH2
R2= Ac
59
Ac4ManNPeoc
R1= O(CH2)3–CH=CH2
R2= O
R3= Ac
59 Ac4GlcNPeoc
R1= O(CH2)3–CH=CH2
R2= Ac
59
Ac4ManNHeoc
R1= O(CH2)4–CH=CH2
R2= O
R3= Ac
59, 60 Ac4GlcNHeoc
R1= O(CH2)4–CH=CH2
R2= Ac
58, 59
Diazirines Ac4ManNDAz(3Me)
R1= (CH2)3-1-methyl 
diazirinyl
R2= O
R3= Ac
61 Ac4GlcNDAz(3Me)
R1= (CH2)3-1-methyldiazirinyl
R2= Ac
61 Ac4GalNDAz(2Me)
R1= (CH2)2-1-methyl 
diazirinyl
R2= Ac
62
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Ac4ManNDAz(4Me)
R1= (CH2)4-1-methyl 
diazirinyl
R2= O 
R3= Ac
61 Ac4GlcNDAz(4Me)
R1= (CH2)4-1-methyldiazirinyl
R2= Ac
61
Isonitrile Ac4ManN-n-Iso
R1= (CH2)2 –N≡C
R2= O 
R3= Ac
63 Ac4GlcN-n-Iso
R1= (CH2)2 –N≡C
R2= Ac
63 Ac4GalN-n-Iso
R1= (CH2)2 –N≡C
R2= Ac
63
Ac4ManN-t-Iso
R1= C(CH3)2CH2–N ≡ C
R2= O
R3= Ac
63 Ac4GlcN-t-Iso
R1= C(CH3)2CH2–N≡C
R2= Ac
63 Ac4GalN-t-Iso
R1= C(CH3)2CH2–N≡C
R2= Ac
63
Diazo-
ketones
Ac4ManDiaz
R1= CHN2
R2= O
R3= Ac
52 Ac4GalDiaz
R1= CHN2
R2= Ac
39
Nor
bornene
Ac4ManNNorbocexo
R1=  
R2= Ac
Ac4ManNNorbocendo
R1=  
R2= Ac
114
Sialic acid Fucose KDO
Neu5Hex
R1= (CH2)3C≡CH
R2= OH
64 FucAl or 6-alkynyl Ac
4
fucose
R1= C≡CH
R2= Ac
R3= Ac
65 9Al-KDO
R1= C≡CH
66
SiaNAl
R1= (CH2)2C≡CH
R2= OH 
67 KDO-alkyne
R1= O(CH2)2C≡CH
68
SiaNProc
R1= OCH2C≡CH
R2= OH
69 Ac
4
FucAz
R1= CH2N3
R2=R3= OAc
70 KDO-N3
R1= N3
66
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9-Cp-NeuAc
R1= CH3
R2=  
67 FucAz
R1= CH2N3
R2= GDP
R3= H
70, 72 KDO-HMMPO
R1=  
68
9BA-Neu5Ac
R1= OH
R2= NHCH2COC6H4COH
73
Xylose Miscellaneous Two functionalities
              Hydrazone
74
             9Al-KDO
75
UDP-2-XylAz
R1= UDP
R2= N3
R3= OAc
R4= OAc
76
6Az-2,4-diaceta-
mido2,4,6-trideoxy-d-man-
nopyranose
77
              9AzSiaDAz
75
UDP-3-XylAz
R1= UDP
R2= OH
R3= N3
R4= OH
76
     1-deoxy-Ac3GlcNAlk
51
UDP-3-XylAz
R1= UDP
R2= OH
R3= OH
R4= N3
76
         6Az-Ac3ManNAc
45
Trehalose Glucose
6dAG
78
2-TreAz: R1= N3; R2= OH; R3= 
OH; R4= OH
79 Arabinose
3-TreAz: R1= OH; R2= N3; R3= 
OH; R4= OH
79
Ac3ArabAz
156
4-TreAz: R1= OH; R2= OH; 
R3= N3; R4= OH
79
6-TreAz: R1= OH; R2= OH; 
R3= OH; R4= N3
79
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3.1 Azides
MOE with azido-labelled glycans is still the most widely adopted variant, and is used in a broad range 
of applications. Azido-containing MOE probes have been successfully used for metabolic labelling in 
various organisms and tissues, such as pancreatic cells46, 80, mice81, and primary hippocampus neuron 
cells.82 Several recent reviews can be found that specifically cover this topic.17, 83, 84 Perhaps their most 
famous application, the labelling of neuraminic acid in complex glycans, is covered in these reviews. 
This section focusses on their recent application in glycan labelling in C. elegans, zebrafish, bacteria, 
and plants.
Currently, all azido probes are O-acetylated when used in MOE. Despite this being the current standard 
method, investigating other esters or groups to mask the probe and facilitate uptake by the target 
organism or cell might be a way to further optimise MOE. Yarema et al. have shown that O-butyrated 
probes are also successfully taken up and recognised by the cellular metabolic machinery.86 Since 
the early discovery that azido-acyl groups on amino sugars are well tolerated and recognised by the 
enzymatic machinery in organisms, no further changes have been made to this golden standard 
chemical handle. The tolerance for bigger chemical handles such as cyclopropenes and diazirine 
suggests that the design of the azido acetyl groups might still be further explored. 
C. elegans: The efficiency of metabolic incorporation of azidosugars in C. elegans was initially 
unknown. Therefore, Bertozzi and co-workers first determined the ability for metabolic incorporation 
of Ac
4
ManNAz, Ac
4
GalNAz, and Ac
4
GlcNAz into C. elegans glycans and glycoconjugates.87 This revealed 
that C. elegans is unable to incorporate Ac
4
ManNAz and Ac
4
GlcNAz, but labelling with Ac
4
GalNAz 
worked. The azido-glycans were first incubated in E. coli and the bacteria were afterwards consumed 
by C. elegans. It is therefore unknown whether C. elegans can actually take up these azido-glycans 
itself or if E. coli metabolises them and C. elegans obtains them by metabolism of E. coli glycans. It 
should also be noted that MOE in E. coli with Ac
4
GalNAz or Ac
4
GlcNAz has never been reported, while 
it has been reported for other Gram-negative bacteria.88, 89 Recently, labelling of glyconconjugates 
using Ac
4
GlcNAz was also observed in primary embryonic C. elegans cells.90 
Zebrafish: The zebrafish is an excellent organism to study O-glycosylation and N-glycosylation with 
MOE and the fact that it is a transparent organism makes fluorescent imaging easier. The research of 
MOE in zebrafish started in the group of Bertozzi in 2008.91 Ac
4
GalNAz was the only studied substrate 
and showed incorporation in O-glycans at concentrations higher than 25 µM, as was visualised with 
DIFO-488. Sialylated glycans were studied in developing zebrafish using Ac
4
ManNAz. Here MOE clearly 
proved superior over the previous performed work on sialylated glycans using aldehyde ligation 
techniques by Baskin et al.92
In later studies fucosylation was studied in developing zebrafish. The fucose salvage pathway is 
active in zebrafish embryos, but efficient processing of azide-modified fucose was poor. Azido-fucose 
labelling strategies in zebrafish are therefore limited to fucosylated glycoproteins active during the 
development. In addition, it has been reported that in certain cases azido-fucose can be toxic for 
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mammalian cells.49, 93 For this reason, the use of alkynyl-fucose analogues in mammalian cell lines has 
since been the preferred approach. 
Bacteria: Glycans are important for the viability of bacteria and almost all bacteria require glycans 
as a carbon source for growth. A wide variety of glycans is exclusively found in microbes, and the 
uniqueness of these bacterial glycans makes them ideal targets for the development of new antibiotics 
that interfere with the bacterial metabolism.94 For this reason, metabolic labelling of bacterial 
glycans is a rapidly growing field of research. Both pathogenic bacteria - like Haemophilus ducreyi,95 
Campylobacter jejuni,96 and Helicobacter pylori - and non-pathogenic bacteria - like Escherichia coli 
MG1655,66 and Bacteroides fragilis,89, 97 have been successfully labelled in this way.
In bacteria, probe incorporation and competing probe degradation via catabolic processes can also 
play an important role and is highly dependent on the type of bacteria. Rather high concentrations of 
azido-glycans are usually added in MOE experiments with bacteria, compared to other organisms or 
cell lines, to compensate for this factor. These rather high concentrations have, however, not shown 
significant toxicity in bacteria. Even the copper used for the CuAAC reaction, which is toxic for most 
organisms, is better tolerated by bacteria. If needed, a biocompatible CuAAC reagent, e.g. the triazole 
ligand BTTAA, can be used to further reduce copper toxicity as shown by Wu and co-workers.97 Since 
many SPAAC reagents have become commercially available (e.g. BCN-rhodamine), both SPAAC and 
CuAAC have been successfully applied in MOE on bacteria. The wide variety of non-common glycans 
present in bacteria requires extensive and complex synthetic routes to systematically generate the 
probes needed to label specific rare microbial glycans. Several synthetic strategies to these unique 
bacterial glycans have, however, been reported, and a selection thereof is detailed in the next 
section.96, 98-103 One interesting example is the metabolic incorporation of azido-Pseudaminic acid (Az-
Pse), a bacterial glycan belonging to the class of sialic acids.96 Mutant C. jejuni cells deficient in Pse 
pathway were fed with the azido-Pse precursor, 6-deoxy-AltdiNAz. This resulted in the decoration of 
the bacterial flagella with azido-Pse. The presence of azido-Pse on the flagella restored the motility 
of C. jejuni. Subsequently, the azido-glycan was visualised using biotin-Staudinger reagent and later 
visualised using streptavidin which was separated on SDS-PAGE. The single labelling in whole-cell 
flagellin lysates, as shown by SDS-PAGE, indicates that flagellin proteins are the only cell-surface-
associated proteins that are glycosylated with Pse. The study of these bacterial glycans is therefore of 
interest as a potential new antibiotic target.
Another Gram-negative bacterium which has been evaluated with MOE, using Ac
4
GlcNAz and GlcNAz, 
is H. pylori. Both azido-glycans were tested to check the need for O-acetylation, to investigate the 
presently still unknown mechanism of uptake by bacteria, and to probe for the presence of esterase 
activity inside the bacteria. The per-acetylated GlcNAz was easily incorporated into N-glycans of H. 
pylori104, but incorporation in O-linked glycans was not seen. Furthermore, the non-acetylated GlcNAz 
was not metabolically consumed and installed on cell surface glycoconjugates. Recently, an extensive 
study with a panel of azido-glycans was recently performed by Kasper and co-workers on human-gut 
related pathogenic and non-pathogenic bacteria in Gram-negative and Gram-positive bacteria.89 Prior 
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to this work, Seibel and co-workers looked into MOE of S. aureus with GlcNAz.105
As mentioned, many bacteria use microbe-specific glyans to construct their cell wall, and the 
disaccharide trehalose is such a glycan. Bertozzi and co-workers introduced an azide on this 
disaccharide for metabolic labelling in mycobacteria, a class of bacteria that includes the pathogen 
Mycobacterium tuberculosis.79 Four different trehalose-azide analogues were synthesised to study 
a recycling process that might be conserved across mycobacterial species. All four trehalose-azide 
analogues showed labelling in a variety of mycobacteria. In a next step this method can therefore be 
used to study glycolipid distribution, trafficking, and dynamics of trehalose biosynthesis, which in turn 
might provide clues on how to target these bacteria with new classes of antibiotics. 
Another relevant microbe-specific glycan is 3-deoxy-d-manno-octulosonic acid (KDO), an essential 
and characteristic part of lipopolysaccharides in Gram-negative bacteria.106 To characterise Gram-
negative bacteria, metabolic labelling with KDO-based probes is thus highly relevant. Vauzeilles and 
co-workers synthesised a 9Az-KDO glycan (see table 2), and incubated this together with several 
classes of bacteria.66 Successful labelling was achieved in E. coli K12, E. coli O86, S. Thyphimurium, and 
L. pneumophilia. 
Azido-glycans in combination with MOE are proving to be a valuable tool to label glycans in many 
types of bacteria. Increasing our insight into bacterial glycobiology through among other MOE and 
finding ways to perturb bacterial glycans in pathogenic bacteria will hopefully provide new leads for 
the development of much needed next-generation antibiotics.
Plants: Metabolic oligosaccharide engineering is relatively new to plant sciences. The first 
implementation of MOE in plants was reported in 2012 by Somerville and co-workers.65 They 
successfully incorporated FucAl into Arabidopsis thaliana and subsequent CuAAC labelling allowed 
fluorescence imaging of fucosylated glycans in the cell wall. Imaging indicated that the fucose-alkyne 
containing glycans were initially incorporated to locations on the cell surface that are likely involved 
in exocytic vesicle fusion. Recently, azido-KDO was metabolically incorporated into the RG-II glycan of 
the pectin-rich cell wall of A. thaliana and Nicotiana tabacum.107 Successful labelling via CuAAC ligation 
with Alexa Fluor® 488-alkyne was observed. Dual labelling using Fuc-Al and KDO-N3 was performed 
by taking advantage of the two bio-orthogonal reactions. This allowed simultaneous imaging of Fuc-Al 
in RG-I and KDO-N3 in RG-II. Chen and coworkers have reported on the metabolic incorporation and 
imaging of N-linked glycans in A. thaliana with Ac
4
GlcNAz.108 Through MOE and direct fluorescent 
imaging of N-glycans they showed that protein N-glycosylation in A. thaliana root tissue possess 
distinct patterns of distribution in the various developmental zones.108 We recently also reported on 
imaging of plant glycans in A. thaliana with both Ac
4
GlcNAz and GlcNAz, the latter probably via active 
uptake. In our study we observed that A. thaliana can interestingly also metabolically incorporate 
Ac
4
GalNAz, probably via an as of yet unidentified enzymatic GalNAc to GlcNAc epimerase activity. We 
also observed successfull MOE in A. thaliana with Ac
4
FucAz and the novel l-arabinofuranose probe, 
Ac3ArabAz. Finally we also demonstrated the succesfull application of strain-promoted azide-alkyne 
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cycloaddition (SPAAC) and inverse electron demand Diels-Alder (invDA) click reactions to allow for 
improved imaging of MOE in live plants.156
3.2 Alkynes
Alkynes were among the first handles used in metabolic oligosaccharide engineering. The virtual 
absence of alkynes in nature, their relative small size, their fast reactivity with azides under CuAAC 
conditions, and their stability makes them very suitable for metabolic labelling. An alkyne derivative 
of N-acetylmannosamine (25 µM) and 6-alkynyl Ac
4
fucose (200 µM) were tested in Jurkat cells back 
in 2007 by Chi-Huey Wong and co-workers.49 In mammals, N-acetylmannosamine is the precursor for 
the sialic acid, N-acetylneuraminic acid (Neu5Ac), and the alkynylated probe versions therefore result 
in alkynylated sialic acids on glycoconjugates. The fucose alkyne was able to label fucosylated glycans 
in vivo.
A more advanced study that compared Ac
4
ManNAl with Ac
4
ManNAz in six different cell lines at a 
concentration of 50 µM was reported by Bertozzi et al. in 2009.109 In all six cell lines metabolic labelling 
of Neu5Ac in glycans with the alkynyl-glycans was more efficient than with the azido-glycans. In a next 
step, in vivo analysis of the alkynyl glycan incorporation in mice showed that after a daily injection of 
Ac
4
ManNAl for seven days, organs were harvested to show metabolic labelling in all tissues.
MOE in bacteria with alkyne glycans has been performed in the Gram-negative class bacteroides. MOE 
was achieved with alkyne-fucose analogues in Bacteroides fragilis and Parabacteroides distasonis. A 
wide variety of glycoproteins proved enriched with alkyne-fucose analogues.97 However, the rising 
popularity of the SPAAC reaction has made the alkynyl glycans that require the generally toxic copper 
for CuAAC less popular for metabolic labelling. This trend is despite the discovery of bio-compatible 
copper reagents. The advantage of these reagents is the reduced amount of free Cu(I) ions which is 
beneficial for labelling in living organisms.110 
McClosky et al. have developed a 6-deoxy-alkynyl glucose analogue for metabolic glucose labelling 
experiments in A. thaliana roots.78 They based their choice for the alkyne handle on the unreported 
assumption that azido analogues of fucose are less well incorporated in the cell wall of plants, compared 
to their alkyne analogues. Acetylated 6-deoxy-alkynyl glucose successfully labelled glycans in A. 
thaliana roots. Other relevant alkynyl-functionalised analogues of glucose, rhamnose, mannose, and 
sucrose were also tested, but did not show any incorporation. Whether 6-deoxy-alkynyl glucose was 
selectively incorporated in the cell wall or also in other cellular components was not yet investigated, 
but would of course be highly interesting. These initial examples of the application of MOE in plants 
highlights the potential for the further development of this technique to study glycobiology in plants.
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3.3 Cyclopropenes, norbornenes, and alkenes
Alkene-functionalised glycans have also been successfully used for MOE. The loss in reaction speed 
for alkene-tetrazine conjugation compared to CuAAC conjugation is compensated by the stability and 
easy synthesis of alkene carbohydrates. Wittmann and co-workers synthesised a variety of alkene-
equiped N-acetylmannosamine analogues.58 The length of the linker did not influence the successful 
labelling in HEK293T and Hela cells.58 In later studies, the length of the linker going from ManNAloc 
to ManHeoc showed an increase in second-order rate constant for the invDA with tetrazines.59 New 
possibilities in MOE emerged with the advent of strained alkenes (or alkynes) that react extremely 
fast under physiological conditions via an inverse electron demand Diels-Alder reaction (invDA). Early 
investigations with trans-cyclooctene (TCO) and bicyclononyne (BCN) showed the potential of this new 
ligation technique in cellular environments.111 
Cyclopropenes are strained alkenes that are ideal for MOE with respect to their bio-orthogonal 
reactivity, and small size (similar to diazirines). Obtaining sufficient stability is essential for the reactive 
cyclopropenes probes, as it is known that they are prone to polymerisation, and can be reactive 
towards thiols and other nucleophiles present in cells.112 Substituents on the cyclopropene ring, such 
as a methyl, showed a big improvement in stability, while retaining their reactivity.71, 111 A few years 
later a carbamate linker instead of an amide linker to the glycan further improved the stability and 
reactivity.57, 113 The groups of Devaraj and Prescher worked independently on cyclopropene-linked 
glycan analogues for MOE.55, 71, 111 After Devaraj proved the biocompatibility of cyclopropenes in 
phospholipid labelling, the Prescher group showed the first application of MOE with a cyclopropene-
linked sialic acid analogue (9-Cp-Neu5Ac).71, 111 Flow cytometry analysis with different concentrations 
of the probe showed efficient metabolic incorporation, although the optimum was found at the 
relative high concentration of 1 mM. In a second step, the compatibility during dual labeling with 
an azido sialic acid probe was tested. Both cyclopropene and azido sialic acids were added to Jurkat 
cells and incubated for 24 hours. Successful labelling with corresponding fluorescent dyes showed the 
orthogonality of tetrazine click with cyclopropene glycans and the SPAAC click with azido glycans. In 
subsequent years, the groups of Devaraj, Prescher, and Wittmann have reported even more successful 
examples of cyclopropenes glycans.55, 57, 113 The utilised concentrations nowadays vary between 10-100 
µM. The independent investigations of cyclopropene glycans resulted in different names for the same 
glycan analogues. Two distinct classes, the amide-linked cyclopropenes and the carbamate-linked 
cyclopropenes have been developed. The amide-linked cyclopropenes are known as NMCp or NCyc for 
the 3-methylated cyclopropene glycan; the carbamate-linked cyclopropenes are named NCyoc or CCp.
In recent years, the effect of either an amide or carbamate linker between the glycan and 
cyclopropene moiety has been investigated. Different probes based on glucosamine, galactosamine, 
and mannosamine with the different linkers have been synthesised and tested in various cell lines. 
Prescher et al. took a closer look at the effect of the carbamate linker in comparison to the amide 
linker for mannose-based chemical probes.57 The invDA-reactions are approx. 100 times faster with 
carbamates at C-3 compared to their amide derivative. A clear 130-fold increase in fluorescence signal 
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was obtained by flow cytometry when the two linkers were directly compared. The disappearance of 
fluorescence output after addition of the natural N-acetylmannosamine substrate suggested that the 
cyclopropene-ManNAc used the sialic acid biosynthetic pathway.
Cyclopropene-labelled glycans are attractive probes for use in MOE. They display fast enough 
reaction kinetics, short syntheses for their preparation and different variants (amide and carbamate 
scaffolds) are available. Over the last years, the relative high concentration of tetrazine counterpart 
needed for post incorporation tagging has also been reduced and is now in the range of 50-100 µM, 
further enhancing the potential of this method.56 Another alkene variant was recently reported by 
Wittmann and co-workers.114 Norbornene-modified mannosamine derivatives were used for MOE and 
successfully applied in HEK 293T cells. Exo and endo norbornene-modified mannosamine derivatives 
were made. The reaction kinetics of exo norbornene mannosamine proved faster than those of the 
endo norbornene mannosamine when reacted in an invDA reaction with a tetrazine.
3.4 Diazirine 
Diazirines are small highly strained heterocycles. The metabolic labelling step is followed by UV 
activated crosslinking of the incorporated diazirine with nearby biomolecules. When the cell is 
irradiated at a 254-400 nm wavelength N2 will be expelled leaving a highly reactive carbene on the 
chemical handle attached to the glycan, which will react very rapidly with a wide variety of different 
functional groups inside or on the outside of the cell. The advantage of this photo-crosslinking is that 
it can be initiated in intact cells. Furthermore, various processes surface-glycans participate in can be 
studied (e.g. sialidases activity or lectin interactions). The use of photo-crosslinking is not limited to 
cell-surface glycans but has of course also successfully applied to other biomolecules.42 A disadvantage 
of diazirines as chemical handles in probes is their lack of selectivity. Once the carbene is generated it 
will react with everything in close proximity.
Before diazirines were explored as metabolic labelling functionalities Paulson et al. reported in 2005 the 
use of aryl azides on Neu5Ac (known as 9-AAz-NeuAc) as a labelling agent for cell-surface glycoproteins 
or glycolipids.115 A benefit of aryl azides is the possibility of using the Staudinger-Bertozzi ligation as an 
extra option to address the labelled glycans. Both tagging methods proved successful in labelling cell 
surface glycans. The use of diazirines in MOE was developed further by the group of Kohler.42 Different 
types of glucosamine, mannosamine, and galactosamine N-acyl-diazirine derivatives were synthesised 
and tested in a wide variety of cell types. The effect of N-acyl chain length of diazirines on MOE was 
investigated by Kohler and co-workers in 2011.61 Diazirine-modified N-acetylmannosamine analogues 
with 2, 3 or 4 methylene groups in between the N-acyl chain and diazirine were synthesised and tested 
in BJA-B, Daudi, and Jurkat cells. All probes were incorporated on sialylated glycoprotein or sialylated 
glycolipids to some extent. It was, however, clearly seen that the short linker (2CH3) was incorporated 
most efficiently, and this resulted in effective cross-linking after photo-irradiation.
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A combination of the Staudinger-Bertozzi ligation and UV irradiation was performed by Jewett and 
co-workers.62 They developed a reagent that uses the traceless Staudinger-Bertozzi ligation to convert 
azides on glycans into an acyl-diazirines handle (Scheme 1). The method has not yet been tested on 
azido-glycans inside cells yet, but it looks promising.
3.5 Isonitrile group
Isonitriles, also known as isocyanides, are overall neutral molecules that can undergo a [4+1] 
cycloaddition with tetrazines or strained alkenes. Although isonitriles have been found in some 
natural products, they are only weak nucleophiles and show excellent stability in biological systems.116 
Hence, isonitriles do not react with common electrophiles like ketones, aldehydes or imines. Although 
isonitrile-containing probes themselves are stable, their imine-containing products after a [4+1] 
cycloaddition can decompose over time (Scheme 2). Inside cells, cycloaddition products of primary 
or secondary isonitriles are easily hydrolysed into amines. Products from tertiary isonitriles are more 
stable but bigger and therefore harder to incorporate into glycoconjugates. Primary isonitriles with 
an additional methylene group tautomerise after the click to a more stable α,β-unsaturated imine. 
Primary isonitrile-containing glycans were used at high concentration (200 µM) to test for toxicity, but 
none was observed.37
After initial experiments with isonitrile labelling on proteins proved successful, the Leeper group 
recently showed the potential of isonitriles as new metabolic oligosaccharide probes for the in 
vitro labelling of mammalian cells.37, 63 Three different probes based on N-acylated mannosamine, 
galactosamine, and glucosamine were synthesised and successfully tested on Lewis lung carcinoma 
cells. A two-step labelling method with tetrazine–biotin followed by neutravidin-DyLight680 provided 
the best signal to noise ratio and flow cytometry was used to quantify incorporation. This study 
showed that these isonitrile glycan probes were successfully incorporated into glycans and are stable 
over the time period of labelling. Interestingly, when comparing incorporation of the glucosamine- and 
mannosamine-based probes they show a reversed trend in comparison with azido-glycans. It is well 
known that compared to ManNAz, GlcNAz is poorly incorporated into glycoconjugates, but Ac
4
GlcN-
Scheme 1. A traceless Staudinger-Bertozzi reagent to install diazirines onto azido-glycans.
Scheme 2. Tetrazine ligation with primary, secondary, or tertiary isonitriles.
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n-Iso was efficiently incorporated, whereas Ac
4
ManN-n-Iso showed poor incorporation.117 However, 
overall azido glycans appear to be incorporated slightly better than isonitrile glycans. 
In conclusion, isonitrile-containing glycans have been successfully applied in MOE, but for not yet fully 
understood reasons they need relatively high concentration (200 μM) compared to azido glycans (50 
μM). Similar to click reactions with alkene/cyclopropene versus azides, isonitriles show orthogonal 
reactivity to azides, which enables future use in dual-labelling MOE experiments.
3.6 Diazo group
In 2014 the Leeper group reported a new bioconjugation reaction with the diazoacetyl group.39 This 
group is smaller than its azide counterpart and reacts under physiological conditions with strained 
alkenes or alkynes.118 Furthermore, the diazoacetyl group can be used in parallel with an alkyne-based 
chemical handle to enable dual bio-orthogonal labelling strategies.
The reaction of diazo compounds with strained alkenes or alkynes has been known for many years. 
For instance, their reactivity with cycloalkynes like DIBO and DIFO has been reported by Raines et 
al. and indicated their potential as chemical handles in metabolic probes.118 The Leeper and Raines 
groups independently investigated the reaction kinetics of various diazo compounds with cyclo-
alkynes and alkenes (for both ± 0.04 M-1 s-1), solvent and stability.39, 118 The Leeper group reported the 
first in vivo labelling with diazo glycans.39 A two-step [3+2] cycloaddition with simple diazo building 
blocks was performed. In the first step an invDA reaction was performed with the highly strained (E,E)-
1,5-cyclooctadiene (COD) (Figure 3). In the second step a [3+2] cycloaddition isomerisation results 
in stable adducts. Imaging the incorporation of a diazoacetyl-GalNAc derivative (Ac
4
GalNDiaz) was 
achieved in Lewis lung carcinoma (LL2) cells via a two-step method using an initial click reaction with 
biotin-TMDIBO, a stable dibenzocyclo-octyne, and subsequent visualisation with avidin or neutravidin-
appended fluorescent dyes. This two-step labelling procedure provided a better signal-to-background 
ratio compared to a one-step labelling method. Although successful, the level of labelling achieved 
with Ac
4
GalNDiaz, as analysed by flow cytometry, was significantly lower when compared with the 
Ac
4
GalNAz. The exact reason(s) for this low level of incorporation or subsequent labelling is still not 
known, but one reason might be that the diazo-glycan is a poor substrate for the enzymes involved in 
the galactosamine salvage pathway or for the associated glycosyltransferases. 
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Figure 3. Mechanisms [3 +2] cycloaddition of diazo substrates with strained alkenes or alkynes.
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A peracetylated diazo-mannose glycan (Ac
4
ManDiaz) has been successfully incorporated in 
Jurkat, CHO K1, HEK293T and HeLa cell lines by the Raines group.52 This matches the fact that the 
enzymes involved in the conversion of N-acetylmannosamine into Neu5Ac have a high tolerance 
for alternatively N-acylated derivatives.85 However, also here Ac
4
ManDiaz was incorporated less 
efficiently compared to ManNAz as shown by flow cytometry. It is known that diazo compounds are 
prone to degradation at low pH via C-protonation and subsequent hydrolysis. So if endosomes are 
involved in the uptake of diazo-glycans, this could also explain the general lower incorporation level. 
Toxicity of diazo glycans was only observed after prolonged labelling times of 60 minutes at 10 µM 
concentration. Diazo compounds are not affected by the CuAAC reaction and a successful dual-
labelling strategy with azido-glycans has been explored.52 Analysis by flow cytometry and microscopy 
showed that both click reactions could be performed without cross-reactivity and are independent of 
the labelling order. No cross-linking was observed for diazo- and azido-glycans, which is an undesired 
known phenomenon for alkyne and azido glycan combinations. This clearly illustrates the potential of 
dual-labelling techniques with diazo-glycans.
3.7 Nitrone-alkyne cycloaddition followed by rearrangement
A new copper-catalysed bioconjugation reaction was discovered by Pezacki and co-workers in 2014, 
involving coupling a terminal alkyne and nitrone to form a β-lactam ring (Scheme 3).119 This reaction 
is fast and both starting materials and product are stable in aqueous media. The copper-catalysed 
nitrone-alkyne cycloaddition followed by rearrangement (CuANCR) has been succesfully performed 
in living cells, like Huh-7 cells, and E. coli. For the labelling in E. coli a nitrone-bearing KDO derivative 
(HMMPO) was synthesised. E. coli was incubated overnight in M9 minimal medium containing 4 
mM KDO with or without an alkyne or nitrone chemical handle. KDO-HMMPO and KDO-alkyne were 
successfully incorporated into the bacterial LPS as shown by SDS-PAGE analysis. The alkyne nitrone 
cycloaddition can also be performed with strained alkynes (SPANC), and is compatible with cyclic or 
acyclic nitrones.120
4. Synthetic strategies for selected members from the MOE toolbox
The MOE toolbox is filled with unnatural glycan derivatives and most of these are not yet commercially 
available. Therefore most studies that are undertaken using MOE still start with the synthesis of 
the required probes using a combination of carbohydrate chemistry and organic chemistry. In this 
section we provide an overview of synthesis strategies used for a diverse selection of glycan-based 
chemical probes used in MOE. In general, the same synthetic strategies apply for the construction of 
all three of the much used N-acylated mannosamine, galactosamine, and glucosamine-based chemical 
probes. For that reason we here only discuss several representative examples for the synthesis of the 
mannosamine-based chemical probes. A comprehensive overview of chemical probes used for MOE 
can be found in the previous section in table 2.
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4.1 Azido-labelled glycans
The first azido-glycans to be reported were the mannosamine, galactosamine, and glucosamine-based 
N-azidoacetyl glycans. These per-acetylated glycans are easily prepared via standard carbodiimide-
mediated amide bond formation with azido acetic acid and the respective amino sugar (Scheme 
4).23, 45 Alternatively, iodoacetic anhydride or iodoacetic acid can be coupled to mannosamine, 
followed by nucleophilic displacement with sodium azide to provide the N-azidoacetyl glycan. The 
final step includes acetylation of all free hydroxyl groups under standard conditions. Aldolases inside 
mammalian cells are able to convert Ac
4
ManNAz 2, once deacetylated, towards a sialic acid, to yield 
azido-labelled neuraminic acid (Neu5Az).23 Neuraminic acid is the most abundant sialic acid, and 
known to be important for many cellular communication and processes. Additional neuraminic acid-
based chemical probes for MOE are known and will be discussed later.
Photoactivatable phenyl azide-based chemical probes have also been made via a similar route. 
2-(4-Azidophenyl)acetic acid was coupled to mannosamine hydrochloride 1, and subsequent 
acetylation provided the Ac
4
Man-2-arylAz 3, which is a precursor for Sia-5-arylAz (Scheme 5).47
Other azido-substituted mannosamine derivatives have been synthesised as well. For example, 4-azido 
N-acetylmannosamine derivative 9 shown in Scheme 6 is made from a 1,6-anhydrosugar intermediate 
6 that itself is made in three steps from N-acetylmannosamine 4.121 A Mitsunobu reaction on the 
1,6-anhydro intermediate 6 was performed to give a 3,4-epoxide 7. Selective axial opening of the 
epoxide 7 with lithium azide provided, after opening of the 1,6-anhydrosugar 8 a di-amino glycan 9. 
This di-amino mannosamine glycan 9 has been used for metabolic labelling in HEK293 cells lacking the 
key enzyme for sialic acid biosynthesis to improve incorporation rate into glycans.48 For membrane 
permeability glycan 9 was peracetylated before it was used in MOE.
6-azido-N-acetylmannosamine 11 is converted inside the cell to 9-azido-N-acetylneuraminic acid. The 
6-azido glycan 11 can be synthesised from N-acetylmannosamine 4 by selectively tosylating the 6-OH 
10 (Scheme 7).45 Nucleophilic substitution with sodium azide at 50 °C for 3 days gave, after acetylation, 
the 6-azido Ac3-N-acetylmannosamine 11.
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Scheme 3. Nitrone-alkyne cycloaddition.
Scheme 4. Synthesis of Ac
4
ManNAz 2.
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3-Deoxy-d-manno-octulosonic Acid (KDO) is a subclass of sialic acids having an eight-carbon skeleton. 
It is highly abundant and essential component in the outer-cell membrane of lipopolysaccharide Gram 
negative bacteria and also found in the RG-II pectin of plant cell walls.107 Human gut bacteria like 
H. pylori are known to have KDO in their LPS, and Dumont an co-workers imaged this via metabolic 
labelling with KDO probes.66 The 8-azido KDO 14 is readily synthesised from d-arabinose 12 (Scheme 
8). After selective tosylation of the primary alcohol, the remaining free alcohols are acetylated, and 
the resulting mixture is then treated with NaN3 in DMF. In the final step sodium methoxide gives the 
5-Az-5-deoxy-d-arabinofuranose 13 in an overall yield of 15%. 8-Azido KDO 14 is made by the reaction 
between 5-Az-5-deoxy-d-arabinofuranose 13 and sodium oxaloacetate under acidic conditions, 
followed by a decarboxylation. 
Metabolic oligosaccharide engineering can also be a highly valuable tool to study the action or 
inaction of glycosyltransferases as recently shown by Bertozzi et al. with the use of UDP-azido glycans 
as metabolic chain inhibitors.76 We here discuss the synthesis of three different UDP azido-glycans 
and the outlook discusses their application in MOE. UDP-2-XylAz 22 was synthesised from d-xylose 
15 as shown in Scheme 9. After protection of the anomeric center 16, selective protection of the 
Scheme 5. Synthesis of Ac
4
Man-2-arylAz 3.
Scheme 6. Synthesis of 4-azido ManNAc 9.
Scheme 7. Synthesis of 6-azido-Ac3-N-acetylglucosamine 11.
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3- and 4-OH with a cyclohexane-1,2-diacetal ‘Ley’ protecting group made functionalisation of the 
2-position possible 17.76 After activation of the 2-OH with Tf2O in pyridine, nucleophilic displacement 
was performed with LiN3. The UDP-donor was prepared by first selectively deprotecting the anomeric 
centre using N-bromosuccinimide. The phosphate analogue was made by treatment with diallyl-N-N-
diisopropylphosphoramidite. UMP-N-methylimidazolide was added, after Pd-catalysed isomerisation 
and cleavage of the allyl groups, to finally provide UDP-2-XylAz 22.
The synthesis of UDP-3-XylAz 30 was performed in 15 steps starting from 1,2-O-isoproplyidene-α-
d-xylofuranose 23 (Scheme 10).76 To install the azide functionality on the 3-position, the hydroxyl 
on this position was first converted from an axial to an equatorial hydroxyl group by oxidation and 
subsequent stereoselective reduction 25. Thereafter, conversion to the 3-OTf and its substitution with 
LiN3 provided the 3-azido glycan 26. The UDP group was installed in the same manner as for the 
2-XylAz glycan 22.
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Scheme 8. Synthesis of 8-Az-KDO 14.
Scheme 9. Synthesis of UDP-2-XylAz 22.
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4-OH Benzoylated l-arabinose 31 proved a perfect starting point for the synthesis of UDP-4-XylAz 35 
(Scheme 11).76, 122 The 4-OH was reacted with triflic anhydride followed by substitution of the triflate 
with LiN3 starting product is easily synthesised from l-arabinose. Deprotection of all benzoyl groups 
followed by acetylation, and selective anomeric deprotection with hydrazine acetate gave acetylated 
1-OH 4-XylAz 33. Installation of the allyl phosphodiester analogue proceeded in moderate to low yield. 
The UDP group was finally installed by removal of the allyl esters followed by coupling with UMP-N-
methylimidazolide.Purification of synthesised UDP-glycans is a challenging step. The described UDP-
glycans were for example purified in a HPLC C-18 column with tributylammonium bicarbonate and 
methanol as mobile phases. Once the crude product eluted from the column it was further purified by 
size exclusion chromatography and sodium ion exchange resin.
Scheme 10. Synthesis of UDP-3-XylAz 30.
Scheme 11. Synthesis of UDP-4-XylAz 35.
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l-Galactonic acid γ-lactone 36 was selected as a starting point for the synthesis of azido fucose 39 
(FucAz) and alkyne fucose 40 (FucAl) analogues (Scheme 12).70 A reduction of the lactone with sodium 
borohydride followed by acetonide protection gave the 6-OH glycan 37. The 6-OH was activated and 
nucleophilic displacement using NaN3 followed by acidic deprotection gave the 6-azido fucose 39 as 
the isopropyl protected anomeric center. FucAl 40 was made as follows; The 6-OH intermediate 37 
was oxidised to the aldehyde with PCC followed by treatment with the Seyferth/Gilbert reagent.123 
Acid deprotection provided FucAl 40 in excellent yield. For MOE the isopropyl acetal was cleaved and 
the hydroxyl groups were acetylated. These azide and alkyne fucose analogues were also used to make 
their GDP-donor counterparts for use in MOE. 
As mentioned, the microbial sialic acid, legionaminic acid, is a relevant target for metabolic labelling 
to study its glycobiology in human associated pathogenic bacteria. An 6-azido hexose-precursor 47 
was synthesised starting from β-D-glucose pentaacetate 41 (Scheme 13).77 A glycosylation reaction 
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Scheme 12. Synthesis of 6-Az fucose 39 and 5-alkyne fucose 40.
Scheme 13. Synthesis of 6-azido Leg Hexose 47.
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with para-methoxyphenol followed by Zemplén deacetylation and subsequent selective benzoylation 
gave the 2,4-dihydroxyl glucose derivative 43. This intermediate was treated with triflic anhydride and 
reacted with tetrabutylammonium azide to install the two azides 44. Removal of the benzoyl groups 
and reduction of the azides followed by controlled acetylation gave the 3,6-dihydroxy intermediate 45. 
Selective tosylation of the primary alcohol, followed by nucleophilic displacement with sodium azide 
and oxidative deprotection of the anomeric PMP group provided the probe 47.
The earlier discussed trehalose azido sugars were synthesised from a series of known 
differentially protected trehalose building blocks 48-51 (Scheme 14).79 Their synthesis involved 
alcohol activation, followed by nucleophilic substitution with an azide source and complete 
deprotection to provide azido-trehalose library (2-TreAz, 3-TreAz, 4-TreAz, and 6-TreAz). 
 
 
Scheme 14. Synthesis of 2-TreAz, 3-TreAz, 4-TreAz, and 6-TreAz.
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4.2 Alkyne-labelled glycans
Terminal alkynes on carbohydrates were among the first probes used for metabolic oligosaccharide 
engineering. Their easy synthesis and stability made it possible to synthesise a variety of different 
alkyne-glycans (see table 1). Alkyne-labelled N-acetylmannosamine glycans are made from 
N-mannosamine hydrochloride 1 in a two-step procedure (Scheme 15). Under basic conditions the 
amine group is reacted with a NHS activated alkyne 52.49 Subsequent acetylation with acetic anhydride 
and pyridine provided the probe 53. The alkyne-labelled N-acetylmannosamine 53 can either be 
directly used for metabolic labelling or first converted to alkyne-labelled N-acetylneuraminic acid 54 
using an enzymatic reaction or the chemical equivalent using a Barbier alkylation and ozonolysis.
For the synthesis of the carbamate-linked alkyne probes, reported by Pratt et al., mannosamine, 
galactosamine, or glucosamine hydrochloride were reacted with propargylchloroformate 55 (Scheme 
16).53 Subsequent acetylation under standard conditions gave the peracetylated propargyl alkyne 
glycans 56. 
Glucose alkynes 60 can be made via an enzymatic procedure starting from α-hydroxylated aldehyde 57 
and dihydroxyacetone phosphate 58 (Scheme 17).124 
54
Scheme 15. Synthesis of mannosamine alkyne glycans 53.
Scheme 16. Synthesis of Ac
4
ManlPoc 56.
Scheme 17. Synthesis of d-glucose alkynes 60.
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4.3 Thiol-labelled glycans
Thiol-containing N-acetyl amino sugars 63 are made from commercially available glucosamine, 
galactosamine, or mannosamine derivatives. Thioacetic acid is coupled to provide, after full acetylation, 
the thio acetate probe 63 that can be used for MOE (Scheme 18).54, 125
The thioacetyl handle has not been reported yet for the traditional metabolic labelling via click 
chemistry, but the thiols are biocompatible and have been successfully incorporated onto surface 
glycans.126
4.4 Cyclopropene-labelled glycans
Highly strained cyclopropenes react very fast with tetrazines making them excellent candidates for 
MOE.55 The synthesis of cyclopropenes is not trivial, however, and yields below 50% for the activated 
cyclopropenes are the standard (Scheme 19). Also, the amide formation to attach them to amino sugars 
is a low yielding step.71 The synthesis of 2-methyl cyclopropenes, in which the methyl substituent is 
important for stability, starts with a rhodium-catalysed cyclopropenation of the appropriate alkyne 64 
with ethyl diazoacetate 65, followed by a reduction of the ethyl ester.57 The resulting cyclopropene-
alcohol products 69 are known to be volatile and prone to polymerisation. Installation of the 
cyclopropene handle onto the amino sugar is achieved via the NHS 68 or p-nitrophenyl carbonate 
activated intermediate 71.
Scheme 18. Synthesis of thio-N-acetylgalactosamine probe 63.
Scheme 19. Synthesis of activated cyclopropenes handles 68 and 71.
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To improve the stability and reaction yields another route to the activated cyclopropene handles was 
developed. A TMS protected alkyne is reacted with ethyl diazoacetate under catalytic amounts of 
rhodium tetraacetate (Scheme 19).56 Reduction of the ester to the alcohol with DIBAL was performed. 
Next, desilylation and subsequent activation was performed in a one-pot reaction using Bu4NF to 
deprotect and p-nitrophenyl chloroformate to activate the alcohol 69. This crystalline activated 
cyclopropene (71; R = CH3) can easily be stored and used for the installation of the cyclopropene group 
onto amino sugars. 9-Azido N-acetylneuraminic acid 72 is an ideal starting point for the synthesis of 
9-cyclopropenyl neuraminic acid 73 (Scheme 20). After Pd-catalysed hydrogenation, NHS-activated 
cyclopropene 68 is added to give the final product.71
The mannosamine cyclopropenes (Ac
4
ManNCyc and Ac
4
ManCCP) are made from d-mannosamine*HCl 
1. When d-mannosamine*HCl 1 was directly reacted with the acid chloride of a cyclopropene handle 
76, it yielded several products making the synthesis low yielding and the purification difficult (Scheme 
21). A three-step procedure with a Boc protection, followed by acetylation, and Boc deprotection 
gave the acetylated mannosamine 75. This O-protected amino sugar could then be converted into the 
cyclopropene probe 77 in good yield (60% over two steps).55, 127
The less reactive NHS-ester of a cyclopropene handle 78 was directly coupled to d-mannosamine*HCl 
1, and subsequent acetylation produced Ac
4
ManCCP 79 in 38% yield (Scheme 22).56, 57 The same route 
was followed to install norbornene-derived mannosamine probes 81 and 82. For that a succinimide 
activated norbornene derivative 80 was synthesised in three steps (Scheme 23).
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Scheme 20. Synthesis of 9-Cp-Neu5Ac 73.
Scheme 21. Synthesis of Ac
4
ManNCyc 77.
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4.5 Diazirine-labelled glycans
Diazirine-based chemical probes 84 are synthesised from mannosamine, glucosamine, or galactosamine 
via an amide coupling with the diazirine building block 83 under standard amide-coupling techniques 
(Scheme 24). Similar synthesis with longer linkers and other amino sugars are known.61 
The diazirine building block 83 is commercially available or can be made from levulinic acid 85 
(Scheme 25). Levulinic acid 85 is converted into the diazirine handle 83 in a two-step reaction with 
hydroxylamine-O-sulfonic acid and ammonia, followed by triethylamine and iodine in methanol 
(Scheme 25).36 With this building block in hand, Kohler and co-workers made the Ac
4
ManNDAz(3Me) 
84 and Ac
4
GlcNDAz(3Me).61
Jewett and co-workers recently reported an elegant alternative way to install diazirines on azide-
containing carbohydrate derivatives using a traceless Staudinger reaction.62 They successfully reduced 
a C-2 azide, for example glucosamine and galactosamine 87, with the phosphine reagent PhosDAz 86, 
trapping the formed aza-ylide by an intramolecular reaction 88 with the ester-appended diazirine 89 
(Scheme 26). 
Scheme 22. Synthesis of Ac
4
ManCCp 79.
Scheme 23. Synthesis of Ac
4
ManNNorboc
exo
 81 and Ac
4
ManNNorboc
endo
 82.
Scheme 24. Synthesis of mannosamine-diazirines derivatives 84.
Chapter 2
57
4.6 Isonitrile-labelled glycans
In 2013 Leeper and co-workers developed isonitrile-labelled probes for MOE (Scheme 27).63 The amide 
coupling of 2-deoxy 2-amino glycans (e.g. d-mannosamine*HCl 1) with a β-alanine formamide 90 
under standard conditions gives the formamide-functionalised carbohydrate. Subsequent acetylation 
followed by formamide dehydration with POCl3 gives the isonitrile-containing probe 91. Isonitriles are 
stable under neutral conditions and can be purified by column chromatography or HPLC. The amide 
couplings can also be performed with the isonitrile β-alanine carboxylic acid in an one step procedure. 
Amide couplings with formamide or isonitriles are challenging and generally result in low yields 
(<30%). Dehydration of formamides can be performed via different procedures. The most common 
procedure uses POCl3, but this rather harsh condition can lead to decomposition of the product. Other 
methods for dehydration exist, for example, Burgess reagent is able to perform the same dehydration 
step under much milder conditions.128
58
Scheme 25. Synthesis of diazirine building block 83.
Scheme 26. Synthesis of galactosamine-diazirine 89 via Staudinger reduction.
Scheme 27. Synthesis of primary 91 and tertiary isonitrile 93 mannosamine glycans.
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Tertiary isonitriles can also be synthesised in a direct coupling between the amino sugar and the isonitrile 
using potassium 2-isocyano-2-methylpropanoate 99 (Scheme 28). 2-Amino-2-methylpropanoic methyl 
ester 95, made from the corresponding acid 94, is exposed to in situ formed acetic formic anhydride 
96 and dehydration of the formamide intermediate with POCl3 gives the methyl-protected tertiary 
isonitrile 97. Saponification of the methyl ester provides the isonitrile 99 ready for coupling to an 
amino sugar.
4.7 Diazo-labelled glycans
The diazo derivative of N-acetylmannosamine or N-acetylgalactosamine 61, ManDiaz or GalDiaz, 
respectively, are easily synthesised via the route published by the Leeper group (Scheme 29).39 
Starting from galactosamine 61, Ac
4
GalDiaz 102 can be synthesised anomerically pure in a three-step 
process involving transient protection of the amine as its imine with anisaldehyde, acetylation of the 
hydroxyls, imine hydrolysis, followed by installing the diazoacetyl group via its NHS ester derivative 
 
 
Scheme 28. Synthesis of formamide building block 90 and tertiary isonitrile building block 99.
Scheme 29. Synthesis of Ac
4
GalNDiaz 102 by Leeper et al. 39
Chapter 2
59
Another method to synthesise Ac
4
ManDiaz 104 was reported by the Raines group (Scheme 30).52 A 
deimidogenation of the parent azido-glycan, via an acyl triazenophosphonium salt intermediate, gave 
the diazo-glycan in high yields.129 Both diazo-glycans proved to be bio-orthogonal as incubation at pH 
7.4 at 37 °C showed no reaction of diazo acetyl glycans with biologically relevant functional groups 
such as thiols, carboxylic acids, and amines. Diazo-acetyl glycans are stable compounds and did not 
show any degradation during synthesis or purification. 
4.8 Nitrone-labelled glycans
Very recently, the use of nitrone-labelled glycans in MOE was reported for the first time (Scheme 31).119 
Nitrone-labelled KDO 108 was made from the earlier discussed 8-azido KDO precursor 105. The azido 
glycan was reduced using PdO, H2 under slightly acidic conditions followed by amide coupling with an 
activated nitrone-succinimide 107. The resulting product was purified by preparative HPLC before it 
was used for metabolic labelling. Metabolic labelling with these nitrone glycans were performed in E. 
coli and Huh-7 cells. The CuANCR reaction was also successfully applied to synthesise unnatural amino 
acids which were incorporated into E. coli, L. innocua, and L. lactis.122
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Scheme 30. Synthesis of Ac
4
ManNDiaz 104 by Raines et al.53
Scheme 31. Synthesis of nitrone-KDO 108 by Pezacki et al.119
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5. Outlook 
In this final section some exciting recent advances are discussed that might impact MOE in the 
near future, as well as several MOE-related developments that might advance the field of chemical 
glycobiology in general.
5.1 Selective exo-enzymatic labelling
A promising complementary method to MOE for the incorporation of labelled glycans is Selective Exo-
Enzymatic Labelling (SEEL), introduced in 2013 by Boons and co-workers.130 In this technique, intact cells 
are exposed to extracellularly added recombinant glycosyltransferases, for example sialyltransferases, 
and incubated together with labelled donor derivatives, for instance C-5 or C-9 azido-modified CMP-
sialic acids. The recombinant sialyltransferase enzymes still recognise and transfer sialic acid donors 
with an azide introduced on these positions. As a result, an azide-labelled sialic acid was introduced 
exclusively on the cell surface glycans that displayed the appropriate terminal acceptor glycans. SEEL 
thus has several advantages over MOE, for example the possibility of selectively labelling glycans on 
the cell surface and the benefit of not interfering with the intracellular metabolic pathways. The main 
disadvantage is the need to synthesise the valuable labelled-glycan donors and prepare and/or add 
the required glycosyltransferases. 
5.2 Metabolically generated glycosyltransferases inhibitors
Glycosyltransferases have, with the exception of glucosylceramide synthase that can be reliably 
targeted by lipophilic iminosugars (like Zavesca and AMP-DNM), remained elusive towards a 
general small molecule design principle for their inhibition. We clearly lack structural insight in 
glycosyltransferases when compared to their metabolic counterpart, glycosidases, and hence hardly 
any effective, bioavailable glycosyltransferase inhibitor currently exists. Many different approaches 
to glycosyltransferases inhibitors are thus known and discussed in a recent review by Gloster and 
Vocadlo.131 However, it has recently been shown that the principles that drive MOE can also be used to 
perturb the activity of glycosyltransferases. The two MOE-related strategies that make use of the cell’s 
glycan salvage pathways are trojan horse donor inhibitors and metabolic chain inhibitors. 
The Paulson group developed a new technique to tune intracellular glycosyltransferase activity 
through the metabolic generation of transferase inhibitors from unnatural glycans derivatives – the 
trojan horse – by hijacking the salvage pathway (Figure 4).115, 131-137 Fluorinated analogues of fucose 
and sialic acid where shown to be taken up and metabolised by cells into fluorinated donors that 
still tightly bind their corresponding glycosyltransferase, but are no longer transferred to an acceptor 
(Figure 5).138 This is caused by the fact that the required active site oxocarbenium ion transition state 
is destabilised by the neighbouring fluorine atom and is thus no longer formed.  The hijacking  of 
the salvage pahtway via this trojan horse strategy also causes a reduced production of the natural 
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nucleotide sugar donors. The Vocadlo group published a similar strategy that instead uses glycan 
derivative in which the endocyclic oxygen is replaced by a thio-group.138 These are similarly metabolised 
into glycosyltransferase substrates that still bind the active site, but are no longer transferred.
An elegant example of metabolic chain inhibitors is the work on azido-xylose analogues by Bertozzi 
and co-workers.76 The azido-xylose glycans were used as chain-terminating metabolic inhibitors of 
glycosaminoglycans (GAG) synthesis in zebrafish. The lack of a salvage pathway that could convert 
azido-xylose glycans to UDP-activated forms gave an extra synthetic challenge. The synthesis of the 2-, 
3- and 4-azido UDP-xylose was discussed in section 4.1. The UDP-azido-xylose analogues were added 
to the zebrafish embryos via microinjection for further study. After development, a SPAAC reaction 
with difluorocyclooctyne-AlexaFluor 488 was performed on the embryos. Successful labelling was only 
observed with UDP-4-XylAz as confirmed by confocal microscopy and flow cytometry. The mechanism 
of action, hence the reason why only UDP-4-XylAz showed successful labelling, is not known yet.
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Figure 4. Two glycosyltransferases inhibitors developed by Paulson et al.139
Figure 5. Overview of principle behind MOE-generated trojan horse glycosyltransferase inhibitors.
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5.3 Dual labelling
Dual labelling is an area of MOE that is gaining increasing attention. Two different types of dual-
labelling strategies are currently being investigated. The first strategy uses two metabolically 
incorporated glycan-based chemical probes with different bio-orthogonal reactive groups, while the 
second strategy uses two bio-orthogonal reactive groups within the same molecule. A recent example 
of the first approach is the successful simultaneous incorporation of Ac
4
GalNAz and Ac
4
GlcN-n-Iso 
and the simultaneously labelling of both these glycans in a single step using SPAAC and invDA. Other 
reported examples used nitrone- and azido-labelled glycans for bioconjugation via SPANC and SPAAC, 
and norbornene or cyclopropene-labelled glycans in combination with azido-labelled glycans for 
dual invDA and SPAAC labelling in HEK 293T cells.53, 114, 139, 140 An example of the second strategy is 
the successfully metabolic incorporation of a sialic acid derivative containing both an azide and a 
photocleavable diazirine group.75
5.4 What’s next for MOE?
Besides the already impressive toolbox of probes and associated bioconjugation methods that are 
currently known for use in MOE, several new bioconjugation reactions have been reported recently 
that might also end up as part of MOE toolbox. Four highly interesting cases are: a) the reaction of 
N-oxides with boron reagents, as developed by Bertozzi; b) the reaction between cyclopropenones 
and functionalised phosphines; c) 2H-azirines that form after ring opening nitrile ylides, and react 
spontaneously with alkene dipolarophiles to produce stable δ1–pyrrolines; and d) the reaction 
between strained cycloalkynes and sulfenic acids. 68, 141-144 On the other hand, the ‘old’ established 
oxime ligation reaction,33 between an aldehyde and oxy-amine, is also still a powerful ally for 
bioconjugation reactions in MOE, especially in view of the recent finding that oximes are formed 
faster in water at neutral pH at -20 °C.145 One of the fastest known click reactions at the moment is 
the Strain-Promoted Oxidation-Controlled Cyclooctyne–1,2-Quinone Cycloaddition (SPOCQ) reaction, 
and its speed might offer chances with respect to competing biological processes and allow specific 
labelling.40 The compatibility of these reactions in polar media suggest future possibilities for their use 
in metabolic oligosaccharide engineering.
The CuAAC and SPAAC are still by far the most popular click reaction currently used for MOE. Many 
studies have focussed on the improvement of the reactivity of the agents by changing the characters 
of the alkyne moiety. Such changes involve the ring strain in the cyclic molecule (SPAAC reagents), the 
lipophilicity of SPAAC reagents (introduction of polar groups), CuAAC-accelerating ligands, and the use 
of iodo-alkynes.24 Interestingly, changing the electronic character of the azide was not investigated 
until recently. One method uses sulfonyl azides as reactive precursor for a variety of applications.24 
In another method, van Delft and co-workers have shown the potential of difluoro azido glycans 
to improve the speed of SPAAC. They synthesised a difluoro azido acetic acid precursor, which can 
be installed via peptide chemistry to glucosamine, galactosamine, or mannosamine glycans.146 This 
reactive probe has not been used for MOE yet.
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Most of the methods described for the labelling of glycans can also be applied to other biomolecules 
such as lipids and proteins. A complete overview of the possibilities and achievements in this field is 
highlighted in other reviews.40, 147, 148
In the past 15 years many different mammalian cell lines have been successfully used in metabolic 
oligosaccharide engineering studies. Furthermore, different organisms like zebrafish, C. elegans, and 
bacteria have also been studied. A promising new target for the study of glycans with MOE are plants. 
At this point, only a few studies have been published that report the use of MOE in plants.65, 78, 107, 108, 
149, 156 These studies alone have already provided valuable insights in the spatiotemporal dynamics of 
plant glycans, but many questions in plant glycobiology are still unanswered. 
Metabolic oligosaccharide engineering uses the glycan salvage pathway of cells. As a consequence 
labelled glycans end up in all biomolecules that contain these glycans, e.g. N- and O-glycans on 
proteins and glycolipids.150 This can be a drawback, as it is difficult to distinguish exactly where the 
incorporated glycans end up and what the ratio of incorporation is across the various glycoconjugates. 
To further advance the application of MOE and the information that can be obtained from its use, 
methods should be developed that either allow for more selective MOE or accurate identification 
and quantification of the various labelled glycan populations. One method that show promise in this 
area is the combination of fluorescence resonance energy transfer (FRET) and MOE which allows for 
intracellular detection of glycosylation of a protein of interest.151-155
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Abstract
Our gut microbiota directly influences human physiology in health and disease. The diverse 
glycoconjugates in the bacterial cell envelope and our gut mucus dominate the microbiota-host 
interface and have been implicated in these complex interactions. We however currently lack a 
sufficient molecular understanding of the composition of these glycoconjugates for most individual 
species in our gut to study their functional activities. Here we report the chemically guided study of 
glycoconjugates in a key mucin-degrading gut microbiota member of the Verrucomicrobia phylum, 
Akkermansia muciniphila. Two novel non-toxic tetrazine click-compatible peptidoglycan probes 
allowed for the first time the demonstration of peptidoglycan synthesis in this intestinal species. 
Furthermore, metabolic labelling with azido-monosaccharides revealed that A. muciniphila can 
recycle components of mucin O-glycans, notably via an l-fucose salvage pathway. Finally, combining 
these bioorthogonal chemical probes allowed for the simultaneous detection of both peptidoglycan 
synthesis and fucosylation of cell surface glycoconjugates in live anaerobic gut bacteria. These findings 
enhance our molecular understanding of Akkermansia muciniphila’s basic physiology and cell envelope 
and offer a general approach to directly study different cell envelope glycoconjugates in other gut 
microbiota members.
Introduction
Research of the past decade has uncovered the great diversity and abundance of the human gut 
microbiota and how these mainly anaerobic bacteria directly influence our physiology in health and 
disease. It protects against invading microbes, aids in degrading non-digestible dietary components, 
produces key nutrients and vitamins, and primes our immune system.1-3 Mapping the microbial 
molecules that mediate microbiota-host interactions is crucial to understand how this bacterial 
community controls human wellbeing by preserving mucosal homeostasis. We currently lack 
knowledge on the key molecules and basic physiology of its individual species to understand these 
complex interactions. Glycans and their glycoconjugates, both human and microbial, dominate the 
host-microbiota interface. Especially the diverse glycoconjugates in the cell envelope of individual 
microbiota members are ideally positioned to modulate these interactions. It is therefore crucial 
that we acquire a molecular understanding of their composition and activities. As the assembly and 
composition of glycans is not genetically encoded, a chemically guided approach is ideally suited 
to identify and modulate their structures in their native setting to allow subsequent study of their 
functional activities. To achieve this for gut microbiota there is however a critical need for validated 
bioorthogonal chemical reporters and techniques that enable these studies in living anaerobic 
bacteria.
We set out to develop such a method for the investigation of the cell envelope glycoconjugates of 
a key member of a healthy human gut microbiota: Akkermansia muciniphila, a Gram-negative, 
oval-shaped and non-motile bacterium that belongs to the phylum Verrucomicrobia.4-5 It colonises 
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the mucus layer of the gastrointestinal tract and specialises in the degradation of complex mucosal 
O-glycans. As a mucin-degrader, A. muciniphila is less dependent on the influx of dietary components, 
being able to use mucus as its sole carbon and nitrogen source,5 and supports other microbiota 
members by providing access to mucus monosaccharides. This places it in a key position to shape 
the overall microbial composition. Due to its close proximity within the mucus layer to its human 
host A. muciniphila may also exert a relatively large effect on our immune system that it has indeed 
been found to stimulate. A. muciniphila also stimulates host mucin production, increases mucus layer 
thickness and strengthens intestinal barrier function.6-10 Its lowered intestinal colonisation has been 
correlated with inflammatory bowel conditions in humans. An intervention study in mice showed its 
potential to protect against high-fat-diet induced obesity and more recently, our laboratory showed 
the potential of A. muciniphila as a therapeutic for human obesity and associated disorders.11-12 
To understand and modulate the interaction of A. muciniphila with its host and the other gut 
microbiota members it is essential to first comprehend its own basic physiology at the molecular level 
and especially its understudied cell envelope glycoconjugates. An important outstanding question in 
this respect is if A. muciniphila, as a member of the PVC clade5, has peptidoglycan (PG) in its cell 
envelope. If present, this glycoconjugate plays a key role in cell division, cell envelope maintenance 
and through human peptidoglycan recognition proteins also in microbiota-host interaction.13 Another 
key question is whether, besides degrading, it can salvage the monosaccharides that it obtains from 
mucin O-glycans and use them to modulate the composition of its own cell envelope glycoconjugates. 
This would allow mimicry of host glycan composition that, especially for l-fucose, has been shown to 
confer a gut colonization advantage.14 
Figure 1. Overview of metabolic labeling with PG probes. PM: plasma membrane, PG: peptidoglycan, UDP: uridine diphosphate.
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Here, we report the development of two non-toxic novel d-Ala-dipetide based PG probes, equipped 
with an isonitrile or cyclopropene chemical reporter, that were used to prove, for the first time, that 
A. muciniphila indeed synthesises peptidoglycan in its cell envelope periplasm (see Figure 1). Both 
probes and their labelling with a tetrazine click reaction proved non-toxic under anaerobic culturing 
conditions and allowed for PG detection via flow cytometry and confocal microscopy in live bacteria. 
Metabolic labelling of A. muciniphila with azido-labelled monosaccharide analogs of key O-glycan 
components, uncovered its ability to salvage l-fucose. Finally, we show that a combination of our 
novel isonitrile-based PG probe and 6-azido-l-fucose enables the simultaneous imaging of PG and 
fucosylated glycoconjugates in the cell envelope of live A. muciniphila. 
Results and Discussion
Design and Synthesis of New Cyclopropene and Isonitrile-based Peptidoglycan Probes. Our first 
goal was to develop probes that would be able to detect and image peptidoglycan synthesis in live 
anaerobic bacteria. As a constituent of bacterial cell envelopes that preserves cell rigidity and shape, 
PG forms an anchoring point for many cell wall-associated molecules and plays a key role in cell growth 
and division.15-17 If present it forms a unique opportunity to get insight in the cell envelope dynamics of 
bacterial cells and as mentioned it is currently unknown if PG is produced by A. muciniphila. PG consists 
of an alternating polymeric chain of β-1,4-linked N-acetylglucosamine and N-acetylmuramic acid with 
a pentapeptide attached to the latter that enables crosslinking between chains. The so-called PG stem 
peptide contains two terminal d-Alanine residues that are of special interest, as these are unique to 
bacterial PG. In recent years, this fact has been exploited to study PG via metabolic incorporation of 
unnatural d-amino acid-based probes (Figure 1). Although some of these probes have a prepended 
bulky fluorophore, most probes rely on a secondary click reaction step between a chemical reporter 
group on the metabolically incorporated d-Ala-based probe and a complementary group attached 
to a fluorophore.18-28 This smaller size of the initial probe also better permits PG labeling of Gram-
negative bacteria whose outer membrane make them less accessible to fluorophore-prepended bulky 
PG probes. Liechti and co-workers used this approach to prove the presence of PG in another PVC 
clade member, Chlamydia trachomatis, with an alkyne-containing d-Ala dipeptide probe.22 Their probe 
however relies on a copper-catalysed azide-alkyne cycloaddition (CuAAC) in which the used copper is 
toxic to bacteria. In general, there is a lack of bioorthogonal PG probes that closely mimic d-alanine 
and even more crucially that have been validated for their efficacy in non-toxic labelling and detection 
of bacterial PG in vivo.
The [4+1] cycloaddition of isonitriles and tetrazines is a recent addition29-30 to the bioorthogonal click 
chemistry toolbox and we envisioned that an isonitrile group would allow for a sterically very close 
d-alanine mimic. This close mimicry should result in only a small pertubation of the PG macromolecular 
structure once incorporated and thereby limit an effect on the dynamics of PG production and 
degradation. Additionally, the inverse electron demand Diels Alder (invDA) reaction between strained 
alkenes and tetrazines is among the fastest bioorthogonal reactions currently known and allows for 
the use of relatively compact cyclopropene chemical reportes.31 Both these copper independent click 
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reactions have been proven to be bioorthogonal and were already applied successfully in in vivo glycan 
imaging.30, 32-33 We therefore designed a d-Ala-based probe with either an isonitrile or cyclopropene 
chemical reporter group. As modified single d-Ala amino acids are sometimes poorly incorporated 
into PG and are not selective in labelling PG formation and maturation dynamics21, 28, we choose to 
adapt the design reported by Liechti and co-workers based on a d-Ala dipeptide motif.22 By installing 
the bio-orthogonal isonitrile or cyclopropene chemical reporter group on the N-terminus of the d-Ala 
dipeptide we could target labelling to the crucial fourth position of the stem peptide22 that is actively 
involved in PG formation and maturation (Figure 1).
We started our synthesis route with the commercially available Fmoc-d-asparagine-OH 1 for both the 
cyclopropene and isonitrile probe (see Scheme 1, detailed synthetic procedures in Appendix A). A 
hypervalent iodine mediated Hofmann rearrangement under basic conditions efficiently produced an 
amine intermediate in 99% yield.34 After temporary Boc-protection of the obtained amine, a peptide 
coupling under standard carbodiimide coupling conditions with d-Ala-OCH3.HCl produced dipeptide 
precursor 2. The Boc-group was removed with TFA, yielding the free amine dipeptide as a TFA salt 
intermediate 3. From this point onwards the synthesis of the cyclopropene 4 and isonitrile 6 dipeptide 
PG probe diverged. In the case of the cyclopropene-containing probe, the free amine was reacted with 
activated para-nitrophenylcarbonate cyclopropene resulting in a cyclopropene handle on the d-Ala 
dipeptide.32 The synthesis of this cyclopropene handle was reported by Prescher and co-workers and 
later adapted by us and others.32-33, 35-36 From the diverse family of cyclopropenes we chose a methyl-
cyclopropene carbamate handle as the most suitable in terms of stability during probe synthesis and 
reactivity during the labelling. 
Scheme 1. Synthesis of novel cyclopropene- and isonitrile-containing d-Ala dipeptide PG probes 4 and 6.
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In case of the isonitrile PG probe, the free amine was reacted with methyl formate. Different 
methods for the formation of a formamide are known,37-38 but the procedure using methyl formate 
proved the most reproducible in providing 5. Other procedures such as formic acid in presence of 
dicyclohexylcarbodiimide (DCC) resulted in byproduct formation while other methods with catalytic 
boric acid gave no product formation. With formamide 5 in hand we next assessed the standard 
method for formamide dehydration with POCl3. Although complete consumption of 5 was observed, 
this method was not successful in producing the isonitrile. A milder dehydration method using Burgess 
reagent did however succeed in producing the isonitrile.39 Next, piperidine treatment removed 
the Fmoc group in both PG dipeptide probe precursors and provided our target PG probes 4 and 6 
(Scheme 1). We expected that the remaining methyl ester on the C-terminal d-Ala amino acid would 
be hydrolysed by nonspecific bacterial esterases, as these dipeptides are believed to selectively label 
PG via a cytoplasmic route.22 The ester might also facilitate the initial passive uptake of the dipeptide 
probe 4 and 6. 
Novel PG probes are non-toxic to bacteria. The aim of our bioorthogonal PG probes was to image PG 
synthesis in live bacteria, but the incorporation of our unnatural d-Ala dipeptides 4 and 6 might have 
detrimental effects on bacterial growth, viability and physiology. Therefore, we first evaluated their 
toxicity. As a benchmark, we first tested toxicity of the probes in Escherichia coli, which did not reveal 
any detrimental effects of the probes on specific growth rate (Figure 2A). Also in A. muciniphila no 
significant growth defect was observed after addition of our isonitrile and cyclopropene probes. Whilst 
addition of the copper-dependent alkyne probe of Liechti et al., which was used as a benchmark, 
resulted in a significant growth defect in A. muciniphila cultures (Figure 2B).22 
Next, we evaluated the combined toxicity of metabolic PG probe incorporation and the subsequent 
click reaction with fluorescent reporter groups for our probes in comparison to the alkyne PG probe 
with associated CuAAC click reaction. The viability of the bacteria was assessed after the click 
reaction by determining colony-forming units on CP-mucin agar for A. muciniphila and LB agar for E. 
coli (Appendix A, Figure S7C and S7D). This clearly revealed the expected cytotoxicity of the copper-
dependent alkyne PG dipeptide probe and subsequent CuAAC reaction. In stark contrast with the 
alkyne probe, both E. coli and A. muciniphila showed sustained viability when subjected to our novel 
cyclopropene 4 and isonitrile 6 PG probes in combination with the bioorthogonal invDA or [4+1] 
cycloaddition reaction.
Labelling of PG in E. coli and Akkermansia muciniphila. The efficacy of both our novel, non-toxic 
dipeptide probes (4 and 6) to detect and image PG synthesis was first successfully confirmed in E. coli 
using flow cytometry (FCM) and confocal imaging experiments (Figure S1 & S2 in Appendix A) and 
favorably compared to the established alkyne-based PG probe of Liechti and coworkers.22 This initial 
result showcases the potential wider application of our probes for PG imaging. 
We next assessed PG presence in the cell envelope periplasm of A. muciniphila. Anaerobic cultures 
were incubated in the presence of either probe 4 or 6 for 1 hour prior to sampling. The invDA or [4+1] 
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cycloaddition with the fluorophore-appended click reagents, such as Cy3 tetrazine dyes, proceeded 
fast and did not affect the morphology of A. muciniphila. Confocal microscopy images of A. muciniphila 
probed (Figure 3 & Figure S4 in Appendix A) with the non-toxic PG dipeptide probes showed clear 
fluorescence and for the first time provide compelling evidence for PG synthesis in this intestinal 
species. The efficacy of PG labelling with isonitrile probe 6 in A. muciniphila was also evaluated by 
FCM analysis (Figure 5B), which was in line with the obtained confocal images. Overall, using both 
probes, the presence of PG in the human gut microbiota member A. muciniphila could be shown. The 
compatibility of these non-toxic probes and subsequent click reactions with bacterial growth opens 
perspectives towards the further use of these probes to monitor PG dynamics in vivo for this and other 
gut microbiota members.
 Figure 3. Confocal microscopy images of A. muciniphila with and without addition of the novel non-toxic PG dipeptide probes. 
Scale bar = 5 μm.
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Figure 2. Specific growth rate (μ) of E. coli (A) and A. muciniphila (B) in the presence of PG dipeptide probes (data represents mean 
of triplicates, error bars depict SEM, T = 37 ˚C). 
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Another advantage of these new PG probes is their orthogonality with other types of bioorthogonal 
chemistries such as the strain-promoted azide-alkyne cycloaddition (SPAAC). 
Investigation of glycan salvage in A. muciniphila. In addition to the role of peptidoglycan in the cell 
envelope maintenance and structure, other bacterial cell envelope glycoconjugates also play a crucial 
but not yet fully understood role in  microbiota-host interactions.40 In this second part of the study 
we aimed to assess the ability of A. muciniphila to salvage glycans, such as mucin O-glycan derived 
monosaccharides, from its environment to incorporate in its own cell surface glycoconjugates, like 
glycoproteins and LPS. In recent years, l-fucose has especially been identified as a key glycan in a 
human gut microbiome homeostasis and dysbiosis.14, 41 Besides an engineered pathway in E. coli,42 a 
native glycan salvage pathway for l-fucose has up till now only been reported for Bacteroides fragilis, 
another important inhabitant of the human gut.14 B. fragilis can salvage mucin glycan derived l-fucose 
monomers, and use these to decorate its surface polysaccharides. Both enzyme functions necessary 
to salvage fucose are present in a bifunctional enzyme Fkp, capable of converting l-fucose to l-fucose 
1-phosphate and generation of GDP-l-fucose.14 
To assess if the mucin-foraging A. muciniphila can use mucin-derived monosaccharides to incorporate 
in its surface glycoconjugates, we set up a metabolic oligosaccharide engineering (MOE) experiment 
(Figure 4A).31 MOE relies on the presence of glycan salvage pathways to incorporate monosaccharides 
equipped with a reporter group (e.g. click handle) into glycoconjugates. For this reason, MOE is 
becoming an increasingly popular technique for the detection and tracking of bacterial glycans, also in 
human gut microbiota members, thus conferring evidence on the presence of glycan salvage pathways 
in these species.43-47 
Figure 4. (A) MOE labelling with Ac
4
FucAz in A. muciniphila and fucose salvage pathway (B) A. muciniphila with control and 
Ac
4
FucAz, labeled with Cy-5. Scale bar = 5 μm.
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We evaluated incorporation of the 6-azido analogue of l-fucose, Ac
4
FucAz, (Figure 4B). Ac
4
FucAz was 
reported to be toxic in mammalian cell lines48 and therefore the alkyne variant was used in various 
organisms including bacteria.49 Here we applied Ac
4
FucAz for the first time in bacteria, as this allowed 
us to use the SPAAC reaction for imaging, excluding the use of cytotoxic copper, and allowing for a 
follow up dual labelling experiment with our PG probes, thus enabling in-depth studies of the cell 
envelope surface glycoconjugates. Results showed strong incorporation of Ac
4
FucAz in the surface 
glycan layer of A. muciniphila (Figure 5B). Confocal imaging results were confirmed by FCM analysis 
(Figure 5C).
Figure 5. FCM analysis of Cy-3/Cy7 fluorescently labelled Akkermansia muciniphila cells with; A: no probe added, B: with PG 
isonitrile probe (4), C: with Ac
4
FucAz probe, D: after dual labelling with both probes.
The presence of highly fucosylated glycoconjugates on the cell surface and thus a fucose salvage 
pathway in A. muciniphila is striking but corroborated by a recently established metabolic model 
of A. muciniphila.9 This model showed the genomic potential of A. muciniphila to salvage l-fucose, 
as it indicates the presence of a l-fucose transporter in A. muciniphila (AMUC_RS09790) and a 
l-fuculokinase (AMUC_RS09775) that can generate the crucial l-fucose-1-phosphate needed for 
salvage (Figure 6A). The genome also harbors several pyrophosphorylases, that can play a role in 
producing the GDP-l-fucose substrate for fucosyltransferases, but it remains to be investigated which 
of these pyrophosphorylases in its genome are involved in the production of GDP-l-fucose.50 Finally, A. 
muciniphila has also been found to harbor fucosyltransferases from the GT11 CAZy family.51
We further determined whether two other azide-modified probe versions of monosaccharide O-glycan 
components, N-acetylglucosamine (Ac
4
GlcNAz) and N-acetylgalactosamine (Ac
4
GalNAz), could be 
salvaged by A. muciniphila and incorporated in its surface glycoconjugates. A MOE experiment indeed 
indicated significant incorporation of GlcNAz and to a lesser extent of GalNAz, thus indicating salvage 
of GlcNAc and GalNAc by A. muciniphila (Figure S5). Overall this successful application of MOE for 
detection and imaging of bacterial glycan salvage and cell surface glycoconjugates in A. muciniphila 
will permit in the future the molecular level study of this and other bacteria in their glycan-dominated 
anaerobic intestinal environment.
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Proof of principle. Live dual imaging of PG synthesis and surface fucosylation of the bacterial cell 
envelope. Dual labeling applications, in which both PG and the dynamics of other key glycoconjugates 
in the cell envelope can be tracked simultaneously or longitudinally in live anaerobic bacteria would 
open interesting perspectives to study their role at the microbiota-host interface. The orthogonality of 
our novel PG dipeptide probes 4 and 6 with other types of bioorthogonal chemical reporters should 
permit this. We therefore performed a dual labelling experiment of PG and surface fucosylation in A. 
muciniphila. We used Ac
4
FucAz for labelling cell surface glycans in A. muciniphila and the isonitrile 
dipeptide probe 6 to label PG. For confocal analysis, the incorporated isonitrile PG dipeptide probe was 
clicked with Cy-3 tetrazine while incorporated Ac
4
FucAz was clicked with Cy-5 DBCO (Figure 6). Single 
labelling control images for both probes are available in Figure S3. Overlay images of live bacteria show 
labelling with both probes in A. muciniphila thus illustrating the orthogonality and bioorthogonality of 
these probes and the attachment of their respective reporter fluorophores (Figure 6). Dual labelling 
was also evaluated using FCM. To ensure compatibility with available FCM filters, Ac
4
FucAz was clicked 
with Cy-7 DBCO, whilst the isonitrile probe was clicked with a Cy-3 tetrazine. Dual labelling of both 
peptidoglycan and fucosylated cell surface glycans in live A. muciniphila cells was confirmed by the 
FCM data (Figure 5D). 
This successful proof of principle experiment illustrates the potential for in vivo follow-up studies of 
cell envelope glycoconjugates in A. muciniphila and other anaerobic gut microbiota members. It allows 
the simultaneous spatial and temporal tracking and modulation of these microbial molecules. One of 
them being peptidoglycan synthesis in the bacterial cell envelope. It functions as a marker for viability 
and active cell envelope maintenance, and is involved in microbiota-host interaction via human 
peptidoglycan binding proteins. The other being the study of surface cell envelope glycoconjugates 
directly, like fucosylated glycoconjugates, that dominate the microbiota-host interface and are 
suspected to influence it, among others via mimicry of host glycan composition. 
Figure 6. Dual labelling in A. muciniphila with isonitrile PG dipeptide probe 6 labelled with Cy-3 tetrazine (top left), Ac
4
FucAz with 
Cy-5 DBCO (top right), brightfield (bottom left), and overlay (bottom right). Scale bar = 5 μm.
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Conclusions
The newly developed non-toxic cyclopropene 4 and isonitrile 6 d-Ala dipeptide PG probes, together 
with the MOE study, allowed us to successfully perform the first cell envelope engineering experiments 
in a live human gut microbiota member, namely the mucin degrader, A. muciniphila. This provided for 
the first time direct evidence for the presence of PG, cell surface glycoconjugates and an active l-fucose 
glycan salvage pathway in this bacterium. Both these classes of cell envelope glycoconjugates are 
positioned at the microbiota-host interface and are implicated but not yet well understood mediators 
of the complex interactions tied to human wellbeing. 
Here we unambiguously show the presence of surface fucosylated glycoconjugates in A. muciniphila 
thus substantiating their predicted presence based on its genomic potential. Elucidating these basic 
aspects of A. muciniphila molecular physiology will aid in further developing therapeutic opportunities 
for this key human gut microbiota member. Furthermore, the orthogonality of these new PG probes 
with the strain promoted azide alkyne cycloadditions (SPAAC) allowed for live dual labelling and 
imaging of both PG and fucosylated glycoconjugates in their native cell envelope setting. 
The here described novel approach, using both d-Ala dipeptide and monosaccharide analogues – 
simultaneously – with bioorthogonal chemical reporters, adds to the bacterial metabolic labelling 
molecular toolbox. It offers an interesting and powerful new chemically guided approach to functionally 
analyse the role of cell envelope glycoconjugates in key microbiota members. Their application in 
both an aerobic and anaerobic bacterium illustrate their potential for the in-situ investigation of the 
glycoconjugate repertoire of both aerobic and anaerobic microbiota members.
Associated content
The Supporting Information, including probe synthesis, can be found in Appendix A (page 167). 
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Probing Akkermansia muciniphila with Chemical Reporters
Metabolic Glycan Labelling with Azido-Monosaccharides in  
Gut Microbiome Members 
 “Any colour you like”
The Dark Side of the Moon, Pink Floyd
Abstract
Glycans and glycan-based interactions shape the human gut microbiome. Tools to study these key 
ligands at a molecular-level are, however, currently insufficient albeit crucial to understanding their 
role in the human gut. Metabolic oligosaccharide engineering (MOE) is a technique that, if a bacte-
rial salvage pathway for a monosaccharide is present, can explore the variety of glycans containing 
this monosaccharide on the cell surface of human microbiome members.  To this end, we selected 
a set of monosaccharides that are found in bacterial mucin O-glycans and equipped these with an 
azido chemical reporter to enable bioorthogonal labelling with a fluorophore after MOE. Using these 
glycan-based probes, we hypothesised that, if present, the salvage pathways of key members of the 
human gut microbiome such as Akkermansia muciniphila, Anaerostipes rhamnosivorans, Intestimonas 
butyriciproducens, and Eubacterium hallii can salvage these glycan-based probes and built it into their 
glycans. Via MOE we could show the complexity of cell surface glycans in A. muciniphila, A. rhamno-
sivorans, I. butyriciproducens, and E. hallii. Furthermore, the application of MOE in Escherichia coli was 
studied extensively and this resulted in a protocol that enables the labelling of glycans in this model or-
ganism. As a proof of principle, MOE was also performed in co-cultures of key microbiota members to 
investigate the effect on efficiency of glycan salvage and labelling of surface glycans when co-culturing 
these species. Overall, this study provides proof-of-principle results on new MOE-based techniques 
and labels to explore the role of glycans in several key human microbiome members.
Manuscript in preparation: Tjerk J. Sminia, Hanne L.P. Tytgat, Nam T. P. Bui, Han Zuilhof, Willem M. de Vos, and Tom Wennekes
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Metabolic Glycan Labelling in Gut Microbiome Members 
Introduction
The human gut microbiome is home to a variety of bacterial species and is vital to our well-being. 
Although we normally benefit from their presence, a microbial imbalance in our gut is often linked to 
diseases, but how these are linked is far from understood.1 Since all cells are covered with glycans, they 
also play an important role in the functioning of these bacterial species. However, the fact that glycan 
synthesis is not template-driven brings an extra challenge to explore the complex biological role of these 
important biomolecules.2 Many outstanding questions remain such as what role glycans play in the 
inter- and intraspecies interactions between bacteria and human cells.3 Nor is it fully understood why 
bacteria modify their proteins or lipids with glycans. The intestine is home to a heavily O-glycosylated 
mucus layer, covering the intestinal epithelial cell layer and thereby providing a protective barrier. 
Mucus consists of a variety of high-molecular–mass glycoproteins called mucins. The main glycans 
found in these mucins are O-glycans that contain N-acetylglucosamine, N-acetylgalactosamine, 
fucose and sialic acid.4 Mucins offer protection and are increasingly being implicated in host-gut 
microbiome communication processes, but also serve as a carbon and energy source to our gut 
bacteria.5 A chemistry-based approach to study these glycans in more detail is to label them with 
chemical reporters using metabolic oligosaccharide engineering (MOE). MOE has been developed in 
the last 15 years, and is a tool to discover and understand glycan processes in cells in greater detail 
(Chapter 2 and Figure 1).6 MOE operates via the principle that certain unnatural monosaccharide 
derivatives are often still recognised by the enzymatic machinery of cells and allows for them to be 
taken up into the cellular glycan salvage pathways and eventual incorporation into cellular glycans. 
Via this approach, monosaccharides bearing unnatural azido-acetyl groups, which do not interfere 
with biological processes, so called bio-orthogonal chemical reporters, can be successfully built into 
complex glycans.6 
Figure 1. Schematic overview of metabolic oligosaccharide engineering.
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A variety of bio-orthogonal groups are known nowadays, among which the azides, strained alkynes, 
and cyclopropenes are the most popular.6 When these bio-orthogonal groups are present on the 
glycans a click reaction can attach an additional molecule, often a fluorescent dye, to the glycans. Over 
the years, MOE has proven to be a powerful tool to directly image glycans in a variety of mammalian 
cell lines, bacteria, and plants.6-9 
After successful synthesis of a chemical probe, MOE starts when the glycan-based probe is taken 
up by the human or bacterial cell. This can either be via active or passive transport. In the cytosol, 
non-specific esterases can hydrolyse any present masking group (often acetyl esters). Next, the 
glycan-based probe enters the salvage pathway and is activated by endogenous enzymes for use as 
a substrate of glycosyltransferases in further glycan assembly. After the assembly and localisation on 
the cell surface, the conjugation reaction (e.g. click reactions such as copper-catalysed azide alkyne 
cycloaddition (CuAAC) or strain-promoted azide alkyne cycloaddition (SPAAC) can happen. A more 
detailed overview of MOE, including examples and limitations of MOE, can be found in chapter 2. 
The study of gut bacteria using MOE is not new. In 2015, Kasper and co-workers reported an extensive 
study of MOE with Ac
4
GlcNAz, Ac
4
GalNAz, and Ac
4
ManNAz in classes of gut commensals such as 
Bacteroides and Lactobacillus.10 The probes used in that study include azido or alkyne derivatives 
of fucose, N-acetylglucosamine, or N-acetylgalactosamine.10-16,17 Kasper and co-workers expanded 
their approach in 2017 by specifically tagging three surface macromolecules, peptidoglycan, 
lipopolysaccharide and capsular polysaccharide, either simultaneously or individually in living 
anaerobic commensal bacteria.18 For PG labelling a fluorescent dye (HADA, see chapter 1) was installed 
on d-Ala, while for LPS and capsular polysaccharides, azide and cyclopropene chemical reporters were 
installed on N-acetylgalactosamine or KDO. 
The glycan-based probes used in this MOE study were selected based on their presence as 
monosaccharides in mucin O-glycans or other carbohydrate-based carbon sources present in food 
(such as l-rhamnose in plants). In recent years, l-fucose has especially been identified as a glycan that 
exerts influence on the human gut and its microbiome. The overall goal was to assess if members 
of the human gut microbiota could salvage these monosaccharides from the environment and 
incorporate them in their own glycans, as was earlier shown in Bacteroides fragilis.19 The azido-glycan-
based probes Ac
4
GlcNAz 1, Ac
4
GalNAz 2, Ac
4
FucAz 3, and Neu5Az 5 were synthesised following a 
protocol based on the work of Bertozzi and co-workers.55 The synthesis of Ac
4
RhamAz 4, was adapted 
from Chen and co-workers.20 To promote passive cellular uptake of the probes, acetylated azido-
monosaccharides were used.
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 Figure 2. Overview of tested azido-monosaccharides.
As targets for these labelled monosaccharides, eight species present in the human gut core microbiota 
were selected in this study; Bacteroides fragilis, Escherichia coli, Akkermansia muciniphila, Anaerostipes 
rhamnosivorans, Intestimonas butyriciproducens,21 Faecalibacterium prausnitzii,22 Ruminococcus 
bromii27 and Eubacterium hallii.23 Below an overview of these bacteria is presented along with a brief 
explanation about their characteristics and specific reasons for their selection (Table 1).
Table 1. Overview of tested microbes in this study.
Overview tested bacterial species Metabolic property REF
Akkermansia muciniphila Mucus degrader and propionate producer 5
Eubacterium hallii L2-7 Glycan degrader and butyrate/vitB12 producer 24
Faecalibacterium prausnitzii Glycan degrader and butyrate producer 25
Intestimonas butyriciproducens AF211 Lysine/glucose degrader and butyrate/vitB12 producer 21, 26
Ruminococcus bromii starch-degrading species 27
Bacteroides fragilis β-lactamase producer 28
Escherichia coli vitamin K2 producer 29
Anaerostipes rhamnosivorans 1Y-2 rhamnose degrader and butyrate producer 30
As a model system for the initial optimisation of the MOE protocol and imaging techniques, Bacteroides 
fragilis was chosen since MOE using Ac
4
FucAl and Ac
4
FucAz 3 is well established in this species.10, 12 
B. fragilis is a Gram-negative obligate anaerobe that produces eight capsular polysaccharides (A-H) 
and many glycoproteins.31 The abundantly fucosylated polysaccharide A on the surface of B. fragilis is 
involved in immunomodulation and a mutant of B. fragilis ∆PSA does not express this polysaccharide.12, 
19  As the latter is a nice control, both strains were selected as targets for MOE using Ac
4
FucAz 3. 
The application of MOE has already been investigated extensively in B. fragilis, but it has never been 
reported in the widely used E. coli lab strain MG1655. This is quite striking given the ubiquitous use 
of E. coli MG1655 in the lab and the abundant availability of all kinds of mutants for this strain, also 
for glycan-related metabolic pathways. Aware of these possibilities and in part also curious about the 
reason for the lack of examples with MOE in this model organism, we also selected it for investigation. 
Furthermore, a variety of strictly anaerobic gut bacteria was selected. For example, the mucus 
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degrader A. muciniphila that was recently discovered to possess a fucose salvage pathway as shown 
by Ottman et al.,32 and was already extensively studied by us as reported in chapter 3. A recent study 
also showed the therapeutic potential of A. muciniphila towards obesity and diabetes.33
Butyrate-producing Gram-positive bacteria in the gut are important for maintaining human health, 
are involved in key pathways for energy metabolism, and are key members of the intestinal food 
chain including cross feeding with many other gut members.34 Glycans are considered as one 
of the main sources for the production of butyrate by these bacteria.35 It is therefore crucial to 
identify all butyrate-producing species in the human gut and to study this process in more detail to 
understand the mechanisms underlying this production. We therefore selected A. rhamnosivorans, 
I. butyriciproducens, F. prausnitzii, and E. hallii according to their unique characteristics as model 
organisms in this process to further investigate (table 1).36 F. prausnitzii is among the most abundant 
bacteria in the human gut of healthy adults and can amount up to more than 5% of the total bacterial 
population.22 The strictly anaerobic species I. butyriciproducens and A. rhamnosivorans30 have been 
isolated only recently and cultivated from the human gut, and can therefore be studied in more detail 
with MOE and the set of glycan-based probes.
Scheme 1. Suggested biosynthesis of GlcNAc-6-P and dTDP-l-rhamnose from Glc.
A prerequisite to perform MOE in bacteria is the presence of a glycan salvage pathway.37-38 Salvage 
pathways of GlcNAc, GalNAc, fucose, and Neu5Ac have been studied using MOE and reported in 
various  organisms, including bacteria.39-42 Nevertheless, it is never proven that our selection of gut 
bacteria do have such a salvage pathway. Besides that, a rhamnose salvage pathway has never been 
identified in bacteria and the current belief is that all bacterial l-rhamnosides are derived from de 
novo biosynthesised l-rhamnose. To investigate if a salvage pathway might be present in anaerobic 
gut bacteria, the azido-rhamnose probe 4 was developed and included in our study. l-Rhamnoside 
biosynthesis occurs via a glycosyltransferase enzyme that adds l-rhamnose onto other bacterial 
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glycoconjugates.43 The substrate for these l-rhamnosyltransferase is dTDP-l-rhamnose that is 
biosynthesised in three steps from dTDP-glucose (Scheme 1). A. rhamnosivorans can make use of this 
biosynthesis pathway to synthesise dTDP-l-rhamnose and GlcNAc-6-P. The dTDP-l-rhamnose synthesis 
is unique for A. rhamnosivorans compared to other human gut bacteria. The azido-rhamnose probe 
4 can therefore, if the corresponding dTDP donor can be biosynthesised from it in the cell, selectively 
label A. rhamnosivorans in the presence of other gut bacteria.
First, we aimed at direct imaging of specific monosaccharides in complex cell surface glycans in 
core human gut microbiota members using MOE as the labelling technique. Secondly, the capacity 
of the different core members of the human gut to salvage glycan-based probes based on common 
monosaccharide glycans was evaluated. Ultimately, as a proof of principle, we also investigated MOE 
as a tool to label specific gut microbiota bacteria in a complex mixture based on their glycome.
Results and Discussion 
Metabolic Oligosaccharide Engineering in Bacteroides fragilis
MOE relies on salvage pathways to incorporate the probes but does not enable studying every step 
in the biosynthesis in great detail. Another potential drawback of MOE is that certain azido probes 
might be converted into other azido-glycans before ending up on the cell-surface. Last but not least, 
the efficiency of labelling is often low. This is mainly caused by the competition for incorporation into 
the salvage pathway between the azido-monosaccharides and naturally present monosaccharides. 
The latter are often also more easily accepted by the involved salvage enzymes as they represent their 
native substrate. Another reason for the low efficiency might be that intracellular glycans will also be 
labelled with the azide probes, as MOE is not selective for surface glycans (chapter 2). Despite these 
challenges MOE enabled new insights into the world of glycans of core members of the human gut. 
MOE with an alkyne or azido fucose has already been successfully applied in Bacteroides fragilis.10, 12 
Inspired by this, we used the azido-l-fucose probe 3 as a positive control.44 Azido chemical reporters 
are more flexible in the subsequent bioconjugation.6 For example, the copper-free click chemistry can 
be used.45 Although, previous experiments showed that the fucose-salvage pathway in zebrafish is not 
able to process this azido-l-fucose probe 3, MOE experiments in plants and bacteria did show salvage 
and incorporation.10, 44 
For live-cell imaging the use of SPAAC labelling is preferred over CuAAC labelling since no cytotoxic 
copper is needed.45 The commercially available DBCO dyes linked to Cy-3 or Cy-5 were used for the 
SPAAC labelling. The DBCO Cy-3 or DBCO Cy-5 SPAAC reactions were chosen as the bioconjugation 
reaction of choice since these reagents are commercially available. To compare our data with the 
existing protocols, CuAAC labelling was initially performed in B. fragilis. The azido-fucose probe 3 
was added to a freshly inoculated culture and incubated overnight. Labelling was evaluated using 
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confocal microscopy after a 30 minute CuAAC reaction with an Alexa Fluor 488 alkyne conjugate 
and subsequent additives (Figure 3). An optimum was found after 2 hours incubation, while after 
3.5 hours the fluorescent signal was no longer observed, probably due to excessive metabolism. For 
further MOE experiments in B. fragilis we therefore chose this 2 hour incubation time as the optimum. 
Other acetylated glycan-based probes (Figure 2) such as N-azidoacetylglucosamine (Ac
4
GlcNAz, 1), 
N-azidoacetylgalactosamine (Ac
4
GalNAz, 2), or 5-azido neuraminic acid (Neu5Az, 5) have been 
successfully tested in B. fragilis by others.10
Figure 3. Metabolic oligosaccharide engineering in Bacteroides fragilis with azido-l-fucose 3. Labelling was performed with 
CuAAC using Alexa Fluor 488 alkyne. Scale bar = 25 μm and for zoom 5 μm.
B. fragilis can express a variety of capsular polysaccharides among which the fucosylated polysaccharide 
A (PSA) is the most abundant31 and as mentioned a ΔPSA mutant was available which lacks this 
polysaccharide.31 Metabolic labelling with the azido-fucose probe 3 in this mutant should therefore be 
lower compared to the wild type B. fragilis. This was indeed observed in our experiments when both 
species were treated with Ac
4
FucAz 3 and provides evidence that indeed fucosylated B. fragilis cell 
surface glycans are being labelled through salvage of 3 (Figure 4).
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Figure 4. Metabolic oligosaccharide engineering in Bacteroides fragilis and Bacteroides fragilis ΔPSA with Ac
4
FucAz 3. Labelling 
was performed with CuAAC using Alexa Fluor 488 alkyne. Scale bar = 25 μm.
Next, we evaluated SPAAC labelling with a DBCO Cy-3 dye on a dense overnight B. fragilis culture 
containing Ac
4
FucAz probe 3. This resulted in fluorescent bacteria (Figure 5) and in the control culture 
without 3 SPAAC labelling with DBCO Cy-3 dye did not result in any fluorescent signal after washing, 
and the amount of a-specific labelling was thus comparable to that observed while using the CuAAC 
control reaction. 
Figure 5. Bacteroides fragilis with Ac
4
FucAz 3 and SPAAC labelling with DBCO Cy-3  dye. Scale bar = 5 μm.
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Metabolic Oligosaccharide Engineering in Escherichia coli
The positive outcome of this initial study in B. fragilis prompted us to investigate the application of MOE 
in Escherichia coli as the starting point, the wild-type E. coli MG1655, the common E. coli lab strain, was 
selected together with the N-acetylglucosamine-based chemical probe, Ac
4
GlcNAz 1. To evaluate if the 
LB medium, which is known to cause autofluorescence, might interfere with the fluorescent signal, 
the M9 minimal medium was also tested. No effects were observed between the two media, and 
therefore we decided to use LB in all our experiments since E. coli grows faster in LB compared to in 
M9. The standard protocol for MOE involves overnight incubation with the chemical probe. However, 
application of this protocol on E. coli did not result in observable labelling after a CuAAC reaction 
with an Alexa Fluor alkyne dye. We speculated that one of the factors that could cause this negative 
result is E. coli’s short generation time of roughly 20 minutes. This could lead to successfully labelled 
glycans being “diluted” over the ever-expanding E. coli population in the sample and subsequent lack 
of fluorescent signal. An additional process that might contribute to this negative result is that the 
relatively high metabolic rate of wild-type E. coli MG1655 probably resulted in increased chemical 
probe catabolism instead of salvage. Furthermore, a comparatively low level of non-specific esterase 
activity has been reported for E. coli.46 This might result in incomplete intracellular unmasking of the 
acetyl esters on the probe, which are there to facilitate passive probe uptake. To investigate the latter 
we conducted an experiment in which non-acetylated GlcNAz was incubated with E. coli, but still no 
labelling was observed. This could be caused by either insufficient uptake of the probe or because of 
the high turnover rate and metabolic rates. To circumvent the fast metabolism in E. coli we decided 
to carry out an experiment where the probe was dosed into the culture medium at multiple times at 
30 minute intervals during the incubation and the culture was also assessed for labelling after every 
30 minute interval (Figure 6). This resulted in labelled glycans on E. coli indicating that uptake of the 
probe is fine. After 180 minutes incubation with the probe and three cycles of dosing additional probe 
the fluorescence signal did start to significantly diminish (data after 180 min not shown).
Figure 6. MOE in Escherichia coli with Ac
4
GlcNAz 1 (100 μM final concentration). Every 30 minutes additional Ac
4
GlcNAz was 
added. Alkyne Alexa Fluor 488 (5 μl of 1 mM stock) was used for CuAAC reaction. Scale bar = 25 μm and for zoom 5 μm.
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Although the circumstances that achieved this labelling were artificial they did for the first time 
reveal that MOE is, in principle, possible in E. coli MG1655. Next, we studied the individual chemical 
pathways in E. coli MG1655 that are involved in GlcNAc metabolism and salvage. The Keio collection, 
a single-gene deletion collection of all nonessential genes in E. coli K-12 was selected to further 
investigate these individual chemical pathways that might influence probe metabolism.47 From this 
collection we selected the following mutants in which enzymes involved in GlcNAc-UDP biosynthesis 
are affected (Scheme 2): NagK (N-acetyl-d-glucosamine kinase), NagE (N-acetyl d-glucosamine PTS 
permease), NagA (N-acetyl glucosamine 6 P deacetylase), NagB (d-glucosamine 6 P deaminase) and 
Pgi (phosphoglucose isomerase). Next to these mutants we also re-evaluated MOE in E. coli MG1655 
itself, but with NaN3 present during the incubation to arrest its overall metabolic processes.
48
Scheme 2. Biosynthesis of UDP-N-acetylglucosamine.
Figure 7. Metabolic oligosaccharide engineering in selected Escherichia coli Keio collection mutants with Ac
4
GlcNAz 1 (100 μM final 
concentration). Alexa Fluor 488 Alkyne (5 μl of 1 mM stock) was used for CuAAC reaction. Scale bar = 25 μm.
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The incubation time for the Ac
4
GlcNAz 1 probe in this experiment had an optimum around 210 
minutes for the NagA E. coli mutant (Figure 7). Longer incubation times showed less labelling or no 
labelling at all. For the NagK mutant the optimum was found around 180 minutes. Both NagE and 
NagB mutants did not result in any labelling at all. NagA catalyses the hydrolysis of the N-acetyl group, 
since labelling was observed, the N-azidoacetyl group was not affected by this hydrolysis. For NagK, 
which catalyses the phosphorylation of N-acetyl-d-glucosamine derived from cell-wall degradation, 
the product of this reaction is a substrate for NagA (GlcNAc-6-P). The other single-gene deletions are 
involved in other cellular processes such as transport inside the cell (NagE) or reversible isomerisation-
deamination towards fructose (Pgi and NagB). NagE is not necessary for N-acetylated glycans while 
the latter gene NagB might not be active with the azido group present on N-acetylglucosamine. The 
last single-gene deletion we tested was Pgi (phosphoglucose isomerase). This gene is a major player 
in the isomerisation of 6-phosphate glucose. We did observe labelling but less compared to the above 
described single-gene deletion mutants.
 
Figure 8. MOE in Escherichia coli with (right) or without (left) addition of NaN3 with Ac4GlcNAz 1 (100 μM final concentration). 
Alexa Fluor 488 Alkyne (5 μl of 1 mM stock) was used for CuAAC reaction. Scale bar = 25 μm.
The addition of sodium azide resulted in no labelling at all (Figure 8). The cytotoxic effect of sodium 
azide on biochemical processes, e.g. the inhibition of cytochrome oxidase in Gram-negative bacteria, 
is responsible for this.49 The above-described study illustrates the challenges for MOE in E. coli. Others 
have also looked into MOE in E. coli but were never clear in their findings nor reported detailed 
findings to illustrate their hypothesis.9, 50 This study shows, for the first time, that MOE in E. coli can 
be achieved, albeit in an artificial way. In order to further elucidate the metabolic pathways in E. coli 
a more detailed study with the Keio collection might be needed but with the current toolbox not 
possible. First of all, other chemical reporters (e.g. cyclopropenes or isonitriles) can have a different 
effect on the single-gene deletion mutants but are synthetically difficult targets.  Second, the study 
where we dosed additional azido-glycan probe showed labelling but is time consuming and needs 
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the availability of large amounts of chemical probe. This is therefore not suitable for further studies. 
Moreover, this system was highly artificial and therefore not directly related to the biological system. 
ECOM4 (Escherichia coli cytochrome oxidase mutant 4), a mutant of E. coli which lacks the cytochrome, 
might be interesting to further investigate.51-52 The metabolism of this species is hampered and thus 
could positively influence MOE in E. coli. Of course, this system remains artificial and therefore cannot 
resemble the real in vivo situation.
Preliminary evidence for rhamnose salvage in A. rhamnosivorans
After successfully achieving MOE in B. fragilis and E. coli, our investigation was continued in anaerobic 
human gut bacteria with our set of glycan-based probes. We first explored MOE in mono-cultures of 
A. rhamnosivorans and A. muciniphila with rhamnose probe 4 and fucose probe 3 (Figure 9). Control 
experiment showed no a-specific labelling with DBCO Cy-3 or Cy-5 dye in both cultures. When the 
azido rhamnose probe 4 was incubated with either of these bacteria, confocal microscopy showed 
fluorescence in A. rhamnosivorans but not in A. muciniphila. The azido fucose probe 3 only labelled 
glycoconjugates in A. muciniphila. This result provides preliminary evidence for the presence of a 
rhamnose salvage pathway in A. rhamnosivorans and a fucose salvage pathway in A. muciniphila. 
For A. rhamnosivorans this information sums up the tolerance towards rhamnose since, previous 
reported data showed that this strain is capable to ferment rhamnose which is unique in Anaerostipes 
genus.30 The fucose salvage pathway in A. muciniphila was reported earlier by us when we performed 
peptidoglycan and glycoconjugates dual labelling in A. muciniphila, and was backed up by a metabolic 
model describing A. muciniphila. (chapter 3). 
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Figure 9. Metabolic oligosaccharide engineering in A: Anaerostipes rhamnosivorans (panel A) and Akkermansia muciniphila (panel 
B) with control (left), Ac
4
RhamAz probe 4 (middle), and Ac
4
FucAz probe 3 (right) clicked with DBCO Cy-5 dye. Scale bar = 5 μm.
Figure 10. Metabolic oligosaccharide engineering in Akkermansia muciniphila with Ac
4
GalNAz 2 (top) and Ac
4
GlcNAz 1 (bottom) 
clicked with DBCO cy5. Scale bar = 5 μm.
Labelling of other glycans in the cell envelope of A. muciniphila was also investigated using our other 
probes. N-azidoacetylglucosamine 1 and N-azidoacetylgalactosamine 2 both showed successful 
labelling in A. muciniphila. According to confocal microscopy images, Ac
4
FucAz 3 was more efficiently 
salvaged compared to Ac
4
GlcNAz 1 and Ac
4
GalNAz 2. These experiments were in line with our results 
obtained in chapter 3. An exciting direction for future studies is for these in vitro experiments to be 
translated to in vivo experiments. In line with the work of Kasper and co-workers A. muciniphila and A. 
rhamnosivorans labelled bacteria can be administered to mice via oral or direct injection into the gut 
for further elucidation of labelled glycans in vivo.18
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Quantification of fluorescent-labelled cells  in E. hallii, I. butyriciproducens, A. rhamnosivorans, and 
A. muciniphila
To quantify the labelling efficiency of MOE in members of the gut microbiota, we performed flow 
cytometry on MOE labelled bacteria. All bacterial cells were stained with Syto-9 before flow cytometry 
analysis. By using this method any aspecific dye aggregates and non-DNA-containing vesicles (e.g. lysed 
bacteria) could be excluded from the analysis. The Syto-9 labelled cell population in flow cytometry 
could then be further analysed. The APC channel detector displays the Cy-5 fluorescence (horizontal 
axis), while the side scatter is correlated to the particle size (vertical axis). Cells that are stained with 
Syto-9 but are not SPAAC labelled with a dye via MOE are visible in quadrant 1 (Q1). In Q3 and Q4 the 
cells or cellular fragments smaller than the control cells can be observed. In general no cell population 
was found in these quadrants. Upon SPAAC labelling with a Cy-5 dye after MOE the cell population 
shifts to Q2 and thus showed increased fluorescence while obtaining the standard bacterial size. 
Figure 11. Flow cytometry results for MOE in Eubacterium hallii with glycan-based probes. SPAAC with DBCO Cy-5 after 24 
hours incubation with probe. A = without DBCO Cy-5 dye. B = with DBCO Cy-5 dye. The major cell population in the control (A) 
is circled with a red dashed line to assist visual assessment of changes. 
The generation time in E. hallii is rather short (20 min) compared to other human-gut members 
included in this study. The metabolic activity in E. coli, which resulted in degradation of the probe, 
was however not seen in E. hallii (Figure 11). When the DBCO fluorescent dye was added to the 
control sample a small population was labelled. This background labelling amounted to ~15% of the 
total population. The sample incubated with Ac
4
GlcNAz 1 (25% labelled cells) or Ac
4
FucAz 3 (37% 
labelled cells) probe showed a small increase in fluorescently labelled cells compared to the control 
sample. In contrast, a clear shift in population was seen for Ac
4
GalNAz 2. In total 65% of the population 
was fluorescently labelled. The sample with Neu5Az probe 5 did not show any labelling above the 
background signal. An explanation for this might be the absence of neuraminic acid in E. hallii. 
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Figure 12. Flow cytometry result for MOE in Intestimonas butyriciproducens with glycan-based probes. Click reaction with 
DBCO Cy-5 performed after 24 hours incubation. A = without DBCO Cy-5 dye. B = with DBCO Cy-5 dye. The major cell population 
in the control (A) is circled with a red dashed line to assist visual assessment of changes.
Next, Intestimonas butyriciproducens was incubated with the chemical probes. A diminished growth 
of I. butyriciproducens was observed in all samples except Ac
4
GalNAz (Figure 12). When the click 
reaction with the fluorescent dye was performed a high background labelling was observed in the 
control sample. The shift in the observed positive samples was comparable to the shift observed in the 
control, so no significant incorporation of the probes was observed. Therefore, it seems that I. 
butyriciproducens cannot salvage the Ac
4
GlcNAz 1 (68% labelled cells), Ac
4
GalNAz 2 (65% labelled 
cells) and, Ac
4
FucAz 3 (58% labelled cells) probes. After the addition of Neu5Az 5 probe 86% of the 
cells were fluorescent labelled, which is significantly higher than the background level of the control 
(66% labelled cells). From this set of experiments the high background labelling, even in the absence 
of azido-glycans needs to be explored further. For example, it is not clear if the fluorescent dye reacts 
with I. butyriciproducens. For future studies a richer medium or a higher sample loading would provide 
a way to increase the cell population. The drawback might, however, be the presence of now competing 
sugars in the medium, which may result in a diminished uptake of the probe. Another possibility can 
be to add an azido- or alkyne-functionalised d-glucose derivative to the medium, with the hypothesis 
that it would be metabolised, since d-glucose is an important nutrient for I. butyriciproducens.
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Figure 13. Flow cytometry result for MOE in Anaerostipes rhamnosivorans with glycan-based probes. Click reaction with DBCO 
Cy-5 performed after 24 hours incubation. A = without DBCO Cy-5 dye. B = with DBCO Cy-5 dye. The major cell population in the 
control (A) is circled with a red dashed line to assist visual assessment of changes.
The azido rhamnose probe 4 was successfully tested in A. rhamnosivorans as showed by confocal 
microscopy (vide supra). Next, we tested Ac
4
GlcNAz 1, Ac
4
FucAz 3, and Neu5Az 5. A high background 
was observed for all experiments in A. rhamnosivorans (Figure 13). The dense cultures, except 
Ac
4
FucAz 3, showed up top 40% a-specific fluorescent labelling in the control sample. The culture 
containing Ac
4
FucAz 3 showed a diminished growth since flow cytometry did not even count 10.000 
events. Toxic effects of the probe, poor growth, and/or the absence of important carbon sources might 
be the cause. Despite the poor growth, labelling was observed rising up to 74% for Ac
4
FucAz 3. Also 
Ac
4
GlcNAz 1 (70% labelled cells), Ac
4
RhamAz 4 (51% labelled cells), and Neu5Az 5 (56% labelled cells) 
showed labelling with the fluorophore above the background signal. These results provide preliminary 
evidence for the presence of a rhamnose salvage pathway in A. rhamnosivorans. Future studies are 
still needed, in order to show that the rhamnose probe 4 is salvaged and not catabolised into another 
metabolite. For example, isolation of the rhamnose-labelled glycans and detailed mass spectrometry 
may reveal the presence of 6-azidorhamnose on the cell surface glycans.
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Figure 14. Flow cytometry result for MOE in Akkermansia muciniphila with glycan-based probes. Click reaction with DBCO Cy-5 
performed after 24 hours incubation. A = without DBCO Cy-5 dye. B = with DBCO Cy-5 dye. The major cell population in the 
control (A) is circled with a red dashed line to assist visual assessment of changes.
In A. muciniphila the growth was also poor when compared to previous experiments (Figure 14). 
Despite the high background labelling the sample containing Ac
4
FucAz probe 3 showed a clear shift in 
population. Interestingly, fucose labelling in A. muciniphila showed aggregation of bacteria as seen by 
confocal microscopy (Figure 9). Due to time restrictions, the corresponding flow cytometry analysis 
were not used to further investigate this phenomenon. Aggregates might be the result of fucose 
lectin present on the surface of A. muciniphila since the formation of aggregates was solely seen in A. 
muciniphila with the Ac
4
FucAz probe 3.53 Alternative washing methods such as with added Tween®, 
or use of more hydrophilic fluorescent dyes such as sulfo-DBCO-Cy-5 should be evaluated in future 
experiments to see the effect on aggregate formation. Many reported MOE protocols use different 
washing procedures without clear statements or evidence for their effectiveness. For the other azide 
probes no clear effect was seen when it was compared to the control sample. Previous attempts showed 
metabolic labelling with an Ac
4
GalNAz probe 2 (Figure 10), but this was not reproduced in this series 
of experiments. Metabolic labelling remains a challenging technique, and further optimisation in A. 
muciniphila is therefore needed to make conclusions about labelling with Ac
4
GalNAz 2 or Ac
4
GlcNAz 1.
Other members of the human-gut microbiome such as F. prausnitzii and R. bromii were also of high 
interest for our metabolic labelling studies. F. prausnitzii and R. bromii are, however, known to be 
oxygen-sensitive and therefore could not handle the amount of oxygen introduced upon addition 
of the azide probe, resulting in diminished or no growth, respectively.27, 54 To prevent oxygen from 
entering, further experiments should add the probe in an oxygen-free solution by flushing it with an 
inert gas. Another factor worth investigating is the solvent (DMSO) in which the probe is dissolved 
which influences growth negatively. Further optimisation of both growing conditions and medium are 
also necessary to study glycoconjugates in F. prausnitzii and R. bromii.
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Quantification of fluorescent-labelled cells in co-cultures of I. butyriciproducens and A. muciniphila, 
and A. muciniphila and A. rhamnosivorans  
The human gut microbiome consists of a wide variety of bacteria. MOE can, in principle, enable selective 
labelling in bacteria if a salvage pathway is absent in one species or if the probe is not metabolised 
/ taken up by a specific species in the presence of another that does. In chapter 2 techniques are 
discussed which might explore the salvage pathway in more detail in the near future. In this series of 
experiments we tested MOE in co-cultures using different glycan-based probes. Our aim was to label 
selective one species over the other in these co-cultures. As a start, we performed MOE in co-cultures 
of A. muciniphila in combination with either I. butyriciproducens or A. rhamnosivorans. This selection 
was based on the distinct morphology of the bacteria (Figure 15), which enabled visual confirmation 
if we indeed could label different bacterial species using MOE.
Figure 15. Microscope images of bacterial species investigated in this study. Scale bar = 10 μm.
For the co-culture studies the different generation times of the species were taken into account. 
Despite this consideration the distribution of A. muciniphila and I. butyriciproducens was not equal 
(Figure 16D). Future experiments should focus on how to achieve an equal distribution of the co-
culture. In the co-culture of I. butyriciproducens and A. muciniphila the Ac
4
FucAz probe 3 was added. 
With the negative labelling result in the mono-culture for I. butyriciproducens and the positive result 
in the mono-culture of A. muciniphila we expected to selectively label A. muciniphila and not I. 
butyriciproducens. In the control samples prior to fluorescent labelling, the cell population (encircled 
with red dashed line) is seen in Q1 (Cy-5 channel plotted against side scatter; Figure 16A). When 
the DBCO dye was added a ~30% shift of the population to Q2 was observed (Figure 16B). In the 
overlay plot it is clearly seen that the whole cell population is shifted after fluorescent labelling 
(Figure 16C), thereby indicating that successful labelling is achieved. However, the high amount of 
a-specific labelling, observed in the mono-culture of I. butyriciproducens (vide supra), prevents a clear 
interpretation of these co-culture results. For that reason, further experiments are needed. As a start, 
the mono-culture of I. butyriciproducens needs to be repeated with different glycan-based probes and 
fluorescent dyes to decrease the a-specific labelling. 
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Figure 16.Flow cytometry results (A, B, and C) of co-culture 1 of Akkermansia muciniphila and Intestimonas butyriciproducens and 
microscopy images of culture (D) and confocal microscopy of fluorescent labelled Akkermansia muciniphila cells (E). The major 
cell population in the control (A) is circled with a red dashed line to assist visual assessment of changes. Scale bar is 5 μm.
The second co-culture we investigated consisted of A. muciniphila and A. rhamnosivorans with 
Ac
4
RhamAz 4 and DBCO Cy-5 dye (Figure 17). In both mono-cultures a shift in the population with 
Ac
4
RhamAz 4 was observed. The initial results showed that rhamnose probe 4 is only incorporated 
in A. rhamnosivorans, and thereby suggest the presence of a rhamnose salvage pathway in A. 
rhamnosivorans. 
The population shift in A. muciniphila can be considered as a-specific labelling since A. muciniphila 
cannot metabolise l-rhamnose. In the co-culture study the cell population before fluorescent labelling 
but with the rhamnose probe 4 fitted in Q1 (Cy-5 channel plotted against side scatter) (Figure 17A). 
When the fluorescent DBCO dye was added 20% of the cell population shifted towards Q2 (Figure 17B) 
and can thus be considered fluorescent labelled with the Cy-5 dye. Since only Ac
4
RhamAz 4 can react 
with the fluorescent dye a first conclusion is that the cells found in Q2 are Ac
4
RhamAz 4 labelled A. 
rhamnosivorans. Confocal microscopy of mono-cultures A. rhamnosivorans and A. muciniphila proved 
that only in A. rhamnosivorans fluorescent bacteria were obtained (Figure 17E). Future studies are 
however necessary to further investigate and validate this.
Figure 17. Flow cytometry results (A, B, and C) and microscopy images (D and E) of co-culture 2 of Akkermansia muciniphila and 
Anaerostipes rhamnosivorans and microscopy images of culture (D) and confocal microscopy of fluorescent labelled Anaerostipes 
rhamnosivorans cells (E). The major cell population in the control (A) is circled with a red dashed line to assist visual assessment 
of changes. Scale bar is 5 μm.
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Conclusion and Outlook
We here present preliminary results that give strong evidence that metabolic oligosaccharide 
engineering (MOE) might become a highly useful tool to label and directly detect glycans in human gut 
bacteria. MOE has the potential to further explore members of the complex microbiota. The results 
shown in this chapter have added new insights into how to apply MOE on human gut microbiota. The 
azido-fucose probe was used to successfully label fucosylated cell surface glycans in B. fragilis. This 
azido-fucose probe enables SPAAC labelling besides CuAAC labelling. SPAAC labelling is important for 
live cell imaging, something which was not possible with the alkyne-fucose probe.
After this successful labelling we focussed on MOE in E. coli MG1655, which has never been reported 
on this strain with glycan-based probes. Labelling in E. coli was possible when the culture was dosed 
every 30 minutes with additional glycan probe to cope with the fast metabolism and dilution of probe 
due to the short generation time in E. coli. With the current MOE toolbox this artificial system cannot 
be studied in more detail. 
Our next target were human gut-related species. A variety of azido-monosaccharides were tested 
in mono-cultures of E. hallii, I. butyriciproducens, A. rhamnosivorans, and A. muciniphila. A-specific 
labelling, and thus a high background signal, was observed in almost all cultures. Future experiments 
should focus on diminishing this high background labelling. Other washing procedures with for example 
Tween® can be performed or the usage of other more hydrophilic dyes. The tested azido-probes 
were not salvaged by I. butyriciproducens. Optimisation of the medium, incubation time, and time 
of addition of the azido-probes can be performed in future studies to further improve the obtained 
labelling in E. hallii and A. muciniphila. All glycan probes, except Neu5Az 5, showed fluorescent 
labelling, as backed up by flow cytometry. It seems however logical that Neu5Az 5 gave no labelling 
in these and other species. In mammalian cell lines, which are known to have more neuraminic acid 
compared to bacteria, labelling with Ac
4
ManNAz results in azido-labelled neuraminic acid and is a 
well-established method nowadays.
To facilitate a faster metabolic uptake and easier synthesis the glycan probes were acetylated. The 
acetyl groups need to be removed inside the cytosol by non-specific esterases in order to be effective. 
One should take into consideration however, the enzyme activity of these esterases which might be 
diminished or not active at the time point the probes are added. If so, other enzymes can interfere in 
the process and thereby metabolise the glycan probe as a pure carbon source. Future studies should 
investigate the enzyme activity by using a set of non-acetylated and acetylated probes.
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The nutrients inside the medium are important for a good growth of the bacteria. For example, A. 
rhamnosivorans can either grow on rhamnose or glucose in bicarbonate buffered medium. Future 
studies can investigate if A. rhamnosivorans can grow on pure rhamnose probe 4. The same idea can 
be performed for A. muciniphila with azide-labelled mucin or Ac
4
GlcNAz probe 1. For the study in 
co-cultures additional experiments are needed. More control experiments (e.g. more counts in flow 
cytometry of both bacteria) and parameters (e.g. use of other dyes) need to be optimised to make 
decisive conclusions.
Metabolic oligosaccharide engineering provides a fast method to label and track glycans in human-gut 
bacteria. A remaining challenge is to characterise the glycans in more detail. One method to study 
glycans or glycoproteins in more detail is enrichment. After probe incubation, the azido-glycans can 
be conjugated with biotin or digoxigenin (DIG). In the next step, selective capturing of this label with 
streptavidin or anti-DIG results in a conjugated glycoprotein which can be separated on gel or blot. In 
a final stage glycoprotein staining, such as PAS staining, can be performed to visualise glycoproteins 
and subsequent downstream analysis using immunoblots and mass spectrometry. In chapter 6 further 
recommendations about these techniques are given. In the near future more optimisation is, however, 
needed to make the labelling more selective and efficient. If this can be optimised, a full labelling and 
tracking of human-gut bacteria can be explored and mapped in full detail.
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Experimental
1. Chemical procedures
General considerations and materials. All moisture-sensitive reactions were carried out under an 
argon atmosphere, using oven-dried glassware overnight, which was allowed to cool in a desiccator 
over anhydrous KOH, unless otherwise stated. Solvents were either purified over aluminium oxide 
under argon using a Pure Solv 400 solvent purification system (Innovative Technology, Amesbury, 
USA) (CH2Cl2, Et2O, toluene, and THF) or dried over 3Å molecular sieves (CH3CN, CH3OH, Pyridine). 
Commercially acquired chemicals were used without further purification unless stated otherwise. 
Alexa Fluor 488 alkyne, DBCO-Cy3, and DBCO-Cy5 were purchased from Sigma-Aldrich. All chemicals 
used for biological experiments were dissolved in DMSO (1 mM stock solution) and filter-sterilised 
prior to use.
Construction of positive control. Azide magnetic beads (Clickchemistrytools) with Cy-3/Cy-5 DBCO 
dye were used as a positive control. The beads were washed 2 times with PBS on a magnetic stand. 
Click reagents were added (CuAAC: dye, CuSO
4
 and ascorbic acid in 500 μl PBS, SPAAC: dye in 500 μl 
PBS) and incubated for 1 hour at room temperature. The beads were washed 3 times with PBS. The 
samples were mounted on microscope slides and analysed by confocal microscopy.
Initially we tested the CuAAC reaction using commercially available CuAAC reagents. The same 
procedures as in chapter 3 were applied in the gut microbiota species. Later, like in chapter 3 we 
switched to SPAAC as our labelling method of choice. The CuAAC and SPAAC labelling reagents were 
evaluated using commercially available azido-magnetic beads. The samples were analysed by confocal 
microscopy to reveal fluorescent beads (Figure 18). 
Figure 18. Positive control with azide magnetic beads and DBCO Cy-5. Scale bar = 20 μm.
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2. Synthesis of chemical probes
Azido-monosaccharides Ac
4
GlcNAz 1, Ac
4
GalNAz 2, Neu5Az 5, Ac
4
RhamAz 4, and Ac
4
FucAz 3 were 
synthesised following literature procedures.12, 20, 55-56 
3. Biological procedures
Bacterial strains and growth conditions. Bacteria used in this study are Bacteroides fragilis, 
Anaerostipes rhamnosivorans, Intestimonas butyriciproducens,21 Eubacterium hallii, and Akkermansia 
muciniphila MucT (ATTC BAA-835). A. muciniphila was grown in CP medium as described earlier or 
in a synthetic medium where mucin was replaced by 6 g/l threonine, 6 g/l proline, CaCl2 (11 g/l) and 
N-acetylglucosamine (50 mM).5 Mucin (5% w/v) was purified essentially as described by Derrien et 
al.5 CP medium was used for I. butyriciproducens and A. rhamnosivorans with the addition of either 
glucose or rhamnose (50 mM), YCFA medium was used for E. hallii. Co-cultures of A. muciniphila with I. 
butyriciproducens or A. rhamnosivorans were grown in CP medium with the above described additives. 
B. fragilis was grown on basal media. For the co-culture of A. muciniphila and I. butyriciproducens, I. 
butyriciproducens was inoculated first and A. muciniphila was added 5 hours later.
Application of bioorthogonal probes. All probes were dissolved in DMSO and stored in the -20 °C 
freezer and filter-sterilised before use. All media were autoclaved before use. Phosphate buffer 
solution (PBS) was made as follows: 800 ml H2O containing potassium phosphate monobasic (1.12 g), 
NaCl (72 g), and sodiumphosphate dibasic (6.36 g).
Bacterial strains were grown till stationary phase when experiments were performed. Strains were 
inoculated and grown till stationary phase. From this culture, 1000x was taken and inoculated into fresh 
medium. For B. fragilis add glycan-probes (50 μM, final concentration) and incubate the cell culture 
overnight (16 hours) at anaerobic conditions at 37 °C. For A. rhamnosivorans, I. butyriciproducens, 
and E. hallii add glycan-probes (50 μM, final concentration) and incubate the cell culture overnight 
(10-16 hours) at anaerobic conditions at 37 °C. For A. muciniphila: add glycan-probes (50 μM, final 
concentration) and incubate the cell culture for maximum 10 hours at anaerobic conditions at 37 °C.
From this culture, take 0.5-1.0 ml cell culture and put in centrifuge for 10 min at 4 °C, 14,000 rpm. 
Wash cells twice with PBS. Pour off supernatant and suspend cells in click buffer (For CuAAC: 5 μl dye, 
10 μl CuSO
4
 (100mM) and 40 μl ascorbic acid (20 mM) in 500 μl PBS, For SPAAC: 500 μl PBS and 5 μl 
dye.) Incubate for 60 minutes at room temperature in the dark. Put samples in centrifuge (10 min 
at 4 °C, 14,000 rpm) and pour off supernatant. Wash the cells 3 times with 0.5 ml PBS, centrifuge in 
between. For flow cytometry or confocal analyses the supernatant was suspended in 100 μl PBS. 
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4. Biological analysis
Confocal microscopy. Ibidi µ-slide 8 well glass bottom slides were used for confocal microscopy. Live 
imaging was performed on a confocal laser scanning microscope (Leica TCS SP8X system). DBCO Cy-3 
and Cy-5 were excited using a white light continuum laser. Images were captured using a 633 water-
immersion objective with a numeric aperture of 1.2 and a pinhole set to 1 Airy unit. Images were 
captured and processed by ImageJ or LAS AF Lite. 
Flow cytometry. Analysis of glycan labelled cells was performed using a MACSQuant® Analyzer 10 
Flow Cytometer. Single cell populations were localised using FCS and SSC (488-nm 20 mW laser), 
gating pulse Area over pulse Width. Furthermore, Syto-9 (488-nm, 502 LP, 530/30 nm) was used to 
counterstain and distinguish cells from background. Data analysis was performed using FlowJo X 
(Treestar, USA).
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Total Synthesis towards Pseudaminic Acid Probes
“What Shall We Do Now?”
Is There Anybody Out There, Pink Floyd
Work in progress: Tjerk J. Sminia, Han Zuilhof, and Tom Wennekes
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A comparative overview: 
(Bio)-Synthesis of Pseudaminic Acid and Legionaminic Acid 
In recent years, several synthesis of pseudaminic (Pse) and legionaminic acid (Leg) have been published 
by different research groups across the world. Our work on the synthesis of pseudaminic acid was 
partly inspired by these routes. The following section provides a comparative overview of the Pse and 
Leg biosynthesis pathways and the synthetic approaches published up to this point towards Pse and 
Leg or variants thereof. 
Biosynthesis Pseudaminic Acid and Legionaminic Acid
The pseudaminic acid biosynthesis starts with an activated N-acetylglucosamine glycan 1 (Scheme 
1). Although a different biosynthesis might be present in other bacteria the biosynthesis as 
characterised in Campylobacter jejuni and Helicobacter pylori will be discussed. A short effective five 
step biosynthesis using a variety of different enzymes is used by these bacteria. In the first step the 
PseB enzyme, a NAD(P)-dependant C-6 dehydratase and C-5 epimerase, produces ketone 2 via the 
N-acetylglucosamine UDP glycoside 1. The second amine is installed on the C-4 position with PseC. 
N-acetylation and removal of the UDP activator is achieved by PseH and PseG. The aldol reaction 
is performed by PseI using phosphoenolpyruvate (PEP). In natural glycoconjugates, sialic acids are 
exclusively present as the α-sialoside. Although glycosylation mechanism are not exactly known, PseF 
makes a β-CMP pseudaminic acid precursor 6 selectively which is ready for glycosylation reactions.
Almost all enzymes involved in the biosynthesis of pseudaminic acid have been isolated and 
characterised. For example PseG, the fourth enzyme in the biosynthesis, was characterised via X-ray 
crystallography with either the apo-form or the UDP-product bound.1 The biosynthesis of legionaminic 
acid was unravelled by Logan and co-workers in 2009 (Scheme 2).2 The most striking point was 
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Scheme 1. Biosynthesis of pseudaminic acid.
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the discovery of GDP-GlcNAc 10 as the key building block rather than UDP-GlcNAc which is more 
common for this class of nonulosonic acid pathways. The pathway unravelled at that time started with 
dehydratase LegB to eliminate water from the C4,6 of the GDP glycan 10. The 4-keto intermediate 
11 was transferred to an amine using LegC, a PLP-dependent aminotransferase. The resulting di-
amino glycan 12 was acetylated using acetyltransferase LegH. LegG, a hydrolysing 2-epimerase 
transposed the equatorial acetylated amine into the axial acetylated amine. In the final transformation 
LegI condenses the hydrolysed glycan 14 with pyruvate to produce Leg 15. The unique GDP-linked 
intermediates suggested that production on large scale would be very challenging.
A few years later, in 2016, an updated biosynthesis was reported by Boddy et al.3 The expertise of 
producing other nonulosonic acids for example Neu5Ac in E. coli resulted in the hypothesis that 
legionaminic acid could also be produced in E. coli. For this system UDP-diNAcBac served as the most 
important glycan intermediate. The resulting optimised biosynthetic pathway produced 120 mg/l of 
Leg in E. coli. Chemical glycosylation studies with legionaminic acid are important. For that purpose 
an α-phenolthioglycoside was generated from pure Leg. First the O-acetyl groups were de-acetylated 
under standard Zemplén conditions followed by ester formation with CH3OH in TFA. The protected 
carboxylic acid was activated with acetyl chloride and subsequently reacted with thio-phenol to give 
the α-phenylthioglycoside. The α-anomer is important since the β-anomer is the natural anomer in 
solution.
Scheme 2. De novo biosynthetic pathway by Schoenhofen and co-workers.
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Synthesis of Pseudaminic Acid by Ito and co-workers
In 2010, Ito and co-workers reported the synthesis of Pse from 6-hexose precursor 6-deoxy-AltdiNAc 
23 starting from N-acetyl-d-glucosamine (d-GlcNAc) (Scheme 3).4 The synthesis was inspired by the 
biosynthesis of Pse and was achieved in 17 steps.
2-acetamido-2-deoxy-d-glucose (d-GlcNAc, 7) was protected at the anomeric centre with a benzyl 
group. The product was treated with benzaldehyde to give the 4,6-benzylidine benzyl glycoside. The 
3-OH position was protected with another benzyl group to give intermediate 16.5-6 Primary iodination 
with I2, imidazole, and triphenylphosphine gave 4-OH benzyl glycoside. To optimise the formation of 
olefin 18 a two-step procedure was followed, first the 4-OH was protected with a triisopropylsilyl 
(TIPS) group followed by β-elimination of the 6-iodine with t-BuOK and finally deprotection with tert-
butylammonium fluoride (TBAF) to give olefin 18. Wilkinson’s catalyst was surprisingly selective in 
reducing the exocyclic olefin towards 2,6-dideoxy-N-acetyl-l-idosamine 19. The most challenging 
step in the synthesis of 6-deoxy-AltdiNAc 23 was the instalment of the 4-deoxy amino functionality. A 
straightforward S
N
2-type reaction by activation and subsequent displacement with sodium azide was 
not successful. Therefore, a reductive amination from an oxime intermediate 21 was achieved. 4-OH 
glycoside 19 was oxidised to the ketone 6 and treated with O-methylhydroxylamine hydrochloride 
to give a mixture of E/Z isomers. The reduction was performed with one-electron reducing agent 
samariumdiiodide to give 4-acetamidoaltrose derivative 22 as a single isomer after acetylation of the 
crude mixture. The other isomer was not formed probably due to unfavourable 1,3-diaxial interaction. 
Hydrogenation gave the biosynthetic intermediate of Pse 23.
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Scheme 3. Synthesis of intermediate 6-deoxy-AltdiNAc by Ito and co-workers.
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In nature chain elongation of the hexose precursor is achieved with pyruvic acid by an aldol 
condensation, catalysed by aldolases.7 A chemical synthesis equivalent of this step is the Barbier 
allylation.8 This process is well known in organic chemistry literature and has been performed 
numerous times on other sialic acid precursors.9-10 In the Ito route, the Barbier allylation with indium 
in the presence of commercially available bromomethylacrylate ester 24 yielded the desired erythro 
product 25 in a 5:4 ratio to the threo isomers (Scheme 4). Several attempts to improve the selectivity 
by adding Lewis acids and chiral ligands did not improve the selectivity. Ozonolysis of the olefin and 
saponification of the ester gave pseudaminic acid 26. Glycosylation with a Pse-based glycosylation 
donor was also investigated. A dibenzyl phosphite Pse donor was reacted with 6-OH protected glucose 
derivative to give the corresponding disaccharide in an excellent α:β ratio of 10:1. The significant by-
product in the glycosylation reaction was an eliminated 2,3-dehydro Pse derivative, a side reaction 
that is often observed in reactions with sialic acids.
A drawback of the synthesis performed by Ito and co-workers is that the protecting group pattern in 
intermediate 6-deoxy-AltdiNAc 23 and pseudaminic acid 26 does not discriminate between the two 
amine functionalities. For chemical biology studies, which is the aim of our studies, selective chemical 
tags on either the 5-NH2 or the 7-NH2 need to be installed. The two amine functionalities can of course 
be discriminate early in the synthesis but this might influence the selectivity of key steps such as the 
reduction with Wilkinson’s catalyst or the chain elongation under Barbier conditions. An advantage of 
the Ito route is that the synthesis of intermediate 6-deoxy-AltdiNAc 23 is relative fast. The continuation 
towards Pse 26 can be achieved in an overall step count of only 17 steps and provided enough material 
to perform glycosylation studies.
Synthesis by Kiefel and co-workers
The synthesis route towards 8-epi-pseudaminic acid 34 as published by Kiefel and co-workers started 
from keto-deoxynonulosonic acid 28 (KDN), a member of the class of nonulosonic acid which also 
include N-acetylneuraminic acid (Scheme 5).11 The starting material, KDN, is commercially available, 
but quite expensive and was therefore synthesised from Neu5Ac 27 via the method of Schreiner and 
Zbiral, and later optimised by Glatzhofer et al.12-13 The key steps in this synthesis are the introduction 
of an amine on C-7 with inverted stereochemistry, the inversion of the amine functionality on the C-5 
position, and the deoxygenation at the C-9 position of Neu5Ac. The methyl ester β-methyl glycoside of 
Neu5Ac 27 was treated with sodium nitrite in acetic anhydride and acetic acid. The initial conditions 
described by Glatzhofer were further optimised to a procedure that uses a large excess of sodium 
Scheme 4. Final steps in the synthesis of Pse by Ito and co-workers.
Chapter 5
115
nitrite at elevated temperatures for several hours. This optimised process resulted in an improved 
yield of 57% of the protected KDN intermediate. Zémplen deacetylation gave the β-methyl glycoside 
methyl ester of KDN 28 as the starting point for the synthesis of 8-epi pseudaminic acid 34.
An acetonide was installed on the 8,9-position. A short reaction time proved crucial to reduce the 
formation of by-products. The C-4 hydroxyl 29 was selectively silylated with tert-butyldimethylsilyl 
chloride in the presence of imidazole and DMF. With only the C-5 and C-7 hydroxyls unprotected, the 
instalment of the amine functionalities on these positions could commence. The two alcohols at C-5 
and C-7 were activated by triflic anhydride and exposed to an excess of sodium azide to provide the bis-
azide 31 in excellent yield. A Staudinger reduction in the presence of acetic anhydride of the bis-azide 
31 was performed to give selectively the 5-azido 7-acetamide intermediate 32. Simple hydrogenation 
of the bis-azide resulted in the formation of a 1,5-lactam by-product while formation of the bis-
acetamide was never seen. The discrimination of the two azides in this intermediate is of high interest 
for the synthesis of pseudaminic acid analogues including chemical probes of pseudaminic acid for 
metabolic labelling. Finally, bis-acetamide 32 was synthesised after hydrogenation with Pd(OH)2/C in 
methanol with trace amounts of p-toluenesulfonic acid. Trifluoroacetic acid treatment gave the free 
hydroxyl precursor. In the last step iodination of the primary alcohol at C-9 and subsequent treatment 
with Pd(OH)2/C with DIPEA and H2 gave 8-epi-pseudaminic acid 34.
The synthesis of 8-epi-pseudaminic acid was achieved in 9 steps starting from Neu5Ac 27. The authors 
do not comment if 8-epi-pseudaminic acid 34 is a good precursor for the natural occurring pseudaminic 
acid. Given this fact, this route is probably not likely to be of interest for the synthesis of pseudaminic 
acid on large scale. Although 8-epi-pseudaminic acid 34 is not known to be present in bacteria it might 
be of interest as a false positive in biological essays.
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Scheme 5. Synthesis of 8-epi-pseudaminic acid by Kiefel and co-workers.
Total Synthesis towards Pseudaminic Acid Probes
Recently, Kiefel and co-workers published a revised version of this route that is able to produce 
natural pseudaminic acid 26 (Scheme 6).14 From intermediate 31 the synthesis was continued with 
TFA treatment followed by TBS protection of the primary alcohol. The inversion on the 8-position, 
the key step in this sequence, was possible by oxidation with Dess-Martin reagent to the ketone 
followed by selective reduction with BH3·THF complex. This procedure was conducted in an one-pot 
experiment with a 74% isolated yield of the desired epimer 36. Reductive acetylation of the di-azide 
36 was unsuccessful probably due to the C-8 alcohol. The C-8 alcohol was therefore first acetylated 
followed by hydrogenation with Pearlman’s catalyst and p-TsOH as catalyst to give the di-amine which 
was immediately converted into the di-acetamide intermediate 37.
In the hydrogenation step, a catalytic amount of p-TsOH proved necessary to prevent the formation 
of a lactam byproduct which was seen after the intramolecular attack of the C-5 amine onto the 
carbonyl of the C-1 methyl ester. Deoxygenation of the 9-position was achieved via the same method 
with iodination followed by addition of base and Pd/C. Finally, saponification of the methyl ester and 
treatment with DOWEX H+ resin provided pseudaminic acid 26.
Scheme 6. Synthesis of pseudaminic acid by Kiefel and co-workers.
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Synthesis Pseudaminic Acid by Zahringer
Around 2000, the group of Zahringer performed a tremendous effort in synthesising all natural 
occurring microbial sialic acids.15-18 For the synthesis of pseudaminic acid the starting point was 
l-rhamnose, the least expensive 6-deoxyhexose. l-Rhamnose was first converted in the methyl 
glycoside. Subsequently, installation of an 2,3-acetonide, benzoylation on the C-3 position, and 
removal of the acetonide gave the 4-OBz l-rhamnose intermediate.19 Acetylation gave the 1,2,3-tri-
O-acetyl l-rhamnose intermediate. A glycosyl bromide was made and subsequently reacted with 
NaCN. Selective de-acetylation of the C-3 position yielded the building block 40 which was used as 
the starting point for the synthesis of pseudaminic acid. Bu2SnO-mediated benzylation of 1,2-diol was 
performed as previous described.19 The mixture of benzyl by-products was separated from the desired 
benzyl β-rhamnopyranoside benzoates.
Treatment of the 2,3,4-triol 40 with 2,2-dimethoxypropane gave the 2,3-acetonide 41. A Swern 
oxidation gave the C-4 ketone which after reduction selectively produced the axial C-4 alcohol 42.20 
The l-taloside derivative was treated with triflic anhydride and reacted with sodium azide to give 
4-azido 4-deoxy l-taloside 43. The acetonide was cleaved and the same procedure was followed 
to install the 2-azido 2-deoxy moiety. For this, a tin ketal was installed. This enabled the selective 
installation of a benzoyl moiety on C-3 44. Now, activation of the C-2 alcohol followed by reaction 
with sodium azide gave 2-azido 2-deoxy l-rhamnose precursor. The diazide was reduced with LiAlH
4
 
and protected with acetyl groups. Finally, the 3-OH position was inverted by activation with MsCl and 
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Scheme 7. Synthesis of pseudaminic acid by Zahringer and co-workers.
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subsequent opening with aqueous 2-methoxyethanol. The microbial sialic acid precursor was hereby 
synthesised in 18 steps. The benzyl glycoside 45 was deprotected and the resulting anomeric mixture 
was condensed with oxalacetic acid and Na2B4O7. After epimerisation of the C-2 position in the starting 
monosaccharide one of the products resulted in pseudaminic acid as well other related epimers. The 
desired pseudaminic acid 26 was obtained in only 3% yield. The above described synthetic route 
towards pseudaminic acid by Zahringer and co-workers is not suitable for further studies. The last 
step is low yielding and not selective, resulting in a mixture of epimers, without any further possibility 
to continue. The epimers however could be separated and therefore a detailed characterisation of all 
epimers by NMR was provided.
 
Legionaminic acid
Zahringer route to 8-epi-Legionaminic Acid from l-rhamnose 
Zahringer and co-workers were the first to report on the synthetic route of 8-epi-legionaminic acid.16, 18 
In a few years two synthetic procedures were developed (Scheme 8 and Scheme 9).
Zahringer and co-workers started the synthesis of 8-epi-legionaminic acid from l-rhamnose. Several 
modifications achieved the desirable configuration of the C-2 and C-4 amines. The 3,4-OBz l-rhamnose 
47 was converted to a tin ketal with Bu2SnO in refluxing benzene before regioselective benzylation 
was performed.19 This reaction gave the desired product as well as isomers where benzoyl migration 
Scheme 8. Zahringer synthesis route towards 8-epi-legionaminic acid from l-rhamnose.
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occurred. Debenzoylation with sodium methoxide gave the 2,3,4-triol l-rhamnose in large quantities. 
The 3-OH intermediate 49 was made via a short sequence of reactions. The benzoyl groups were 
removed followed by installation of an orthoester. This orthoester was opened selective to give the 
3-OH intermediate 49. The free hydroxyl was reacted with triflic anhydride to activate the alcohol. 
Zemplén de-acetylation and intramolecular attack of the triflate by the liberated alkoxide, resulted 
in formation of the epoxide 50. The 2-OH was activated with triflic anhydride at 0 °C followed by 
nucleophilic displacement with sodium azide to give 2-deoxy 2-azido glycan 51. At elevated 
temperatures the epoxide was selectively opened from the axial position to give the di-azide 52. A 
sequence of hydrogenation with Pd(OH)2, N-acetylation, and again hydrogenation to remove the 
benzyl group resulted in the 8-epi-legionaminic acid precursor 54. Oxalacetic acid in the presence of 
Na2B4O7 at basic pH gave a condensation reaction resulting in a mixture of nonulosonic isomers. The 
isomers were separated by anion-exchange chromatography to give 8-epi-legionaminic acid 52 in 18% 
yield while the 4-epi-legionaminic acid was obtained in 20% yield.
Zahringer route to 8-epi-Legionaminic acid from d-fucose
A few years later Zahringer and co-workers also developed a synthesis towards 8-epi-legionaminic 
acid from d-fucose 56 (Scheme 9).17 After selective protection of the 3-OH with a benzoyl group the 
two remaining alcohols were activated with triflic anhydride. Nucleophilic substitution with Bu
4
NN3 
gave the di-azide product 58. The di-azide was reduced with Pd(OH)2/C and immediately acetylated. 
The di-amino mannose derivative 60 can be chemically or enzymatically elongated by condensation 
with oxalacetic acid under basic conditions or natural enzymes isolated from bacterial species having 
8-epi-legionaminic acid.
This synthesis of 8-epi-legionaminic acid by Zahringer and co-workers is relatively short. A main 
disadvantage is the lack of orthogonal protection of both amines. For metabolic labelling this would 
be a requisite. In order to make metabolic probes based on this route the yields have to be optimised. 
For example the first steps and the final step occurred in poor yields. 
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Scheme 9. Zahringer synthesis route towards 8-epi-legionaminic acid from d-fucose.
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Vauzeilles route for an 9-azido Legionaminic Acid Derivative 
Metabolic oligosaccharide engineering is a powerful tool to study surface glycans (chapter 2). 
Vauzeilles and co-workers reported in 2014 a metabolic labelling probe for legionaminic acid.21 An 
6-azido hexose, 6-azido-2,4-diacetamido-2,4,6-trideoxy-d-mannopyranose 67 was synthesised in 11 
steps (Scheme 10). The non-acetylated variant was also synthesised in order to study the differences 
in metabolic uptake into the cell. The synthesis was mainly inspired by the Zahringer synthesis with 
modification or improvements where necessary. 
β-d-galactose penta-acetate 61 was first protected at the anomeric centre as para-methoxyphenyl 
glycoside 62. Zemplén de-acetylation followed by selective installation of two benzoyl groups on the 
3 and 6-position was achieved in 70% overall yield (two steps). The two remaining alcohols 63 were 
activated with triflic anhydride and reacted with Bu
4
NN3 to give 64. The di-azide was debenzoylated 
under Zemplén conditions followed by hydrogenation with Pd(OH)2/C. The two amines were acetylated 
in one-pot to give 65. The alcohol on the 6-position was activated with TsCl and immediately reacted 
with sodium azide. The 6-azido legionaminic acid precursor 66 was deprotected at the anomeric 
centre to achieve an overall yield of 17%. For metabolic labelling purposes 6-azido legionaminic acid 
precursor 67 is a valuable substrate. The performed route by Vauzeilles and co-workers is well suited 
for this purpose.21 
Seeberger Route Legionaminic Acid
The structural complexity of legionaminic acid is one of the reasons why only a few synthesis towards 
legionaminic acid are known. In 2015, Seeberger et al. published an elegant de novo synthesis of 
orthogonally protected legionaminic acid in 12 steps from aldehyde intermediate 69 (Scheme 11).22
Scheme 10. Synthesis of legionaminic acid azido-precursor by Vauzeilles and co-workers.
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d-Threonine 68 was chosen as a starting point to make, according to a slightly modified literature 
procedure, Garner aldehyde derivative 69.23 The intermediate d-allo-threonine is commercially 
available but notoriously expensive. Therefore, d-allo-threonine was made via methyl ester protection 
and subsequently N-benzoylation of d-threonine. Followed by the necessary C3-epimerisation which 
was performed by thionyl chloride induced cyclisation and acidic hydrolysis. Next, d-allo-threonine was 
treated with dimethoxypropane under catalytic acidic conditions to install the acetonide. Reduction of 
the ester with DIBAL-H gave the desired aldehyde 69. To install the amine functionalities on aldehyde 
69 a Petasis borono-Mannich reaction was chosen.24 For this, aldehyde 69 was first reacted in a 
Cram-chelated organometallic addition reaction with 2-lithiofuran to yield the desired syn-alcohol 
70.25 Ozonolysis in the presence of methanol gave a methyl ester which was reduced with lithium 
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Scheme 11. Formal synthesis of legionaminic acid by Seeberger and co-workers.
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borohydride to give diol 71. X-ray crystallography confirmed the correct stereo-chemical assignment. 
Oxidation of the primary alcohol was rather challenging. Dess-Martin oxidation or TEMPO-mediated 
oxidation gave low conversion and no conversion at all, respectively. A modified TEMPO-oxidation 
following Anelli’s optimisation gave the desired aldehyde 72 in quantitative yield without loss of the 
stereochemical purity.26-27 With the aldehyde 68 in hand the Petasis borono Mannich reaction was 
tested and extensively optimised. Monoallyl amine in ethanol in the presence of (E)-styrylboronic acid 
gave exclusive formation of the anti-diastereoisomers with d.r. > 19:1 in 76% yield. The allyl groups 
on the installed amine functionality were isomerized with Pd(0), hydrolysed and the liberated primary 
amine was acetylated for further use. Oxidative cleavage with ozone was problematic in the work-up. 
Resin bounded triphenylphosphine finally resulted in complete conversion to the aldehyde without 
loss of the stereochemistry outcome of the reaction. The mild indium-mediated Barbier allylation 
was performed in aqueous media while sonicated to install a masked pyruvate unit 75. A mixture 
of alcohols was obtained which was used in the next step for the oxidative cleavage. A reductive 
workup and separation of the diastereoisomers gave protected 4-epi-legionaminic acid (not shown) 
and protected legionaminic acid 76 in good yield.
The synthesis of legionaminic acid as performed by Seeberger and co-workers is full of excellent 
synthetic manipulations which requires skilled organic chemists. Although a large scale synthesis 
via this route is probably not suitable to produce enough material to do extensive glycosylation and 
subsequent studies. The use of Garner aldehyde derivative ones again proves how valuable this 
intermediate is for synthesis of microbial sialic acids. The use of an amino acid as starting point is, 
given the complex structure, a smart starting point for both pseudaminic and legionaminic acid.
Conclusion comparative overview
Over the last years pseudaminic and legionaminic acid achieved a lot of interest. It is therefore 
not surprisingly that new synthetic routes have been developed towards Pse or Leg, precursors or 
derivatives thereof. New routes will probably be published soon after which the biological studies can 
have greater impact, and from which new insights in the relevance of Pse and Leg will likely follow 
soon.
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Results and Discussion Synthesis Towards Pseudaminic acid
The l-mannose and l-glycine configurations in Pse (pseudaminic acid, 26) provide a formidable 
synthetic challenge for which currently only a few chemical synthesis strategies exist (vide supra). 
Inspired by the biosynthesis of Pse in Nature and the known synthesis for Pse, we envisioned a two-
phase strategy.4, 11 In the first phase a Pse hexose derivative 76, the natural precursor towards Pse, 
would be synthesised. From this intermediate we should then be able to prepare Pse 26 using the 
well-developed chemistry for this final C-3 elongation in sialic acid chemical synthesis.4, 10, 28 In Figure 1 
the retrosynthetic analysis for Pse is shown. 
The key step in this proposed route would be the Henry reaction between a nitro 79 and 
α-aminoaldehyde moiety 80. The corresponding nitro-alcohol  77 can then be further functionalised, 
in the second phase, to Pse with a Barbier allylation and ozonolysis. The α-aminoaldehyde 80, a Garner 
aldehyde derivative, needed for the Henry reaction can be synthesised from l-threonine 82 via the 
l-allo-threonine 81 intermediate. The nitro counterpart for the Henry reaction can be synthesised in 
a two-step procedure. The initial goal of the project, to synthesise chemical probes for metabolic Pse 
labelling is suitable via this route. The orthogonality of the amine functionalities (NBoc protection 
and a NO2/N3 masked amine) should result in controlled selective instalment of the azido-acetamide 
groups. As explained in chapter 2, other bioorthogonal groups such as cyclopropene or isonitrile also 
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Figure 1. Retrosynthetic analysis of pseudaminic acid 26 and Pse azido precursor 76.
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are worth considering. Orthogonal protection groups during the synthesis allow for easy selective 
modification of our targets. The orthogonal protection groups allow us to synthesise a variety of 
chemical probes from the same intermediate. This might be of interest since some chemical probes 
might interfere with the biological pathways. 
l-allo-Thr 81 would be a very expensive starting material to employ for a large scale synthesis of Pse 26 
at €400,- per gram. l-Thr 82 on the other hand is a cheap starting material at €13,- per gram. The first 
step in the route is therefore to invert the stereochemistry of the alcohol moiety in l-Thr 82 (Scheme 
12).
For the conversion of l-Thr 82 into l-allo-Thr 81 the carboxylic acid was protected as a methyl ester 
and the amine with a benzoyl group according to standard procedures.29,30 Alcohol 83 was inverted 
via a two-step method.31 First thionyl chloride was added to give a cyclic oxazole intermediate 84 with 
inversion of stereochemistry at C-3. When the oxazole intermediate 84 was poured into acid, l-allo-
Thr 81 was obtained in quantitative yield. Overall l-allo-Thr 81 was obtained in gram-quantities over 4 
steps in excellent yields and employing only one purification method, either crystallisation or column 
chromatography. The total synthesis continued with two more protection steps (Scheme 13).
Carboxylic acid 81 was reprotected as a methyl ester and amine 85 was Boc-protected using Boc 
anhydride.29,32 An isopropylidene ring was installed on the alcohol 86 (scheme 14). The rigid ring 
system in combination with the Boc-carbamate resulted in rotamers as seen by NMR.
Methyl protected carboxylic acid 88 was converted into an α-aminoaldehydes 80 via a two-step 
procedure involving ester reduction and reoxidation of the alcohol intermediate to the aldehyde. To 
Scheme 12. Synthesis of l-allo-threonine.HCl 82 from l-threonine.HCl 81.
Scheme 13. Synthesis of BocHN-l-allo-Thr-OCH3.
Scheme 14. Synthesis of Garner aldehyde derivative 80.
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preempt stability issues with the α-chiral aldehyde 80, the alcohol was stored in larger quantities while 
the α-aminoaldehyde was always directly used after synthesis. Overall the Garner aldehyde derivative 
80 was obtained in 36% overall yield in 9 steps. 
With 80 in hand, the key nitro-aldol reaction could be explored. For our target, Pse, the stereoselectivity 
of this reaction needs to be tuned to yield a syn alcohol-amino/nitro motif. This motif corresponds to 
the C5-amino and C5-ring oxygen in Pse. The nitro-aldol reaction, also known as the Henry reaction, 
is a powerful reaction discovered in the late 19th century by L. Henry (Scheme 15).33-34 Over the last 
decades numerous synthetic transformations have been employed using the Henry reaction as a key 
step.35 Also α-aminoaldehydes have been successfully used in the nitro-aldol reaction (vide infra).
Table 1. Overview of performed attempts in the nitro-aldol reaction with Garner aldehyde derivative. 
Reagents Entry Catalyst or 
additive
solvent reaction 
time
yield (mixture) T (°C) REF
89a
3M in THF
THF 1-4 days 17 % -40 - 0 °C 36
89b LiOH THF-H2O
(3:2)
1-4 days 30% 0 °C
89b NaOH THF-H2O
(3:2)
1-4 days 30% 0 °C
89c LiOH dioxane-H2O
(3:2)
16 h 9% 0 °C
89d wt-HbHNL TBME / 
P h o s p h a t e 
buffer
- rt 37
90a LiOH THF-H2O
(3:2)
1-4 days 13% 0 °C 38
Scheme 15. Generic reaction scheme for the nitro-aldol reaction with Garner aldehyde derivative.
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91a LiOH THF-H2O
(3:2)
3 days traces rt
91b cetyltrimethyl 
ammonium 
chloride
NaOH 
(0.25 M)
3 days - rt 39
91c LiOH THF-H2O
(3:2)
16 h - 0 °C
91d LiOH THF-H2O
(3:2)
16 h - 0 °C
92a NbCl3 (DME) THF - rt 40
90b hydroxynitrile 
lyase from He-
vea brasiliensis
TBDME 4 days - rt 41
89e cetyltrimethyl 
ammonium 
chloride
NaOH 
(0.25 M)
THF
39
89f Al2O3 THF 42
89g tert-butyl  
ammonium 
fluoride
THF - 43
*conversion is consumption of starting material as evaluated by TLC and NMR. Yields are reported when isolated products were 
purified and characterised. - = not determined/analysed. rt = room temperature.
We started, inspired by Shibasaki et al, with a catalytic Henry reaction using a lanthanum-lithium binol 
complex 93.36-38 A set of different rare earth metal catalyst have been designed and tested by Shibasaki 
and co-workers for the nitro-aldol reaction.39 The lanthanum-lithium binol complex 93 (Table 1, entry 
1) was for our substrate the best option since this catalyst showed good syn-selectivity in high yield 
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on a similar substrate in the work of Shibasaki.37, 40 We prepared catalyst 93 ourselves and tested 
it in a simple nitro-aldol reaction (Scheme 16). For the preparation of the catalyst two lanthanum 
sources can be used, LaCl3·7H2O or La(O-i-Pr)3. Both substrates were equally selective but the former 
lanthanum source is cheaper.
The synthesis of this lanthanum-lithium complex 93 was successfully performed as showed by a 
test reaction between an aldehyde 93 and nitroethanol 91  (see experimental section for detailed 
synthesis). Other rare earth metal catalyst were not investigated since catalyst 93 clearly showed the 
best results in the desired syn-stereochemistry.41 
The nitro-reagent 79 was made in a one-step procedure from trimethylformate 97 and nitromethane 
98 and distilled before use as described by Royer et al., (Scheme 17).42 The distillation reaction was a low 
yielding step but gave enough material to perform the Henry reactions. Highly pure Zn-catalyst (dried 
after refluxed in thionyl chloride43) or higher catalyst loading did however not improve the reaction 
yield. For the synthesis of diethoxynitroethane the same procedure was followed. Initial screening 
of the Henry reaction was performed with dimethoxynitromethane 79 but often the procedure 
was compared with diethoxynitroethane. The Henry reaction proved to be rather challenging with 
our aldehyde. The Shibasaki procedure using the lanthanum catalyst 93 provided, after extensive 
optimisation a poor 17% yield and was obtained as a mixture of diastereoisomers (entry 89a).40 
Separation on a chiral column (Chiralpak IA column with mobile phase: hexane / 2-propanol) was 
possible but we decided to look for alternative, better yielding reactions. Furthermore, the reaction 
was not well suited for the large scale we aimed to synthesise this intermediate at. Another example 
of the Henry reaction, employing a simple inorganic base, was reported by Schmölzer et al. in 2013.44 
Scheme 16. Show-case example of lanthanum-catalysed nitro-aldol reaction.
Scheme 17. Synthesis of nitro-acetaldehyde 79.
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They showed that inorganic bases such as LiOH in THF–water mixtures were able to perform the 
nitro-aldol reaction in excellent yield and scale on a diastereomer of the Garner aldehyde derivative 
(Scheme 18). Based on this procedure, we reproduced their experiment with our aldehyde 80 and 
1.2-7 equivalents of the nitro reagent 79. With cooling (0 °C) and long reaction times (varying between 
1-4 days) we found an optimum after 4 days (entry 89b). An isolated yield of only 30% was however 
obtained of the desired product as an inseparable mixture of diastereomer. According to NMR, a 1:1 
ratio of diastereomers was obtained of two products. These two products corresponds to anti-syn 
89 and anti-anti 89. Changing the ratio between THF and water did not improve the yield compared 
to the standard ratio of THF – water 3:2. THF-water froze if the reaction was performed below -5 °C. 
Dioxane, which does not freeze at – 5 °C like THF, also did not improve the reaction yields (entry 89d). 
The addition of more base (LiOH) 1.0 or 2.0 equivalents also did not improve the reaction outcome. 
Changing the bases from LiOH to NaOH or KOH did not improve the reaction conversion or yield (entry 
89c). Organic bases such as Et3N or DBU gave no conversion at all. The Henry reaction with inorganic 
bases was also performed in deuterated solvents inside a NMR tube. We clearly observed fast product 
formation in the first hours but it clearly reached an equilibrium at a later stage. When we changed 
the nitro-reagent 79 to the diethoxynitroethane 90 we were able to isolate product in poor yield 
(entry 90a). Other nitro-reagents such as nitroethanol 91 or THP-protected nitroethanol hardly gave 
conversion to the desired products (entry 91a-d). An old literature procedure with a benzylimine 
acetal 92 and stoichiometric amounts of niobium trichloride was also investigated.45 The proposed 
product an amino-alcohol was however never formed (entry 92a).
Nitro-aldol condensation reactions have also been catalysed using cetyl trimethylammonium chloride, 
aluminium or tert-butylammonium fluoride, but this did not work in our hands (entry 89e-g).46-48 
Inspired by nature, we also performed an enzymatic reaction which is able to perform nitro-aldol 
reaction.49-50 For this enzymatic transformation we used hydroxynitrile lyase from Hevea brasiliensis. 
This class is generally used for the formation and cleavage of cyanohydrins. At pH 7 in phosphate buffer 
we performed first a test reaction with benzaldehyde and diethoxynitroethane but only obtained 1% 
yield after extensive column chromatography. With aldehyde 80 we never observed product formation 
(entry 90b).
Scheme 18. Generic reaction scheme for the nitro-aldol reaction with Garner aldehyde 99 and an isomer of Garner aldehyde 
derivative 100.
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Table 2. Overview of performed attempts in the nitro-aldol reaction with Garner aldehyde and isomers thereof.
Reagents Catalyst or 
additive
Solvent Reaction 
time
conver-
sion
yield (mixture) T (°C) REF
LiOH THF - 
H2O (3:2)
16 h - 101: 19 %
102: 37%
- 0 °C 38
*conversion is consumption of starting material as evaluated by TLC. Yields are reported when isolated products were purified 
and characterised. - = not determined/analysed.
To test the reproducibility of the literature procedure of Schmölzer et al. we synthesised the isomer 
of the Garner aldehyde derivative and the Garner aldehyde (Scheme 18).51 For compound 102 we 
could isolate the desired product in 37% yield (Table 2). The Henry reaction with Garner aldehyde 101 
yielded 19% of the desired product. These results clearly indicated the potential of the Henry reaction 
on Garner aldehyde isomers but also clearly stated the importance of the correct stereochemistry of 
these isomers.
All steps in the nitro-aldol reaction are completely reversible. After deprotonation with a base the 
resonance stabilised anion easily performs the aldol reaction. If lithium ions are present a chair-like 
conformation is obtained (Scheme 19). Different conformations are possible depending a lot on the 
sterics of the R-groups. If the Garner aldehyde derivative 80 derived from l-allo-Thr 81 was used we 
obtained the product in poor yield. The corresponding Garner aldehyde derivative 100 derived from 
l-Thr 82 gave however satisfying outcome.44
The installation of an amino-alcohol functionality onto α-aminoaldehyde 80 is notoriously difficult. A 
Cram-chelate controlled organometallic addition on α-aminoaldehyde 80 is for example not possible.25 
The desired anti-addition cannot be controlled due to steric effects and therefore will result in mainly 
syn-addition (Figure 2). Anti-addition is achieved when nucleophilic attack happens from the si face in 
conformation B. The N,O-isopropylidene moiety, C-4 methyl, and the carbonyl group have influence 
on the conformation, resulting in rotamer A as the preferred conformation. 
Scheme 19. Proposed reaction mechanism nitro-aldol reaction.
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On the enantiomer aldehyde 100 such a Cram-chelate controlled organometallic addition is possible 
as showed by Seeberger and co-workers.22 This method was used for the de novo synthesis of 
legionaminic acid in 2015. 
Tethered aminohydroxylation
After all the above described efforts to perform a successful nitro-aldol reaction we started looking 
for other synthetic reactions to install an amine-alcohol motive in our molecule. A possible synthetic 
manipulation to install an amine and alcohol moiety would be the tethered aminohydroxylation.52 The 
tethered aminohydroxylation is a variant of the aminohydroxylation.53 In the aminohydroxylation, first 
described in 1996 by Sharpless and co-workers, alkenes are turned into vicinal amino alcohols. Since it 
also occurred in an enantioselective fashion this transformation is known as the Sharpless asymmetric 
aminohydroxylation. One of the limitations of this reaction is the lack of regiochemistry on more 
complicated unsymmetrical alkenes. To circumvent this potential problem Donohoe et al., tethered 
the source of nitrogen to an achiral allylic alcohol 103.54 This method achieved regiochemistry of the 
amino alcohol motif in the product 104 (Scheme 20). 
The mechanism for the tethered aminohydroxylation was proposed by Donohoe and co-workers 
in 2012 (Scheme 21).55 It is in line with the proposed mechanism for the Sharpless asymmetric 
dihydroxylation.56 In the first step an trioxoimido osmium complex 106 is formed between 
the osmium salt and the N-oxy-carbamate 105. An intramolecular [3+2] cycloaddition follows 
between the osmium complex and the alkene. The formed cycloadduct 107 can undergo another 
oxidation with new N-oxy-carbamate 108. If hydrolysis is fast, product 110 is formed immediately. 
It is, however, also possible that a second cycloaddition happens with a second alkene. The 
secondary cycle strongly indicates that the addition of asymmetric ligands to improve the 
enantioselectivity will not help since the osmium metal remains hindered during the catalytic cycle. 
Figure 2. Schematic scheme for the Cram-chelate organometallic addition on Garner aldehyde isomers.
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For our system the tethered aminohydroxylation would be helpful to install the amino-alcohol moiety 
and circumvent the need for the troublesome Henry reaction. To build the tethered amino source a 
Grignard reaction on aldehyde 80 was performed. Unfortunately, no selectivity was obtained in this 
step. Moreover, the diastereoisomers of 112 could not be separated at this stage.
The vinyl alcohol 112 was further functionalised towards the tethered amine source. A N-oxy-
carbamate 113 was installed using hydroxylamine hydrochloride after CDI activation. This one-pot 
reaction was performed on gram-scale with variable success (56% yield). One of the reasons was the 
high polarity of the product, which caused problems especially in column chromatography.
A few aryl chlorides 114-116 were coupled to the N-oxy-carbamate linker 113 to explore the effect 
on the efficiency in the tethered aminohydroxylation. In 2007 Donohoe and co-workers reported that 
the penta-fluor aryl moiety 116 was the best substrate for the tethered aminohydroxylation.57 The 
yield with this group improved significantly and the osmium catalyst loading could be lowered to 1 
mol% without the loss of diastereoselectivity. In later work by Donohoe et al, 2,4,6-trimethylbenzoyl 
chloride 115 showed the best reaction yields on the most complex structures.58 A clear explanation 
Scheme 20. Tethered aminohydroxylation of allylic carbamates.
Scheme 21. Proposed reaction mechanism of the tethered aminohydroxylation.
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for this observed behaviour was however not provided. Benzoyl chloride 114 will result in an aryl 
substituent without extra electronic potential. The 2,4,6-trimethylbenzoyl chloride 115 is even more 
bulky than the benzoyl variant 114. Last, penta-fluor benzoyl chloride 116 was coupled to explore 
the effect of its electronic withdrawing character. In our hands the synthesis of both benzoyl 114 
and 2,4,6-trimethylbenzoyl N-hydroxy carbamates 115 went fine, yielding foamy white products. The 
installation of 2,4,6-trimethylbenzoyl 118 was performed in 84% yield compared to 77% yield for the 
benzoyl moiety 117. The penta-fluor moiety 116 caused more problems. We therefore decided to 
focus on the two other substrates. 
The tethered aminohydroxylation was performed on both substrates 117 and 118 (Scheme 24). In both 
cases addition was performed from the same side giving syn-products. Since both diastereoisomers 
were present in the reaction mixture we obtained again a mixture of diastereoisomers. At this point, 
however, partial separation was possible.
Next, we aimed for the Barbier allylation.28 The Barbier allylation is widely explored in the synthesis of 
several naturally occurring higher carbon sugars.10, 59-60 One of the main advantages is that the Barbier 
allylation can be performed on unprotected carbohydrates. As a consequence, this reaction can be 
performed in aqueous solvents and is therefore relative safe and simple. The original procedure as 
developed by Barbier used magnesium, nowadays other metals such as Sn, In, or Zn are mostly used. 
The Ito route also used this chain-elongation reaction in their synthesis towards pseudaminic acid.4 
A commercially available bromomethylacrylate ester was used in combination with indium. Two 
isomers, erythro and threo were obtained with a slight preference for erythro. Attempts to improve the 
selectivity with Lewis acids and chiral ligands did not help. We envisioned a same lack of selectivity for 
Scheme 22. Grignard reaction on Garner aldehyde derivative 80.
Scheme 23. Synthesis towards the tethered amine source 117-119.
Chapter 5
133
our building block in the Barbier allylation. To perform the Barbier allylation, the primary alcohol 120 
needed to be oxidised to aldehyde 121 (Scheme 25). A variety of oxidation reactions were evaluated 
to achieve this. Dess-Martin periodane reagent only gave trace amounts of the product, leaving the 
majority of the starting material untouched.61-62 Swern oxidation with DMSO and oxalyl chloride gave 
degradation during the work-up. Oxidation with TEMPO, IBX, or tetrapropylammonium perruthenate 
(TPAP) resulted in no conversion of the starting material. Acetylation of the primary alcohol also led to 
N-acetylation. This was not seen as a potential problem, however, the attempted selective removal of 
the O-acetyl groups after the N-acetylation gave back the initial starting material. In literature only one 
example was found where this motif of a primary alcohol next to a cyclic carbamate was oxidised.63  In 
our hands this procedure also gave product formation but never reached full consumption of starting 
material. Since the cyclic carbamate need to be removed at a later stage anyway we decided to switch 
the order of reactions. First the cyclic carbamate was removed and then we focussed on the oxidation 
of the primary alcohol. The synthesis continued with the hydrolysis of the cyclic carbamate under 
basic conditions. The conversion was smoothly completed in two hours and the crude mixture 122 was 
submitted to the next step without further purification. 
To discriminate between the two amine functionalities we wanted to protect the amine. The protection 
group should be acid stable and small, in order not to interfere with later modifications. We therefore 
decided to install an azide on this position. Deprotection is easily performed under hydrogenation 
yielding an primary amine which can later be modified towards an azido-acetyl group which can be 
used for metabolic labelling. The recently developed diazotransfer reagent 123 by Stick et al. was 
used to install the syn-azido alcohol 124 (scheme 24).64-66 Different imidazole sulfonyl diazotransfer 
reagents were developed in recent years but the imidazole sulfonyl diazotransfer sulfate salt 123 
proved to be efficient, shelf-stable, and easy to prepare. After the removal of the cyclic carbamate and 
conversion of the amine into the azide we turned back to the oxidation of the primary alcohol. Dess-
Martin periodane was now, indeed able to oxidise alcohol 124 selectively towards the aldehyde in the 
presence of the secondary alcohol (scheme 25).
Scheme 24. Synthesis of cyclic carbamate using the tethered aminohydroxylation.
Scheme 25. Proposed oxidation of the primary alcohol.
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Time limitations and the availability of material prohibited us to continue at this stage. Further 
investigations are needed to accomplish a successful total synthesis of Pse or its metabolic hexose 
precursor. For metabolic labelling studies a smart design of the probes is desired. If a variety of 
chemical probes will be evaluated one common synthetic intermediate would be ideal. Furthermore 
orthogonal protection groups are preferred in order to selectively modify functional groups and to 
synthesise the chemical probes. 
Experimental section
General
For reactions conducted under anhydrous conditions glassware was dried overnight in an oven at 150 
°C and was allowed to cool in a desiccators over anhydrous KOH. Anhydrous reactions were carried 
out under nitrogen. Reagents/solvents for anhydrous reactions were obtained from a Pure Process 
Technology Glass Contour solvent purification system (SPS) (CH2Cl2, THF, diethyl ether, toluene), with 
3Å molecular sieves (DMF, CH3CN, CH3OH, toluene, pyridine) or Na2SO4 (acetone). Commercially 
acquired chemicals were used without further purification unless stated otherwise. 
Flash Column Chromatography
Flash column chromatography was carried out according to standard procedures using silica gel (40-63 
µm mesh) from Screening Devices, Amersfoort.60 Prior to loading an appropriate eluent was chosen 
by running a TLC of the crude mixture which was to be purified. Loading was performed with celite or 
small volumes of the eluent.67
Scheme 26. Synthesis of syn-azido alcohol 124.
Scheme 27. Oxidation of the primary alcohol 124 with Dess-Martin periodane.
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Thin Layer Chromatography (TLC)
Thin layer chromatography was carried out on and visualised using UV (254 nm), Hanessian stain, 
sulfuric acid, KMnO
4
, I2 or ninhydrin stain. The quoted Rf values are rounded to the nearest 0.05.
Nuclear Magnetic Resonance (NMR)
1H- and 13C-NMR were run on a Bruker Avance 400 NMR spectrometer (400 MHz). Chemical shifts are 
reported in parts per million (ppm) with reference to tetramethylsilane (TMS) as internal standard. 
Coupling constants (J) are reported in Hertz (Hz), rounded to the nearest 0.5 Hz. Signal assignment was 
made from unambiguous chemical shifts and COSY, HSQC, HMBC, and/or DEPTQ. 
High Resolution Mass Spectroscopy (HRMS)
High-resolution ESI mass analyses were recorded on a Orbitrap high-resolution mass spectrometer. 
The orbitrap high-resolution mass spectrometer system consisted of a ESI ion source (Ion-Sense, 
Saugus, USA) coupled to an Exactive high resolution MS system (Thermo Fisher Scientific, San Jose, CA, 
USA). The MS was calibrated daily using ProteoMass™ LTQ/FT-Hybrid ESI (positive and negative mode) 
Cal Mix (Sigma Aldrich), which is applicable for the m/z range 100‒2000. XCalibur software (version 
2.1) was used for instrument control, data acquisition and data processing.
Infrared Spectroscopy (IR)
Infrared spectra were recorded on a FT-IR spectrometer apparatus (Bruker) with a universal ATR 
accessory. Both solid and oily compounds were recorded. FT-IR signals are reported in wavenumbers 
(cm-1).
Optical Rotation Measurements
Optical rotation was recorded on a Perkin Elmer 241 polarimeter. The polarimeter temperature was 
allowed to equilibrate at 23 °C for 3 hours prior to the first measurements. Products (50.0 mg) were 
dissolved in HPLC grade CH3OH using a 5 ml graduated flask to give a final volume of 5 ml. Optical 
rotation was recorded using the sodium D line (589 nm) at 23 °C and are given in units of 10-1 deg dm2 
g-1.
Cooled reactions
All reactions below room temperature were cooled using a cryostat apparatus using acetone as 
cooling agent.
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Diazotransfer reagent
1H-Imidazole-1-sulfonyl azide.H2SO4. The imidazole sulfonyl diazotransfer reagent was 
prepared according to literature procedures.64-66
Synthesis of Dess Martin periodane
Two literature procedures were followed for the synthesis of Dess Martin periodane.61-62
Oxone (37.20 g, 60 mmol, 1.3 eqv) was dissolved in H2O. 
To the solution iodobenzoic acid (12.90 g, 20 mmol, 1 
eqv) was added and the resulting mixture was stirred at 
70 °C for 3 h. The reaction mixture was cooled to 5 °C and the resulting precipitate was washed with 
water and acetone. The white solid was concentrated in vacuo and dried at high vacuum overnight.
The white solid was dissolved in acetic anhydride (100 ml) and equipped with a calcium chloride tube. 
Camphor sulfonic acid (100 mg) was added and the suspension was stirred at 80 °C. The reaction 
mixture was completely dissolved after 1.5 hour, stirred for 30 min, and cooled to 5 °C. The white 
precipitate was filtered and washed with anhydrous ether to obtain the Dess Martin reagent which 
was stored at -20 °C under argon. MP: 131 °C.
Lanthanum lithium catalyst.40 R-BINOL (500 mg, 1.75 mmol) was 
dissolved in anhydrous THF (9 ml) and charged to an oven-dried 
roundbottomflask. The resulting mixture was cooled to 0 °C before n-Buli 
(2.19 ml, 3.51 mmol) was added. Meanwhile, LaCl3.H2O (240 mg, 0.65 
mmol) was dissolved/suspended in THF and sonicated for 30 min. The 
binol-lithium mixture was slowly added to the lanthanum suspension over 3 min and was stirred at 
room temperature for 1 hour. NatBu in THF (0.50 M) was added over 3 min and stirring was continued 
18 h before it was heated to 50 °C and stirred for two days. The orange mixture was allowed to cool to 
room temperature without stirring and stored in the fridge. The supernatant of the lanthanum-lithium 
catalyst 93 was used as a 0.03 M solution in THF.
Test reaction. 2-Nitroethanol and 3-phenylpropanal were 
distilled before use. A roundbottom flask was charged with 
(R)-LLB (5 mol%, 0.03 M in THF) and THF (5 ml) and stirred at 
-40 °C. 2-nitroethanol (0.06 ml, 0.84 mmol, 1.1 eqv) was added after 30 min. After 30 min, 
3-phenylpropanal (0.01 ml, 0.76 mmol, 1.0 eqv) was added and the reaction mixture was stirred for 90 
h at -40 °C. The reaction mixture was quenched with HCl (2 ml) and slowly warmed to room 
temperature. The aqueous phase was extracted three times with EtOAc (3 × 20 ml) and the combined 
organic phases were washed with brine (3 × 20 ml), dried over Na2SO4, and concentrated in vacuo. The 
product was recrystallised from hexane:ether (1:1, 20 ml) to give 90 mg of the product (47%).
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1,1-Dimethoxy-2-nitroethane42. To a 500 ml roundbottom flask, equipped with a 
magnetic stirring bar, 5-cm Vigreux column, column head, Claisen distilling head, 
and thermometer, were charged trimethylorthoformate (97, 100 ml, 0.6 mol), 
nitromethane (98, 180 gram, 2.95 mol) and anhydrous ZnCl2 (5 gram). The reaction 
mixture was heated at 90 °C and stirred overnight. Methanol (5 ml) was collected whereafter the 
remaining mixture was filtered at room temperature. The brown liquid was distilled using the same 
distillation setup. At reduced pressure, nitromethane (bp ca 30 °C at 35 mmHg) and 1,1-dimethoxy-2-
nitroethane (79, bp ca 130 °C at 1 mmHg, 3.63 gram, 6% yield) were obtained as colourless liquids. 1H 
NMR (400 MHz, CDCl3) δ 4.92 (1H, t, J = 5.6, CH), 4.40 (2H, d, J = 6.0, CH2), 3.35 (6H, s, 2 × OCH3). 13C 
NMR (100 MHz, CDCl3) δ 100.4 (CH), 76.0 (CH2NO2), 54.5 (OCH3). The same procedure was followed to 
make 1,1-diethoxy-2-nitroethane (90, 18 ml, 18% yield). 1H NMR (400 MHz, CDCl3) δ; 4.99 (1H, t, J = 
5.8, CH), 4.35 (2H, d, J = 6.0, CH2), 3.60-3.45 (4H, m, 2 × OCH2), 1.06 (6H, t, J = 8.0, 2 × CH3). Anhydrous 
ZnCl2 was prepared from refluxing ZnCl2 in thionyl chloride.
43
Garner’s Aldehyde Derivative Synthesis
(2S,3R)-Methyl 2-amino-3-hydroxybutanoate hydrochloride (H2N-l-Thr-OCH3.
HCl). To a roundbottom flask with anhydrous methanol (50 ml), thionyl chloride 
(4.83 ml, 67.0 mmol) was added dropwise over 5 min. The reaction mixture was 
cooled to 0 °C after which l-threonine (82, 8 g, 67 mmol) was added over 5 min in 
several smaller portions. The reaction mixture was stirred for 1 hour at 0 °C, followed by refluxing for 
4 h and stirring overnight at room temperature. A water aspirator was used to concentrate the reaction 
mixture under reduced pressure. The resulting viscous oil (11.36 g, 99%) was used without any further 
purifications. Rf = 0.23 (3:1:2; CH2Cl2:CH3OH:EtOAc). 1H NMR (400 MHz, CDCl3) δ 4.28-4.20 (1H, m, 
β-H), 3.92 (1H, s, α-H), 3.37 (3H, s, CH3), 1.34 (3H, d, J = 6.7, CH3). 
13C NMR (100 MHz, CDCl3) δ 169.5 
(C=O), 66.3 (CHOH), 59.8 (CHNH2), 53.9 (OCH3), 20.7 (CH3)
(2S)-Methyl 2-benzamido-3-hydroxybutanoate (83, BzHN-l-Thr-OCH3). 
Methylester threonine (1.4 g, 8.4 mmol) was dissolved in CH2Cl2 (20 ml) and 
cooled to 0 °C. With a dropping funnel, benzoyl chloride (0.87 ml, 7.57 mmol) 
dissolved in CH2Cl2 was added over 10 min. The reaction mixture was stirred for 
1 hour at 0 °C  before it was stirred overnight at room temperature. The 
reaction mixture was diluted with water (50 ml) and extracted with CH2Cl2 (3 × 20 ml). The organic 
layer was washed with NH
4
Cl (3 × 20 ml) and Na2HCO3 (3 × 20 ml), dried over Na2SO4, and concentrated 
in vacuo. Flash column chromatography (25% EtOAc in petroleum ether (v/v/)) gave protected 
threonine (83, 0.50 g, 25%) as white crystals. Rf = 0.31 (95:5; CH2Cl2:CH3OH). 1H NMR (400 MHz, CDCl3) 
δ 7.88-7.85 (2H, m, 2 × CHar, 7.57-7.53 (1H, m, CHar), 7.49-7.45 (2H, m, 2 × CHar), 6.98-6.96 (1H, d, J = 
8.8, NH), 4.87-4.84 (1H, dd, J = 8.8, 2.4, βH), 4.50-4.48 (1H, m, α-H), 3.80 (3H, s, CH3), 2.41-2.40 (1H, d, 
J = 4.8, OH), 1.33-1.31 (3H, d, J = 6.4, CH3). 
13C NMR (100 MHz, CDCl3) δ = 171.6 (C=O), 167.8 (C=O), 
133.8 (Car), 131.9 (Car), 128.6 (Car), 127.2 (Car), 68.3 (βC), 57.5 (αC), 52.0 (OCH3), 20.1 (CH3). MS: found 
260.08 [M+Na]+, calculated for [C12H15NO4 + Na]
+ 260.09. 
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(4R,5S)-Methyl 5-methyl-2-phenyl-4,5-dihydrooxazole-4-carboxylate 
hydrochloride 84. Amide (83, 0.50 mg, 2.1 mmol) was dissolved in anhydrous CH2Cl2 
and cooled to 0 °C. Thionyl chloride (1.4 ml, 19.33 mmol) was slowly added to the 
solution over 10 min. The reaction mixture was stirred overnight at 0 °C before it 
was concentrated in vacuo and dissolved in CH2Cl2. The reaction mixture was 
washed with Na2HCO3 (2 × 10 ml), and brine (2 × 10 ml), dried over Na2SO4, and 
concentrated in vacuo to give oxazole 84 as an oil (350 mg, 65%). Rf = 0.75 (90:10; CH2Cl2:CH3OH). 1H 
NMR (400 MHz, CDCl3) δ = 8.09-8.08 (2H, m, 2 × CHar), 7.52-7.55 (1H, m, CHar), 7.44-7.43 (2H, m, 2 × 
CHar), 5.14-5.09 (1H, m, β-H), 5.03-5.01 (1H, m, α-H), 3.85 (3H, s, OCH3), 1.43-1.41 (3H, d, J =6.3, CH3). 
13C NMR (100 MHz, CDCl3) δ 168.0 (C=O) , 167.3 (C=N), 134.8 (Car), 131.7 (Car), 130.8 (Car), 129.8 (Car), 
70.6 (CHCH3), 58.5 (CH), 54.9 (OCH3), 17.9 (CH3).
l-allo-Threonine hydrochloride (81, H2N-l-allo-Thr-OH .HCl). Oxazole  (84, 350 
mg, 1.37 mmol) was added to a stirred solution of aqueous hydrochloric acid at 
room temperature. The reaction mixture was refluxed for 3 h, stirred at room 
temperature overnight and diluted with H2O (10 ml). The aqueous layer was 
washed with diethylether (3 × 10 ml) and concentrated in vacuo to give a 
brown precipitate (81, 212 mg, 99%) which was used without any further purification. 1H NMR (400 
MHz, CDCl3) δ = 4.35-4.25 (1H, m, β-H), 4.10-4.09 (1H, d, J = 3.5, α-H), 1.28-1.26 (3H, d, J = 6.7, CH3). 
13C NMR (100 MHz, CDCl3) δ = 171.8 (C=O), 65.4 (CHOH), 59.7 (CHNH2), 16.2 (CH3). [α]D23 +7.98 (c 0.01, 
H2O).
Methyl-l-allo-threonine.HCl (85, H2N-l-allo-Thr-OCH3). To a roundbottom flask 
with anhydrous methanol (20 ml), thionyl chloride (128 µl, 1.77 mmol) was added 
dropwise over 5 min. The reaction mixture was cooled to 0 °C after which l-allo-
threonine (81, 212 mg, 1.37 mmol) was added over 5 min in several smaller 
portions. The reaction mixture was stirred for 1 hour at 0 °C, followed by refluxing for 4 h and stirring 
overnight at room temperature. A water aspirator was used to concentrate the reaction mixture under 
reduced pressure. The resulting viscous oil (85, 220 mg, 95%) was used without any further 
purifications. Rf = 0.23 (3:1:2; CH2Cl2:CH3OH:EtOAc). 1H NMR (400 MHz, CDCl3) δ = 4.33-4.31 (1H, m, 
β-H), 4.03-4.02 (1H, m, α-H), 3.37 (3H, s, OCH3), 1.30-1.28 (3H, d, J = 6.6, CH3). 
13C NMR (100 MHz, 
CDCl3) δ = 168.8 (C=O), 66.6 (CH), 59.5 (CH), 53.7 (OCH3), 18.8 (CH3).
Methyl (tert-butoxycarbonyl)-l-allo-threonine (86, BocHN-l-allo-Thr-OCH3).
Methyl-l-allo-threoninate (85, 2.99 g, 17.27 mmol) was dissolved in water: 
methanol (50 ml, 1:1) and NaHCO3 (4.39 g, 52.26 mmol). Boc2O (5.85 g, 26.80 
mmol) was added slowly and a white cloudy suspension was observed. The 
reaction was left stirring overnight. After full completion of the reaction, the reaction mixture was 
concentrated and subsequently diluted with ethyl acetate (100 ml). Sulfate buffer (1M, 100 ml) was 
added to neutralise the sodium bicarbonate. The aqueous layer was extracted with ethyl acetate (3 × 
30 ml) and the organic layers were combined, dried over Na2SO4 and concentrated under reduced 
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pressure to obtain yellow oil 86 in 72% yield (2.98 g, 12.78 mmol). Rf = 0.46 (3:1; Hept.:EtOAc). 1H NMR 
(400 MHz, CDCl3) δ 5.46 (1H, d, J = 7.6, NH), 4.40 – 4.34 (1H, m, αH), 4.12 (1H, m, J = 7.1, βH), 3.77 (3H, 
d, J = 1.4, OCH3), 1.48 (9H, s, 3 × CH3), 1.19 (3H, d, J = 6.4, CH3). 
13C NMR (100 MHz, CDCl3) δ 171.0 
(C=O), 156.1 (C=O), 80.5 (C
q
), 69.0 (CH), 59.1 (CH), 52.4 (OCH3), 28.2 (3 × CH3) , 18.8 (CH3). MS: found 
256.11 [M+Na]+, calculated for [C
10
H
19
NO
5
 + Na]+ 256.12.
3-(tert-Butyl) 4-methyl (4S, 5S)-2,2,5-trimethyloxazolidine-3,4-dicarboxylate 
88. BocHN-l-allo-threonine (2.98 g, 12.79 mmol) was dissolved in anhydrous 
toluene (50 ml) and camphor sulfonic acid was added (315.6 mg, 1.35 mmol). 
The pH was set to 4-5. Dimethoxypropane 87 was added slowly (4.4 ml, 35.91 
mmol) and the reaction mixture was stirred overnight. After stirring overnight, 
the reaction mixture was quenched with triethylamine (1 ml), concentrated under reduced pressure 
and the procedure was repeated: the oil was dissolved in anhydrous toluene (50 ml), camphor sulfonic 
acid (30.5 mg, 0.13 mmol) was added, the pH was set to 5 and dimethoxypropane (4.4 ml, 35.91 
mmol) was added. The reaction was left stirring overnight, isolated and purified by flash column 
chromatography (eluent: EtOAc: Heptane; 1: 8 (v/v) for fraction 1 to 19 and EtOAc: Heptane; 1: 4 (v/v) 
for fraction 20-24) was performed. A colourless oil in 40% yield (88, 1.47 g, 5.38 mmol) was obtained. 
Rf = 0.45 (3:1; Hept.:EtOAc). 1H NMR (400 MHz, CDCl3) δ 4.40 – 4.23 (2H, m, αH and βH), 3.70 (3H, s, 
OCH3), 1.69 (6H, s, 2 × CH3), 1.46 (9H, s, 3 × CH3), 1.31 – 1.16 (3H, m, CH3). 
13C NMR (100 MHz, CDCl3) δ 
170.5 (C=O) , 151.0 (C=O) , 94.4 (C
q
), 80.7 (C
q
), 71.4 (CHNBoc), 63.6 (CH), 51.7 (OCH3), 28.2 (3 × CH3), 
25.5 (2 × CH3), 15.4 (CH3). MS: found 296.17 [M+Na]
+, calculated for [C13H23NO5 + Na]
+ 296.15.
((4R, 5S)-2,2,5-Trimethyloxazolidin-4-yl)methanol. The Garner ester (88, 1.47 
g, 5.38 mmol) was dissolved in anhydrous THF (50 ml) and cooled to 0 °C in an 
ice bath. LiAlH
4
 solution (8.3 ml, 1 M) was added slowly via a syringe and the 
reaction was left stirring for 2 h. After completion of the reaction, ethyl acetate 
(20 ml) was slowly added to the mixture and then a saturated solution of 
Rochelles salt (20 ml) was added. The reaction was left stirring vigorously for circa 15 min and was 
filtered through celite. The aqueous layer was extracted (3 × 30 ml) with ethyl acetate and after the 
second extraction some brine (10 ml) was added. The organic layers are combined, dried over Na2SO4, 
and concentrated under reduced pressure to obtain a yellow oil and a white solid in quantitative yield. 
Rf = 0.50 (1:1; Hept.:EtOAc). 1H NMR (400 MHz, CDCl3) δ 4.25 (1H, m, βH), 3.99 (1H, m, αH), 3.78-3.54 
(2H, m, J = 10.8, 4.2, CH2), 1.53 (6H, s, 2 × CH3), 1.47 (9H, s, 3 × CH3), 1.26 (3H, d, J = 6.5, CH3). 
13C NMR 
(100 MHz, CDCl3) δ 154.5 (C=O), 92.7 (Cq), 81.1 (Cq), 71.3 (CHCH3), 63.1 (CH2), 61.6 (CHCHCH2), 28.4 (3 
× CH3),27.8 (CH3C), 24.5 (CH3C), 14.4 (CH3). MS: found 268.17 [M+Na]
+, calculated for [C12H23NO4 + Na]
+ 
268.15.
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(4S, 5S)-2,2,5-Trimethyloxazolidin-4-carbaldehyde 80. The Garner alcohol 
(0.24 g, 1.04 mmol) was dissolved in anhydrous dichloromethane and Dess-
Martin reagent was added (0.48 g, 1.14 mmol). After 2 h 0.1 eqv. Dess Martin 
reagent (0.07 g, 0.17 mmol) was added in addition. The reaction mixture was 
quenched after 5 h with 25 ml of Na2S2O3(aq): NaHCO3(aq); 1:1 (v/v) for 40 min. 
The product was extracted with CH2Cl2 (3 × 75 ml), dried over Na2SO4 and concentrated in vacuo to 
obtain an orange oil in quantitative yield (0.24 g, 1.04 mmol).
Or:
A 250 ml three necked round bottom flask was equipped two dropping funnels. One dropping funnel 
was charged with DMSO (2.0 ml, 28.6 mmol, 3 eqv., in 2.5 ml CH2Cl2) the other one with tert-butyl 
(4R,5S)-4-(hydroxymethyl)-2,2,5-trimethyloxazolidine-3-carboxylate (2.32 g, 9.54 mmol in 15 ml 
CH2Cl2). The three necked round bottom flask was charged with oxalyl chloride (1.20 ml, 14.30 mmol, 
1.5 eqv., in 20 ml CH2Cl2). The flask was cooled to -78 °C and the DMSO solution was dropwise added 
over a period of 15 min. Next the solution of alcohol was dropwise added followed by rinsing of the 
dropping funnel with CH2Cl2 (2 × 5 ml) and the dropping funnel was subsequently charged with DIEA 
(9.0 ml, 51.6 mmol, 5.5 eqv.). The reaction mixture was allowed to warm up to -40 °C and after 30 min 
DIEA was dropwise added. The reaction mixture was allowed to warm up to -0 °C and 1M HCl (35 ml) 
was added. The aqueous layer was extracted with CH2Cl2 (3 × 10 ml) and the combined organic phases 
were washed with phosphate buffer (pH 7, 4 × 20 ml). The organic phase was dried (Na2SO4) and 
concentrated in vacuo to afford tert-butyl (4S,5S)-4-formyl-2,2,5-trimethyloxazolidine-3-carboxylate 
(1.83 g, 7.52 mmol) as a yellow oil in 80% yield. Rf = 0.38 (4:1; Hept.:EtOAc). 1H NMR (400 MHz, CDCl3) 
δ 9.49 (1H, dd, J = 20.9, 3.4, COH), 4.25 (1H, p, J = 6.6, αH), 4.04-3.88 (1H, m, βH), 1.53 (6H, s, 2 × CH3), 
1.47 (9H, s, 3 × CH3), 1.26 (3H, d, J = 6.5, CH3). 
13C NMR (100 MHz, CDCl3) δ 200.6 (COH), 152.5 (C=O), 
94.5 (C
q
), 80.8 (C
q
), 72.3 (CH), 68.0 (CHCH3), 28.3 (3 × CH3), 26.7 (2 × CH3), 15.2 (CH3). MS: found 298.25 
[M+CH3OH+Na]
+, calculated for [C12H21NO4 + CH3OH + Na]
+ 298.16; found 266.17 [M+Na]+, calculated 
for [C12H21NO4 + Na]
+ 266.14.
General procedure Henry reaction
For analysis Henry reaction: A visual reaction 
was clearly seen when base was added, the 
colourless solution turned into brown orange 
like solutions.
inorganic bases. The aldehyde (1.0 eqv) was dissolved in THF:water mixtures (3:2 / 1 gram aldehyde in 
150 ml) and cooled to the desired temperature. Inorganic base (0.1 eqv) was added followed by nitro-
acetal (7 eqv). The reaction mixture was stirred overnight at the set temperature. The solvent was 
removed under reduced pressure and the residue was extracted with CH2Cl2 and washed with water 
(3 × 50 ml). The organic phase was dried over Na2SO4 and the solvent was removed in vacuo. Column 
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chromatography was performed with EtOAc in heptane (1:4) to give the desired product typically as a 
mixture of diastereomers. 
Organic bases or catalyst. The aldehyde (1.0 eqv) was dissolved in anhydrous THF and cooled to -40 °C. 
Nitro-acetal (7 eqv) was added followed by organic base or catalyst. The reaction mixture was stirred 
at -40 °C overnight or longer if needed. The reaction mixture was diluted with EtOAc. The organic layer 
was washed with NH
4
Cl (3 × 10 ml) and water (3 × 10 ml). The organic layer was dried over Na2SO4 and 
concentrated in vacuo. Column chromatography was performed with EtOAc in heptane (1:4) to give 
the desired product typically as a mixture of diastereomers. 
tert-Butyl (4R,5S)-4-((R)-1-hydroxyallyl)-2,2,5-trimethyloxazolidine-3-
carboxylate 112. A round bottom flask was charged with tert-butyl (4S,5S)-4-
formyl-2,2,5-trimethyloxazolidine-3-carboxylate (80, 1.83 g, 7.52 mmol) in 
anhydrous THF (15 ml) and cooled to -78 °C. After 15 min, Vinylmagnesium 
bromide solution (1.0 M, 8.27 ml, 1.1 eqv.) was dropwise added. After 5 h, sat. 
aq. NH
4
Cl (20 ml) was added. The aqueous layer was extracted with EtOAc (4 × 50 ml) and the combined 
organic phases were washed with brine (1 × 50 ml). The organic phase was dried over Na2SO4 and 
concentrated in vacuo. Flash column chromatography (SiO2, 1:1 Hept.:EtOAc » 1:3 Hept.:EtOAc) 
afforded tert-butyl (4R,5S)-4-((R)-1-hydroxyallyl)-2,2,5-trimethyloxazolidine-3-carboxylate  (112, 1.39 
g, 5.12 mmol) as a yellow oil in 68% yield. Rf = 0.43 (2:1; Hept.:EtOAc). 1H NMR (400 MHz, CDCl3) 
(mixture of rotamers, main / minor) δ 5.99-5.83 (1H, m, CHCH2), 5.31/5.38 (1H, dt, J = 17, 1.5, CH2), 
5.22-5.14 (1H, m, CH2), 4.33 (1H, t, J= 6.5, CHCH3), 4.26 (2H, m, 2 x CH), 1.53 (3H, s, CH3C), 1.45 (12H, 
m, CH3C and 3 × CH3), 1.34 (3H, d, J = 6.5, CH3). 
13C NMR (100 MHz, CDCl3) (mixture of rotamers, main 
/ minor) δ 155.4 (C=O), 138.5/139.3 (CCH2), 115.0/116.0 (CH2CH), 93.1 (Cq), 81.4 (Cq), 72.5 (CH3CH), 
71.4 (HOCH), 65.8 (CHCHCH), 26.5 (CH3), 24.4 (CH3), 28.4 (3 × CH3), 15.3 (CH3). MS: found 294.17 
[M+Na]+, calculated for [C
14
H
25
NO
4
 + Na]+ 294.17.
tert-Butyl (4R,5S)-4-((R)-1-((hydroxycarbamoyl)oxy) but-3-en-2-yl)-2,2,5- 
trimethyloxazolidine-3-carboxylate hydrochloride 113. The vinyl alcohol (112a, 800 
mg, 2.95 mmol) was dissolved in anhydrous pyridine (20 ml) and stirred at 40 °C. To the 
reaction mixture was added 1,1-carbodiimidazole (2.87 g, 17.69 mmol, 6 eqv). After 4 
h, the reaction mixture was cooled to 0 °C before hydroxylamine.HCl (4 gram, 20 eqv) 
was added. The reaction mixture was stirred overnight at room temperature and quenched with 
water. The product was extracted with EtOAc. The organic layer was washed with water and dried over 
Na2SO4 before it was concentrated in vacuo. Column chromatography with heptane and EtOAc (1:1) 
gave the product in moderate yield (51%, 550 mg, 1.50 mmol). 1H NMR (400 MHz, CDCl3) δ 5.99 – 5.74 
(1H, m, CHCH2), 5.37 – 5.17 (2H, m, CH2), 5.16 – 5.06 (1H, m, NH), 4.31 – 4.23 (1H, m, CHO), 4.07 (1H, 
dd, J = 6.6, 1.7, CH), 3.40 (1H, s, OH), 1.47-1.40 (15H, m, 2 × CH3 +  3 × CH3), 1.27 (3H, t, J = 4.9, CH3). 
13C NMR (100 MHz, CDCl3) δ 154.9 (C=O), 138.3 (CHCH2), 114.9 (CH2), 93.0 (Cq), 81.3 (Cq), 72.3 (CH), 
71.3 (CH), 65.7 (CH), 28.3 (3 × CH3), 24.8 (2 × CH3) 15.2 (CH3). HRMS: found 413.2658 calculated for 
[C
16
H
29
N2O6Cl + CH3OH + H]
+ 413.2035.
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tert-Butyl (4R,5S)-2,2,5-trimethyl-4-((R)-1-((((2,4,6-trimethylbenzoyl)oxy)
carbamoyl)oxy)but-3-en-2-yl)oxazolidine-3-carboxylate 118. The 
hydroxylamine (113, 550 mg, 1.50 mmol) was dissolved in anhydrous CH2Cl2 
and cooled to 0 °C. Triethylamine (275 μl, 1.65 mmol, 1.1 eqv) and 
2,4,6-trimethylbenzoyl chloride (460 μl, 3.30 mmol, 2.2 eqv) were slowly 
added. The reaction mixture was stirred overnight at room temperature. The reaction mixture was 
quenched with NaHCO3 (20 ml) and extracted with CH2Cl2 (3 × 10 ml). The organic layer was washed 
with brine, water (both 2 × 5 ml), and dried over Na2SO4 before it was concentrated in vacuo. Column 
chromatography was performed with heptane and EtOAc (H4:E1) to give the product 118, as a white 
foam (600 mg, 84% yield). 1H NMR (400 MHz, CDCl3) δ 6.87 (2H, s, 2 × CH), 5.97-5.84 (1H, m, CH2CH), 
5.62-5.33 (2H, m, CH2), 4.31-4.26 (1H, m, CH3CH), 4.19-4.17 (1H, m, CHO), 4.04-3.95 (CHCHCH3), 2.36 
(3H, s, 1 × CH3), 2.29 (6H, s, 2 × CH3), 1.56 (6H, m, 2 × CH3), 1.49 (9H, m, 3 × CH3), 1.35 (3H, d, J = 4, CH3). 
13C NMR (100 MHz, CDCl3) δ 168.9 (C=O), 155.4 (C=O), 152.8 (C=O), 136.7 (Cq), 133.3 (CHCH2), 128.6 
(CHar), 126.5 (Cq), 119.2 (CH2), 92.6 (Cq), 80.5 (Cq), 72.3 (CH3CH), 61.0 (CHCHCH2), 60.8 (CHN), 28.4 (3 × 
CH3), 24.9 (2 × CH3), 19.9 (3 × CH3), 14.7 (CH3). For the synthesis of benzoyl 117 and pentafluorbenzoyl 
119 the same procedure was used. The products were obtained in 77% and 40% respectively.
tert-Butyl (4S,4’R,5S,5’R)-4’-(hydroxymethyl)-2,2,5-trimethyl-2’-oxo-[4,5’-
bioxazolidine]-3-carboxylate 120. The trimethylene benzoyl carbamate (118, 
200 mg, 0.42 mmol) was dissolved in t-BuOH:CH3CN:H2O, (4:4:1, 2 ml), a 
catalytic amount of potassium osmate (VI) dihydrate (5 mol%) was added and 
the reaction mixture was stirred overnight. The reaction was quenched with 
sat. aq. Na2SO3. The aqueous layer was extracted with EtOAc (3 × 10 ml) and the organic phases were 
dried over MgSO
4
 and concentrated in vacuo. Column chromatography was performed (2.5% CH3OH 
in CH2Cl2) to obtain the product as a mixture of diastereoisomers (120, 70 mg, 50% yield). 1H NMR (400 
MHz, CDCl3) δ 4.38 (1H, s, CHO), 4.27 – 4.06 (4H, m, CH3CH, CH2, and CHN), 3.62 (1H, dd, J = 11.4, 3.7, 
CHNH), 3.47 (1H s, OH), 1.41 (6H, s, 2 × CH3), 1.32 (3H, d, J = 6.5, CH3), 1.29 – 1.12 (9H, m, 3 × CH3). 
13C 
NMR (100 MHz, CDCl3) δ 159.7 (C=O), 153.8 (C=O), 93.4 (Cq), 81.3 (Cq), 75.9 (CHO), 72.2 (CH3CH), 63.6 
(CHNH), 60.5 (CHN), 55.9 (CH2), 28.3 (3 × CH3), 24.9 (2 × CH3), 14.4 (CH3). HRMS: found 353.1680 
[M+Na]+ calculated for [C
15
H
26
N2O6]  330.1689.
tert-Butyl (4R,5S)-4-((1R)-2-amino-1,3-dihydroxypropyl)-2,2,5-
trimethyloxazolidine-3-carboxylate 122. tert-butyl (4S,5S,5’R)-4’-
(hydroxymethyl)-2,2,5-trimethyl-2’-oxo-[4,5’-bioxazolidine]-3-carboxylate (120, 
28 mg, 0.09 mmol, 1 eqv) was dissolved in ethanol (4 ml) and refluxed at 66 °C. 
NaOH (2M, 2 ml) was slowly added and stirring was continued for 6 h. The reaction 
mixture was concentrated in vacuo and used in the next step without any further purification. MS: 
found 305.33 [M+H]+, calculated for [C
14
H
29
N2O5]
+ 305.39.
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tert-Butyl (4R,5S)-4-((1S)-2-azido-1,3-dihydroxypropyl)-2,2,5-
trimethyloxazolidine-3-carboxylate 124. tert-butyl (4R,5S)-4-((1R)-2-amino-1,3-
dihydroxypropyl)-2,2,5-trimethyloxazolidine-3-carboxylate (122, 30 mg, 0.09 
mmol, 1 eqv) was dissolved in CH3OH – H2O (8:2, 10 ml). NaHCO3 (16.60 mg, 0.20 
mmol, 2.2 eqv) and CuSO
4
.5H2O (5 mg, 0.018 mmol, 0.2 eqv) were added and the 
pH was adjusted to 8-9. Diazotransfer reagent (123, 30 mg, 0.11 mmol, 1.2 eqv) was added and the 
reaction mixture was stirred at room temperature for 4h. The reaction mixture was diluted with H2O 
and the product was extracted with CH2Cl2 (3 × 10 ml). The organic layer was dried over Na2SO4 and 
concentrated in vacuo. Column chromatography was performed with 5% CH3OH in CH2Cl2 to give the 
desired product (20 mg, 67% yield). 1H NMR (400 MHz, CDCl3) 5.83 (1H, bs, OH), 4.55 (1H, m, CHOH), 
4.36 – 4.14 (3H, m, CH3CH, CH3CHCH, and CHN3), 3.53 (2H, m, CH2), 1.58-1.40 (18H, m, 2 x CH3, 3 x 
BocCH3, and CH3). 
13C NMR (100 MHz, CDCl3) δ 159.3 (C=O), 93.6 (CH3Cq), 81.2 ((CH3)3Cq), 71.4 (CH), 
63.8, (CH) 60.2 (CH2), 55.9 (CH), 53.4 (CH), 28.3 (3 x CH3), 26.8, 24.9 (2 × CH3Cq), 14.6 (CH3). MS: found 
353.25 [M+Na]+, calculated for [C
14
H
26
N
4
O
5
]+ 330.19. 
tert-Butyl (4R,5S)-4-((1S)-2-azido-1-hydroxy-3-oxopropyl)-2,2,5-
trimethyloxazolidine-3-carboxylate 125. The azido alcohol (124, 15 mg, 0.045 
mmol, 1 eqv) was dissolved in anhydrous CH2Cl2 (3 ml). Dess-Martin reagent (0.3 
M, 10 μl) was added and the reaction mixture was stirred at room temperature 
for 4.5 h. The reaction mixture was diluted with CH2Cl2 (5 ml) and quenched with 
Na2S2O3 and NaHCO3 (both 2 ml). The product was extracted with CH2Cl2 (3 × 5 ml), dried over Na2SO4, 
and concentrated in vacuo to give a crude mixture (125, 10 mg, 67% yield).
144
Total Synthesis towards Pseudaminic Acid Probes
References
1. Rangarajan, E. S.; Proteau, A.; Cui, Q.; Logan, S. M.; Potetinova, Z.; Whitfield, D.; Purisima, E. O.; Cygler, M.; Matte, A.; 
 Sulea, T.; Schoenhofen, I. C., J. Biol. Chem. 2009, 284 (31), 20989-1000.
2. Schoenhofen, I. C.; Vinogradov, E.; Whitfield, D. M.; Brisson, J. R.; Logan, S. M., Glycobiology 2009, 19 (7), 715-25.
3. Hassan, M. I.; Lundgren, B. R.; Chaumun, M.; Whitfield, D. M.; Clark, B.; Schoenhofen, I. C.; Boddy, C. N., Angew. Chem. 
 2016, 55 (39), 12018-21.
4. Lee, Y. J.; Kubota, A.; Ishiwata, A.; Ito, Y., Tetrahedron Lett. 2011, 52 (3), 418-421.
5. Gross, P. H.; Jeanloz, R. W., J. Org. Chem. 1967, 32 (9), 2759-63.
6. Sharma, M.; Bernacki, R. J.; Paul, B.; Korytnyk, W., Carbohydr. Res. 1990, 198 (2), 205-21.
7. Rosenberg, A., Biology of the Sialic Acids. Plenum Press: New York, 1995.
8. Barbier, P., Compt. Rend. 1899, 128 (110).
9. Csuk, R.; Hugener, M.; Vasella, A., Helv. Chim. Acta 1988, 71 (3), 609-618.
10. Gordon, D. M.; Whitesides, G. M., J. Org. Chem. 1993, 58 (27), 7937-7938.
11. Zunk, M.; Williams, J.; Carter, J.; Kiefel, M. J., Org. Biomol. Chem. 2014, 12 (18), 2918-25.
12. Glatzhofer, D. T.; Roy, R. R.; Cossey, K. N., Org. Lett. 2002, 4 (14), 2349-52.
13. Schreiner, E.; Zbiral, E., Justus Liebigs Ann. Chem. 1990,  (6), 581-586.
14. Williams, J. T.; Corcilius, L.; Kiefel, M. J.; Payne, R. J., J. Org. Chem. 2016, 81 (6), 2607-11.
15. Knirel, Y. A.; Shashkov, A. S.; Tsvetkov, Y. E.; Jansson, P. E.; Zahringer, U., Adv. Carbohydr. Chem. Biochem. 2003, 58, 371-
 417.
16. Tsvetkov, Y. E.; Shashkov, A. S.; Knirel, Y. A.; Backinowsky, L. V.; Zahringer, U., Mendeleev Commun. 2000, (3), 90-91.
17. Tsvetkov, Y. E.; Shashkov, A. S.; Knirel, Y. A.; Zahringer, U., Carbohydr. Res. 2001, 335 (4), 221-43.
18. Tsvetkov, Y. E.; Shashkov, A. S.; Knirel, Y. A.; Zahringer, U., Carbohydr. Res. 2001, 331 (3), 233-7.
19. Kochetkov, N. K.; Byramova, N. E.; Tsvetkov, Y. E.; Backinowsky, L. V., Tetrahedron 1985, 41 (16), 3363-3375.
20. Eis, M. J.; Ganem, B., Carbohydr. Res. 1988, 176 (2), 316-323.
21. Mas Pons, J.; Dumont, A.; Sautejeau, G.; Fugier, E.; Baron, A.; Dukan, S.; Vauzeilles, B., Angew. Chem. 2014, 53 (5), 
 1275-8.
22. Matthies, S.; Stallforth, P.; Seeberger, P. H., J. Am. Chem. Soc. 2015, 137 (8), 2848-51.
23. Liang, X.; Lee, C. J.; Chen, X.; Chung, H. S.; Zeng, D.; Raetz, C. R.; Li, Y.; Zhou, P.; Toone, E. J., Bioorg. Med. Chem. 2011, 
 19 (2), 852-60.
24. Candeias, N. R.; Montalbano, F.; Cal, P. M.; Gois, P. M., Chem. Rev. 2010, 110 (10), 6169-93.
25. Szechner, B.; Achmatowicz, O.; Galdecki, Z.; Fruzinski, A., Tetrahedron 1994, 50 (25), 7611-7624.
26. Anelli, P. L.; Biffi, C.; Montanari, F.; Quici, S., J. Org. Chem. 1987, 52 (12), 2559-2562.
27. Soule, J. F.; Mathieu, A.; Norsikian, S.; Beau, J. M., Org. Lett. 2010, 12 (22), 5322-5.
28. Choi, S. K.; Lee, S.; Whitesides, G. M., J. Org. Chem. 1996, 61 (25), 8739-8745.
29. Lall, M. S.; Ramtohul, Y. K.; James, M. N.; Vederas, J. C., J. Org. Chem. 2002, 67 (5), 1536-47.
30. Ait-Haddou, H.; Hoarau, O.; Cramailere, D.; Pezet, F.; Daran, J. C.; Balavoine, G. G., Chemistry 2004, 10 (3), 699-707.
31. Elliott, D. F., J. Chem Soc. 1950, (Jan), 62-68.
32. Kelly, G. T.; Sharma, V.; Watanabe, C. M., Bioorg. Chem. 2008, 36 (1), 4-15.
33. Henry, L., C. R. Acad. Sci. Ser. C 1895, 120, 1265.
Chapter 5
145
34. Henry, L., Bull. Soc. Chim. France 1895, 13, 999.
35. Luzzio, F. A., The Henry reaction: recent examples. Tetrahedron 2001, 57 (6), 915-945.
36. Sasai, H.; Itoh, N.; Suzuki, T.; Shibasaki, M.,  Tetrahedron Lett. 1993, 34 (5), 855-858.
37. Sasai, H.; Suzuki, T.; Itoh, N.; Shibasaki, M., Tetrahedron Lett. 1993, 34 (5), 851-854.
38. Sasai, H.; Suzuki, T.; Itoh, N.; Tanaka, K.; Date, T.; Okamura, K.; Shibasaki, M., J. Am. Chem. Soc. 1993, 115 (22), 10372-
 10373.
39. Shibasaki, M.; Kanai, M.; Matsunaga, S.; Kumagai, N., Acc. Chem. Res. 2009, 42 (8), 1117-27.
40. Sasai, H.; Watanabe, S.; Suzuki, T.; Shibasaki, M., Org. Synth. 2002, 78 (14).
41. Sasai, H.; Kim, W. S.; Suzuki, T.; Shibasaki, M.; Mitsuda, M.; Hasegawa, J.; Ohashi, T., Tetrahedron Lett. 1994, 35 (33), 
 6123-6126.
42. Rene, L.; Royer, R., Synthesis-Stuttgart 1981,  (11), 878-878.
43. Weberg, R. T.; Haltiwanger, R. C.; Laurie, J. C. V.; Dubois, M. R., J. Am. Chem. Soc. 1986, 108 (20), 6242-6250.
44. Schmölzer, C.; Nowikow, C.; Kahlig, H.; Schmid, W., Carbohydr. Res. 2013, 367, 1-4.
45. Roskamp, E. J.; Pedersen, S. F., J. Am. Chem. Soc. 1987, 109 (21), 6551-6553.
46. Hanessian, S.; Devasthale, P. V., Bioorg. Med. Chem. Lett. 1996, 6 (18), 2201-2206.
47. Hanessian, S.; Devasthale, P. V., Tetrahedron Lett. 1996, 37 (7), 987-990.
48. Menzel, A.; Ohrlein, R.; Griesser, H.; Wehner, V.; Jager, V.,  Synthesis-Stuttgart 1999, (11), 2000-2000.
49. Kitayama, T., Tetrahedron 1996, 52 (17), 6139-6148.
50. Gruber-Khadjawi, M.; Purkarthofer, T.; Skranc, W.; Griengl, H., Adv. Synth. Catal. 2007, 349 (8-9), 1445-1450.
51. Dondoni, A.; Perrone, D., Org. Synth. 2000, 77, 64.
52. Donohoe, T. J.; Johnson, P. D.; Pye, R. J., Org. Biomol. Chem. 2003, 1 (12), 2025-8.
53. Li, G. G.; Chang, H. T.; Sharpless, K. B., Angew. Chem. 1996, 35 (4), 451-454.
54. Donohoe, T. J.; Chughtai, M. J.; Klauber, D. J.; Griffin, D.; Campbell, A. D., J. Am. Chem. Soc. 2006, 128 (8), 2514-2515.
55. Donohoe, T. J.; Callens, C. K. A.; Lacy, A. R.; Winter, C., Eur. J. Org. Chem. 2012, (4), 655-663.
56. Wai, J. S. M.; Marko, I.; Svendsen, J. S.; Finn, M. G.; Jacobsen, E. N.; Sharpless, K. B., A J. Am. Chem. Soc. 1989, 111 (3), 
 1123-1125.
57. Donohoe, T. J.; Bataille, C. J.; Gattrell, W.; Kloesges, J.; Rossignol, E., Org. Lett. 2007, 9 (9), 1725-8.
58. Pullin, R. D.; Rathi, A. H.; Melikhova, E. Y.; Winter, C.; Thompson, A. L.; Donohoe, T. J., Org. Lett. 2013, 15 (21), 5492-5.
59. Gao, J. M.; Harter, R.; Gordon, D. M.; Whitesides, G. M., J. Org. Chem. 1994, 59 (13), 3714-3715.
60. Warwel, M.; Fessner, W. D., Synlett 2000,  (6), 865-867.
61. Ireland, R. E.; Liu, L. B.,  J. Org. Chem. 1993, 58 (10), 2899-2899.
62. Frigerio, M.; Santagostino, M.; Sputore, S., (IBX). J. Org. Chem. 1999, 64 (12), 4537-4538.
63. Spielvogel, D.; Kammerer, J.; Keller, M.; Prinzbach, H., Tetrahedron Lett. 2000, 41 (41), 7863-7867.
64. Goddard-Borger, E. D.; Stick, R. V., Org. Lett. 2007, 9 (19), 3797-800.
65. Fischer, N.; Goddard-Borger, E. D.; Greiner, R.; Klapotke, T. M.; Skelton, B. W.; Stierstorfer, J., J. Org. Chem. 2012, 77 (4), 
 1760-1764.
66. Potter, G. T.; Jayson, G. C.; Miller, G. J.; Gardiner, J. M., J. Org. Chem. 2016, 81 (8), 3443-6.
67. Still, W. C.; Kahn, M.; Mitra, A., J. Org. Chem. 1978, 43 (14), 2923-2925.
146
Total Synthesis towards Pseudaminic Acid Probes
General Discussion 
“Keep talking”
The Division Bell, Pink Floyd
 
 
 
147
General discussion
The previous three research chapters in this thesis each focussed on a specific study within the field of 
chemical microbiology. Furthermore, chapter 2 reviewed the progress made in the field of metabolic 
oligosaccharide engineering over the last five years. A chemistry-based approach was chosen to 
contribute to the fascinating world of bacterial carbohydrates in the human gut. This combination 
between chemical biology and microbiology - chemical microbiology - is rather challenging as this 
thesis clearly illustrates. Many outstanding research questions are yet to be answered.  In the present 
chapter we further discuss the results presented in the previous chapters, elaborate on these, suggest 
alternatives, and provide an outlook towards further research and/or applications. 
Chapter 2: Getting a Grip on Glycans: a Current Overview of the Metabolic Oligosaccharide 
Engineering Toolbox
In chapter 2 a review of advances in the field of metabolic oligosaccharide engineering (MOE) over 
the last five years is reported, with a focus on the synthesis and structure-activity relationship of the 
chemical probes used in this technique. The most recent key developments (2016-2017) in this field, 
since publication of the review, are discussed below. 
New bioconjugation techniques
Non-covalent interactions between a carbohydrate and a fluorescent marker would offer an interesting 
alternative to covalent interactions. Galan and co-workers recently reported an imidazolium-based 
ionic liquids tags (ITags) for use on N-acetylmannosamine derivatives (Scheme 1).1 The ITag was 
tolerated by aldolases since the imidazolium N-acetylmannosamine probe 3 was in situ successfully 
transformed into the corresponding neuraminic acid probe. Different cell lines, such as Jurkat and 
HeLa, were incubated with probe 3 and fluorescence was detected after incubation and fluorescent 
labelling. When the cells were exposed to sialidases after incubation with 3, the fluorescent signal was 
diminished. It remains to be seen if this method is applicable in bacteria. 
Scheme 1. Synthesis of imidazolium-based ionic liquid tagged probe 3 from N-acetylmannosamine 1.
As reviewed in chapter 2, the last decade saw a rapid development of new bioconjugation reactions 
and two recent discoveries in this field rely on the element boron. Boronic acid-containing molecules 
remain highly interesting for chemical biological applications due to their hydrophilicity, stability, low 
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toxicity and as bioisosteres of carboxylic acids. In 2016, Bonger and co-workers reported the Carboni-
Lindsey reaction, an inverse electron-demand Diels–Alder cycloaddition between a tetrazine 4 and 
vinylboronic acid 5 (Scheme 2A).2 The method was successfully applied in protein bioconjugation and 
might be an interesting candidate for application in metabolic oligosaccharide engineering (MOE). 
One of the earliest reported bioconjugation reactions is the formation of an oxime and hydrazone 
between aldehydes/ketones and (hydroxy)amines. The slow reaction kinetics, however, make this 
system not suitable for live cell imaging to label and image fast biological processes. Inspired by a 
report from the 1960s, on the conjugation of phenylhydrazine and boronic acid, Gao and co-workers 
further explored the possibility of diazaborine heterocycles (Scheme 2B).3 4 2-Acetylphenylboronic 
acid 7 readily conjugated with semicarbazide 8 to form diazaborine 9. This method was successfully 
applied in bacterial cell wall labelling of 7 in Escherichia coli.  
Scheme 2. A) The Carboni-Lindsey reaction with vinylboronic acids and tetrazine. B) iminoboronate ligation. 
New bioconjugation reactions
There is always room for better bioconjugation reactions, meaning faster and still bioorthogonal, 
electron-deficient azides might offer a new class and were therefore explored in more detail.7 These 
azides are electron-poor and are easy to make from commercially available perfluorophenylazides.8 
The mechanism of action is via an inverse electron-demand cycloaddition of electron-deficient azides 
with aliphatic cyclooctynes as published by Van Delft and co-workers.9 They recently showed that 
electron-deficient aryl azides reacts 29 times faster with bicyclo[6.1.0]nonyne (BCN) than their 
aliphatic azide counterparts. Based on these findings, we hypothesised that a terminal alkoxy-alkyne 
functional group might also lead to a cycloaddition with an electron-deficient azide. Furthermore, we 
hypothesised that this reaction will proceed without the cytotoxic copper catalyst normally needed for 
this reaction with terminal alkynes. To test this hypothesis we synthesised an alkyne attached to a 
methoxyethylene glycol. The glycol moiety was added to increase the water solubility of the compound. 
2-Methoxyethan-1-ol 12 was reacted with propargylbromide in the presence of a strong base such as 
sodium hydride in THF to produce the desired alkyne (scheme 4). For comparison, we also tested the 
commercially available ethoxyethyne 10, but it was quickly abandoned as during the course of the 
reaction exposure to water efficiently transformed it into ethyl acetate 11 (Scheme 3). 
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Scheme 3. Reaction of ethoxyethyne and water.
The electron-deficient azide was commercially acquired as the tetrafluoro azido benzoic acid 17. A 
peptide coupling with 2-(2-aminoethoxy)ethan-1-ol 18 gave the desired product 15. We also installed 
an ethyleneglycol group on this reagent to improve its water solubility (scheme 4). Alkoxy-alkyne 14 
and electron deficient azide 15 were combined in a series of test tubes containing various deuterated 
solvents. One with only acetonitrile, one with a 1:1 mixture of acetonitrile and water, and one with 
only deuterated water. No reaction towards product 19 at room temperature was observed in any of 
the test tubes.
.
Scheme 4. Click reaction between a electron deficient azide species and aliphatic alkyne.
Inspired by the work of Fokin and Sharpless we also tested iodo-alkynes as suitable reagents for this 
reaction. Iodo-alkynes are easily accessible alkynes, which are more electron-rich than standard 
alkynes and thereby increase the reaction kinetics.10 1-Iodobut-1-yne was synthesised in two steps 
involving a lithium halogen exchange reaction (Scheme 4).11 Reacting the iodo-alkyne 16 with 15 also 
did not result in any product formation 20. Unfortunately, these two attempts towards new variations 
of the copper-free click reaction between electron-poor azides and aliphatic alkynes failed, but if a 
sterically small alkyne can be identified that is capable of this copper-free click reaction it would be a 
great addition as a chemical reporter on probes in the MOE/bioorthogonal reaction toolbox.
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Chapter 3: Probing Peptidoglycan Synthesis and l-fucose Salvage in the Gut Commensal Akkermansia 
muciniphila with Bioorthogonal Chemical Reporters 
In chapter 3, peptidoglycan synthesis in the bacterial cell wall of Akkermansia muciniphila was 
probed with d-Ala-d-Ala dipeptide derivatives with isonitrile and cyclopropene chemical reporters. 
Furthermore, metabolic labelling of cell envelope glycans with azido-fucose was also performed in 
Akkermansia muciniphila. MOE relies heavily on active or passive transport of the chemical probes 
into the cytoplasm. To facilitate passive uptake in MOE for instance acetylated carbohydrates are often 
used. Non-specific esterases in the cytoplasm hydrolyse the acetylated carbohydrates, followed by 
metabolism of the unmasked probe in the salvage pathway.12 Although these non-specific esterases 
are considered as an advantage for this application, potential challenges in the design of chemical 
probes need to be taken into account. For example, the cyclopropene peptidoglycan (PG) dipeptide 
contains a carbamate group which might be sensitive to hydrolysis by non-specific esterases.13 
However, this phenomenon has not yet been reported for carbamate-linked cyclopropene-glycans.14-16 
The diminished labelling of the cyclopropene PG dipeptide probe compared to the isonitrile PG 
dipeptide probe might thus be the result of non-specific esterases which cleave the carbamate linked 
cyclopropene from the core-dipeptide. Another factor might be the size of the chemical reporter 
group. Our new isonitrile PG dipeptide probe, is, compared to the cyclopropene probe, relatively small 
and only slightly bigger than the natural d-Ala dipeptide probe. Others, however, showed that larger 
substituents, such as fluorescent dyes, are also tolerated by the PG biosynthesis pathway in bacteria. 
As Leeper and co-workers showed on glycan analogues, the isonitrile dipeptide probe can also be 
elongated.17 Our synthesis of the PG probes can easily give access to these or other PG probes from 
amino dipeptide intermediate 21.
Scheme 5. Proposed alternative isonitrile PG dipeptide probe.
An elongated isonitrile PG dipeptide probe, such as 23, has extra options in terms of stability. A 
secondary or tertiary isonitrile version of the probe can for instance be made. Leeper et al.17 showed 
that the tertiary isonitriles on N-acetylglucosamine sugars are more stable after the click reaction 
compared to the primary or secondary isonitrile on N-acetylglucosamine sugars. Like the here 
proposed elongated isonitrile PG probe 23, the isonitrile PG probe reported in Chapter 3 does already 
contain a carbonyl group on the γ-position, which should benefit the stability of the tetrazine-clicked 
product by forming a stable α,β-unsaturated system.18
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From the microbiology point of view further investigation is also possible. Akkermansia muciniphila 
can easily grow on a synthetic (CP) medium with the addition of vitamins and a carbon source, such as 
mucin or N-acetylglucosamine. Cultures that can grow on GlcNAc might also grow on the azido-variant 
of GlcNAc, GlcNAz. In contrast, when we treated A. muciniphila with Ac
4
GlcNAz in CP medium we did 
not observe any growth. The acetylated sugar can probably not enter the cell via the standard active 
transport. When 10% of GlcNAc was present, however, we did observe slow culture growth that never 
reached exponential phase. The addition of more GlcNAc was necessary to reach standard culture 
density after overnight growth. The optimisation of the medium for A. muciniphila is an interesting 
step to improve the labelling efficiency. For example, addition of probe over a certain time window or 
using the non-acetylated version of the probe might be explored in future studies.
Chapter 4. Metabolic Glycan Labelling with Azido-Monosaccharides in Human-gut Related Microbes 
The study of metabolic labelling of peptidoglycan (PG) in chapter 3 was further continued towards 
other human-gut related microbes in chapter 4. In all tested species, azido-glycans were added 
immediately to freshly inoculated samples. Since glycans are important carbon sources for the energy 
generation by bacteria the glycan-based probes are likely to be directly metabolised, catabolised, or 
incorporated into other cellular glycans. Moreover, they can be incorporated into internal or external 
(cell-surface) glycans. For PG labelling this may be slightly different since PG-glycans are an essential 
component of the cell envelope and may be primarily needed when cells start to divide. Based on 
these assumptions, we always added the PG probes after a few hours of initial growth and the glycan 
probes immediately from the start. Further studies should aim to unravel the kinetics of the probe 
incorporation and provide further insight in the processes underlying the labelling. Furthermore, more 
detailed analyses on the outer surface, e.g. involving mass spectrometry, is needed to elucidate the 
chemical structures of labelled cell-surface glycans.
For glycan-based metabolic labelling and visualisation on a blot, a common combination is biotin-
alkyne for labelling and streptavidin to visualise on blot.19 A more preferred combination is, however, 
digoxigenin (DIG) and the commercially available anti-digoxigenin antibody.20 DIG is a steroid found 
exclusively in the Digitalis plant, and the anti-DIG antibody does not show any cross-reactivity with 
other steroids. For that reason DIG – anti-DIG was chosen above the more common biotin streptavidin 
labelling. Tempted by this more selective labelling method, we decided to investigate it and first 
prepared DIG-alkyne 26 via a one-step synthesis from commercially available DIG-NHS 25 and amino-
PEG4-alkyne 24 (Scheme 6). Alkyne 24 can be added to azido-glycans present on the surface of bacterial 
cells. The attached DIG ligand can after separation then react with anti-DIG to allow visualisation.
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Scheme 6. Synthesis of DIG-Alkyne.
After labelling of cell envelope glycans using MOE, direct analysis of the exact glycoconjugate 
composition is not possible. One technique which enables separation of cell surface glycans is sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). SDS-PAGE can serve as an additional 
separation or isolation technique for the analysis of glycans on glycoproteins. The thus separated 
glycans can subsequently be transferred to a blot and visualised by staining using dye-labelled 
lectins or specific glycoprotein stains. The mechanism of action of the latter glycoprotein staining 
is based on periodate-based oxidative cleavage of vicinal diols in glycoconjugates to aldehydes, 
followed by Schiff base formation with a reporter group (e.g. an amine with fluorescent dye). When 
clear separation is observed mass spectrometry can reveal the glycan composition in more detail. 
Our work with glycoprotein staining was focussed on A. muciniphila and B. fragilis with Ac
4
FucAz. 
When A. muciniphila or B. fragilis were both incubated with Ac
4
FucAz following the standard protocol 
as described in chapter 3 we observed labelling as controlled by confocal microscopy. Next, after 
washing, DIG-alkyne was added and the culture was incubated for one hour at room temperature. 
After three more washing steps the cultures were heated at 95 °C for five minutes and loaded onto 
SDS-PAGE gels. After separation we transferred the gel to a blot and after blocking labelling with 
anti-DIG was performed. Even after thorough optimisation we observed mainly a-specific binding to 
our samples. A-specific binding was even seen in samples without any azido-probe present and also 
with pure cultures. When biotin-streptavidin combinations were used we again observed a-specific 
binding. Despite known methods to perform glycoproteins-labelling and separation via SDS-PAGE we 
never observed positive results.21 SDS-PAGE is optimised for protein separation based on molecular 
mass but since glycoproteins may be heterogeneous and show differential SDS binding, some tailing 
is often seen when glycoproteins are analysed in this way. This was observed when we performed 
initial tests with SDS-PAGE. To optimise this process other gel types or denaturation techniques need 
to be explored. Future experiments should investigate the optimisation of steps prior to loading on 
the gel. Furthermore, as showed by confocal microscopy and flow cytometry analysis the efficiency of 
incorporation of azido-glycans onto surface glycans is sometimes below 10%. This will also negatively 
influence a successful detection on SDS-PAGE and subsequent analysis via mass spectrometry.
For our analysis of the MOE results we heavily relied on fluorescence imaging. Fluorescent imaging 
of gut microbiota is however rather challenging. Molecular biology-based tagging methods, such as 
fluorescent proteins, cannot be installed in peptidoglycan, glycolipids, and other glycoconjugates 
since these are not directly encoded in the genes. Furthermore, most gut-bacteria are anaerobic 
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which causes problems for live cell imaging fluorescence measurements since this often exposes 
the sample to oxygen. Live cell imaging provides another challenge. The constant movement of the 
bacteria in the media may result in unfocussed images. A variety of techniques to immobilise cells 
without killing them are available such as poly-l-lysine coating22 and cell tak23. Poly-l-lysine coating 
is based on electrostatic interactions with the cell membrane of bacteria and the positively-charged 
l-lysine ions on the surface. Cell tak is a commercially available mixture of compounds that is based 
on a natural extract from mussels where it serves as an adhesive protein. To improve unfocussed 
microscopy images such commercially available immobilisation techniques need to be implemented 
and standardised.
 
 
Personal Note on Metabolic Oligosaccharide Engineering in Bacteria
Metabolic oligosaccharide engineering (MOE) is widely adapted as a tool to explore glycans on the 
outer surface of cells. It is nowadays a well-established method in glycan-labelling of mammalian 
cell lines. For bacteria, however, labelling is not always straightforward. For mammalian cells versus 
bacterial cells, different MOE protocols need to be employed. Especially in bacteria an extra set of 
important parameters need to be considered: growth rate, metabolism, culture density, point of 
inoculum, concentration of the probe, and the nutrients present in the medium. Compared to MOE 
in eukaryotes a higher concentration of chemical probe is added to perform MOE in bacterial cells 
(minimum 10 times more concentrated compared to eukaryotes). Inoculation for MOE experiments 
is often performed from a pre-culture which was allowed to reach full growth. Inoculation from a 
late-stage exponential phase, thus from an active culture, can result in direct active metabolism after 
inoculation and thereby benefit metabolic uptake of the probe. Another important factor for MOE 
in bacteria is the medium. A variety of nutrients are available for the bacteria. If there is too much 
nutrient present, especially carbohydrate-based, the chance the chemical probe will be consumed 
is less likely compared to a minimal medium. Extensive optimisation is needed to further explore 
all these possibilities. Only after that, MOE can be a powerful tool in studying bacteria. Besides this 
experimental design, the actual experimental procedures are also crucial. Important parameters such 
as final concentration of the probe after inoculation, the exact washing procedure (volumes, time and 
repetition), the incubation time and the exact settings of fluorescent imaging equipment are often not 
unambiguously reported in current scientific literature.24-26 A more detailed experimental procedure 
would speed up the rate at which MOE in bacteria is further developed and thereby improve our 
insight into the role of glycans in the human microbiome. Despite the need for a more standard 
method the wide variety of bacterial species will remain challenging. Moreover, bacteria live in a 
mixed environment and analysis in these mixed communities, as illustrated in chapter 4, is even more 
challenging than MOE in single cultures.
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Chapter 5: Total Synthesis towards Pseudaminic Acid Probes
A major goal of the studies presented in this thesis was the total synthesis of pseudaminic acid (Pse) 
and the subsequent development of chemical probes based on its structure. Results towards this goal 
can be found in chapter 5. In a total synthesis route important choices need to be made all the time 
as planned transformations fail and alternative routes can always be devised on paper to obtain the 
target structure. At the start of such a project it is hard to predict beforehand which route will turn 
out to be most efficient or better yielding. In chapter 5 we explored both the Henry reaction and 
tethered aminohydroxylation in great detail as the key transformation to obtain the hexose precursor 
of pseudaminic acid. Several suggestions for alternative routes are discussed below. Furthermore, we 
elaborate on how to synthesise chemical probe versions of the Pse hexose precursor and pseudaminic 
acid itself.
The Garner aldehyde derivative 28 served as a key intermediate in our pursued total synthesis route 
towards pseudaminic acid (chapter 5). An alternative strategy towards pseudaminic acid from this 
aldehyde 28 is an aldol-Darzens reaction with lithium olefin 29 (Scheme 7).27 The resulting epoxide 30 
can be opened using a nucleophile such as sodium azide in order to install the amine alcohol moiety. 
More steps are needed to further transform this intermediate to pseudaminic acid.
Scheme 7. Proposed alternative synthesis from towards amino-alcohol motif 31.
In order to perform metabolic labelling with Pse-derivatives a chemical reporter needs to be 
installed. A few considerations need to be made when selecting a chemical reporter. First, a 
bioorthogonal strategy needs to be employed to perform efficient metabolic labelling experiments 
on live bacteria. Next, the selection of the preferred chemical reporter (e.g. azide or isonitrile) 
needs to be made.28 The Pse hexose precursor 32 can be turned into a chemical probe on the 
C4-position. The azide can be reduced to an amine and coupled to a cyclopropene group or 
transformed into an azide. After deprotection of the benzoyl and thiophenol glycoside, followed by 
acetylation, an acetyl-protected Pse hexose precursor-based probe 33 can be obtained (Scheme 8). 
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Scheme 8. Proposed synthesis of Pse hexose chemical probe 34.
The orthogonal protected precursor 32 can, of course, at this stage be modified into a Pse-based 
chemical probe (Scheme 9). It is not fully clear whether the remaining synthetic manipulations will 
affect the activity of the chemical probe. Since the C4-azido group in 32 will not survive the Barbier 
allylation it can be reduced to an amine and protected with a phthalimide 35.29 After the Barbier 
allylation ozonolysis of the olefin produces product 38.30 In the final steps the two orthogonally 
protected amines can be turned into chemical reporters. After a final deprotection step the Pse 
chemical probe should be ready for metabolic labelling experiments (Scheme 9).
Scheme 9. Proposed synthesis of Pse chemical probe 40.
The usefulness of Pse-based chemical probes for MOE is illustrated by a striking chemical biology 
experiment with azido-modified Pse, performed by Tanner and co-workers in 2009. A pseudo-
chemoenzymatic synthesis allowed them to produce 6-deoxy-AltNAc4Az.31 This azido-Pse precursor 
was fed to Campylobacter jejuni and metabolic uptake resulting in azido-Pse on the cell surface glycans. 
C. jejuni was genetically modified in such a way that the flagella was not present.  After the addition 
of azido-Pse the bacteria started producing flagella and restored their motility. Hence, the importance 
of Pse for the motility of C. jejuni was proven. In H. pylori, another pathogenic gastric bacteria, Pse 
also plays a pivotal role. Dube and co-workers identified a list of glycosylated proteins containing Pse.32 
They also showed that Pse is essential for functional flagella in H. pylori. The glycosylated proteins 
containing azido-Pse on the flagella of H. pylori and C. jejuni have the potential to elucidate the 
function of bacterial glycoproteins in bacterial-host interactions.33-36
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Pseudaminic acid is a difficult target for total synthesis due to a axial methyl group in the Pse precursor. 
To install the 6-methyl in an axial position, Ito and co-workers performed a hydrogenation using 
Wilkinson’s catalyst on an olefin. This reaction was performed with remarkable selectivity to yield the 
axial 6-methyl group. Synthetic challenges in the hydrogenation step of the olefin on similar substrates 
can however be expected. To circumvent the potential difficult hydrogenation step on our slightly 
different olefin another route starting from l-fucose 41 can be chosen following a route of Sharon 
and co-workers.37-38 Although l-fucose is an expensive starting point (25 gram ~ € 700,-) for a total 
synthesis, routes are known from this building block.37 The benefit of l-fucose is the fact that it already 
contains the 6-methyl group with the right stereochemistry. Further functionalisation to install the 
two chiral amine moieties does, however, requires quite a few synthetic steps as showed by Sharon 
and co-workers.37-38 
Scheme 10. Synthesis towards Pse from Sharon et al.37
In order to obtain a probe suitable for MOE, the azides need to be transformed into azido-acetamide 
groups. Differentiation between the two azides for attachment of a chemical reporter can, of course, 
not be achieved via this method. However, for initial studies in Pse-containing species this synthetic 
route might be interesting.
Lengthier routes towards Pse starting from cheaper starting sources can also be designed. 6-Deoxy-l-
gulose is an interesting starting point towards Pse, although many synthetic manipulations are needed 
(Scheme 11).39 In 1980, Ireland and co-workers reported the synthesis of unprotected 6-deoxy-l-gulose 
from d-(+)-Glucuronic acid γ-lactone (100 gram, €60,-) in six steps. 6-Deoxy-l-gulose has the correct 
stereochemistry on the C-3 and C-5 position. Furthermore the 2,4-diol has the opposite configuration 
making it possible to perform after activation a S
N
2 type nucleophilic addition with an azide source. 
An improved synthesis of protected 3-OAc 6-deoxy-l-gulose 45 was reported by Kulkarni and co-
workers in 2016 (Scheme 11).40 From l-rhamnose (100 gram, €400,-) 47, 3-OAc 6-deoxy-l-gulose 45 
was prepared in five steps. At this point, the synthesis can continue with activation of the hydroxyl 
groups and S
N
2 displacement with sodium azide to install the two protected amine functionalities and 
obtain the Pse building block.
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Scheme 11. Proposed synthesis of Pse building block from 6-deoxy-l-gulose.
Inspired by the route published by Ito and co-workers we also worked on the total synthesis of 
pseudaminic acid starting from d-glucosamine 48.41 β-thiophenol donor 50 was made in three steps 
from d-glucosamine 48 (Scheme 12).42 
Scheme 12. Synthesis of β-thiophenol N-acetylglucosamine 50.
A 4,6-benzylidene moiety was installed to enable modification of the C3-position. The standard method, 
using camphor sulfonic acid and dimethylbenzaldehyde acetal, did not work in our hands. First of all the 
solubility of the starting material caused problems, and in fact in standard organic solvents modified 
N-acetylglucosamine sugars are known to cause solubility issues. Secondly, no full conversion was seen 
using this method. Catalytic amounts of copper triflate in the presence of dimethylbenzaldehyde acetal 
was used and the reaction mixture was sonicated for 1 hour to obtain the desired product 51 in 94% 
yield.43 We envisioned that a benzoyl group on the C3-position would be ideal, compared to the benzyl 
group used by Ito and co-workers.41 Selective ring opening of the benzylidene proved challenging. A 
variety of procedures was tested ranging from aluminium trichloride with borane trimethylamine44 
to TMSOTf and borane in THF.45 Unfortunately, no selective opening was observed and only mixtures 
were isolated. We could, however, retrieve the desired 6-OH product 53 from the reaction mixture. The 
deoxygenation of C-6 and inversion of C-5 also proved challenging. 6-OH activation was performed 
with either TsCl, triflic anhydride, or NBS followed by iodonation.46 The small amount of product 54 
that could be isolated was treated with t-BuOK, but only trace amounts of the desired alkene 55 were 
observed.41 Also throughout the whole synthesis the low solubility of the intermediates was a practical 
issue that caused loss of products during work up and purification. At this stage, due to these challenges 
and a lack of precursors, this synthetic route towards Pse was therefore discontinued (Scheme 13). 
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 Scheme 13. Synthesis of β-thiophenol N-acetylglucosamine alkene 55.
At that stage we reasoned that the low solubility of the GlcNAc-based intermediates in this synthesis 
could perhaps be solved by the conversion of the amine into an azide. Diazotransfer reagent 56 
was successfully applied on commercially available d-glucosamine 48. After conversion to the azide 
and acetylation of the alcohols the corresponding β-thiophenol 59 was synthesised. Zémplen de-
acetylation was followed by installation of a naphtyl acetal on the 4,6-position. The naphtyl acetal was 
preferred over the benzyl acetal, since the naphtyl group can also be removed selectively with DDQ.47 
This naphtyl protection, however, never reached full conversion and due to lack of precursor this route 
was also not further pursued (Scheme 14).
Scheme 14. Synthesis of β-thiophenol azidoglucosamine 60.
Future directions
I propose to continue the synthesis towards Pse following the route of Ito and co-workers.41 Alkene 62 
can be selectively reduced to the axial 6-methyl 63 using Wilkinson’s catalyst. The synthetic challenges 
related to this step might be solved using another approach. To install the 4-amino moiety I propose 
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to deprotect the benzyl group under hydrogenation conditions followed by activation and nucleophilic 
displacement with sodium azide to obtain thio-glycoside 64. On the related building block used by Ito 
and co-workers this was however not possible as discussed in chapter 5.41 An alternative route is the 
installation of an oxazine on the 4,6-position (Scheme 15). Opening of the oxazine with acetic acid 
gives a 4-amino and 6-hydroxy group as reported earlier.48 
Scheme 15. Proposed synthesis of 4-NHAc azido glucosamine.
This Pse hexose 65 can be seen as a precursor towards Pse if the 6-OAc group is converted into an 
axial deoxy 6-methyl using the method of Ito and co-workers using Wilkinson’s catalyst. One can 
either transform the 4-azido into a 4-azidoacetamide group, deprotect the benzoyl and thiophenol 
group and do metabolic labelling or perform Barbier allylation on the hydrolysed glycoside to obtain 
alkene 67. After some more additional steps it should be feasible to obtain Pse probes to do metabolic 
labelling (Scheme 16).
Scheme 16. Proposed synthesis of Pse precursor 65.
What is next?
The era of chemical (micro)biology has just started. Numerous bioconjugation reactions have been 
developed and applied in a variety of (biological) systems and organisms, e.g. plants and microbes. 
This thesis for example showed the synthesis of two novel PG dipeptide probes which were 
successfully imaged in A. muciniphila and E. coli. The imaging of other cellular glycans in human 
gut related microbes is however rather challenging as chapter 4 illustrated. In the next decade all 
these (biological) systems will be mapped in even more detail, especially focussing on the diversity 
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of glycans. Metabolic labelling techniques such as metabolic oligosaccharide engineering (MOE) and 
selective exo-enzymatic labelling (SEEL) will be further improved to obtain better selectivity in MOE 
and the easier excess to complex molecules needed for SEEL. These methods are needed in order to 
elucidate the biological role of important microbial glycans such as pseudaminic and legionaminic 
acid. Synthetic chemistry can advance this by developing chemical probes of bacterial glycans as we 
showed in chapter 5. More knowledge about bacterial glycans will help to understand in even more 
detail the important role of glycans in microbes related to human life.
Experimental section
General
For reactions conducted under anhydrous conditions glassware was dried overnight in an oven at 150 
°C and was subsequently allowed to cool in a desiccators over anhydrous KOH. Anhydrous reactions 
were carried out under nitrogen. Reagents/solvents for anhydrous reactions were obtained from a 
Pure Process Technology Glass Contour solvent purification system (SPS) (CH2Cl2, THF, diethyl ether, 
toluene), with 3Å molecular sieves (DMF, CH3CN, CH3OH, toluene, pyridine) or Na2SO4 (acetone). 
Commercially acquired chemicals were used without further purification unless stated otherwise. 
Flash Column Chromatography
Flash column chromatography was carried out according to standard procedures using silica gel 60 
(40-63 µm mesh) from Screening Devices, Amersfoort. Prior to loading an appropriate eluent was 
chosen by running a TLC of the crude mixture which was to be purified. Loading was performed with 
celite or small volumes of the eluent.47
Thin Layer Chromatography (TLC)
Thin layer chromatography was carried out on and visualised using UV (254 nm), Hanessian stain, 
sulfuric acid, KMnO
4
, I2 or ninhydrin stain. The quoted Rf values are rounded to the nearest 0.05.
Nuclear Magnetic Resonance (NMR)
1H- and 13C-NMR were run on a Bruker Avance 400 NMR spectrometer (400 MHz). Chemical shifts are 
reported in parts per million (ppm) with reference to tetramethylsilane (TMS) as internal standard. 
Coupling constants (J) are reported in Hertz (Hz), rounded to the nearest 0.5 Hz. Signal assignment 
was based on unambiguous chemical shifts in combination with COSY, HSQC, HMBC, and/or DEPTQ. 
High Resolution Mass Spectroscopy (HRMS)
High-resolution ESI mass analyses were recorded on a Orbitrap high-resolution mass spectrometer. 
The orbitrap high-resolution mass spectrometer system consisted of a ESI ion source (Ion-Sense, 
Saugus, USA) coupled to an Exactive high resolution MS system (Thermo Fisher Scientific, San Jose, CA, 
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USA). The MS was calibrated daily using ProteoMass™ LTQ/FT-Hybrid ESI (positive and negative mode) 
Cal Mix (Sigma Aldrich), which is applicable for the m/z range 100‒2000. XCalibur software (version 
2.1) was used for instrument control, data acquisition and data processing.
Infrared Spectroscopy (IR)
Infrared spectra were recorded on a FT-IR spectrometer apparatus (Bruker Tensor) with a universal 
ATR accessory. Both solid and oily compounds were recorded. FT-IR signals are reported in cm-1.
1-Iodo-3-(2-methoxyethoxy)prop-1-yne Propargylmethoxyethanol (50 mg, 
0.44 mmol) was dissolved in anhydrous THF (10 ml) and stirred at room 
temperature. Copper iodide (4 mg, 0.021 mmol, 0.05 eqv) and N-iodomorpholine.
KI (164 mg, 0.48, 1.1 eqv) was added and the reaction mixture was stirred overnight at room 
temperature. The reaction mixture was filtered over neutral alumina and washed with CH2Cl2 (3 × 5 
ml). The organic layer was dried over Na2SO4 and concentrated in vacuo. The crude mixture was 
purified using flash column chromatography (heptane 4:1 EtOAc) to give the product 16. 1H NMR (400 
MHz, CDCl3) δ 4.22 (2H, s, CH2), 3.42 (3H, s, OCH3), 1.3-1.24 (4H, m, 2 × CH2).
 
 
 
DIG-NHS ester was purchased from Enzo lifesciences. Amino-PEG4-alkyne was purchased from 
Sigma-Aldrich.
DIG-NHS ester (5 mg, 0.075 mmol) was dissolved in anhydrous DMF (1 ml) and 
triethylamine (16 µl). Amino-PEG4-alkyne (16 mg, 0.068 mmol) was added and 
the reaction mixture was stirred overnight at room temperature. The reaction 
mixture was concentrated in vacuo and used without any further purification. 
Product 26 was obtained as a colourless oil (6 mg, quantitative yield).
MS: found 797.5 [M+Na+], calculated for [C
42
H
66
N2O11 + H
+] 774.99.
Reference: Bioconjugate Chemistry 2011, 22 (7), 1422-1432.
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Chapter 5: additional experimental 
(2R,3R,4R,5S,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl 
triacetate d-Glucosamine.HCl (48, 22 g, 102 mmol, 1 eqv) was suspended in pyridine 
(100 ml) at room temperature. Acetic anhydride (94 ml, 998 mmol, 9.8 eqv) was 
added and the mixture was stirred overnight at room temperature. The reaction 
mixture was poured into H2O (500 ml) and extracted with CH2Cl2 (3 × 100 ml). The 
organic layers were dried over Na2SO4 and concentrated in vacuo. The oily residue was crystallised by 
adding CH2Cl2:Et2O (1:10, 200 ml).  The α-anomer 49 was obtained in 52% yield. 1H NMR (400 MHz, 
CD3OD) δ 6.01 (1H, d, J = 3.6, C-1), 5.24 (1H, dd, J = 11.1, 9.3, C-3), 5.03 (1H, t, J = 4.0, 10.0, C-4), 4.40 
– 4.26 (1H, m, C-2), 4.22 (1H, m, C6b), 4.08 (1H, m, C-5), 3.99 (dd, J = 12.4, 2.4, C-6a), 2.13 (3H, s, CH3), 
2.05 – 1.89 (9H, m, 3 × CH3), 1.85 (3H, s, CH3). 
13C NMR (100 MHz, CD3OD) δ 174.0 (C=O), 173.9 (C=O), 
172.7 (C=O), 172.3 (C=O), 171.6 (C=O), 171.1 (C=O), 91.6 (C-1), 71.8 (C-5), 70.9 (C-4), 69.8 (C-3), 62.9 
(C-6), 51.94 (C-2), 20.7 (5 × CH3).
(2R,3S,4R,5R,6S)-5-Acetamido-2-(acetoxymethyl)-6-(phenylthio) tetrahydro-
2H-pyran-3,4-diyl diacetate α-d-Glucosaminepentaacetate 49 (20 g, 51 mmol, 
1 eqv) was dissolved in CH2Cl2 (100 ml) and charged with thiophenol (6 ml, 61 
mmol, 1.2 eqv). Tintetrachloride (1M, 4.21 ml, 36 mmol, 0.7 eqv) was added 
and the reaction mixture was refluxed overnight. The reaction mixture was 
quenched with NaHCO3 (250 ml) and extracted with CH2Cl2 (3 × 75 ml). The organic layer was washed 
with brine (3 × 20 ml), dried over Na2SO4 and concentrated in vacuo. The product was crystallised from 
Et2O and hexanes (10:1) to obtain the product 71 (21 g, 98% yield). 1H NMR (400 MHz, CD3OD) δ 7.55 
– 7.44 (2H, m, CHar), 7.36 – 7.27 (2H, m, CHar), 5.65 (1H, d, J = 9.2, C-1), 5.22 (1H, dd, J = 10.2, 9.3, C-3), 
5.04 (1H, t, J = 9.7, C-5), 4.85 (1H, d, J = 10.4, C-4), 4.28 – 4.11 (2H, m, C-2 and C-6a), 3.72 (1H, ddd, J = 
10.0, 5.3, 2.7, C-6b), 2.31 – 1.76 (12H, m, 4 × CH3). 
13C NMR (100 MHz, CD3OD) δ 171.0 (C=O), 170.6 
(C=O), 170.0 (C=O), 169.3 (C=O), 132.5 (Ar-CH), 132.4 (Ar-CH), 128.9 (Ar-CH), 128.0 (C-S), 86.6 (C-1), 
75.8 (C-5), 73.7 (C-4), 68.4 (C-3), 62.4 (C-6), 53.4 (C-2), 23.3 (CH3), 20.7 (CH3), 20.7 (CH3), 20.6 (CH3).
N-((2S,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-(phenylthio)
tetrahydro-2H-pyran-3-yl)acetamide Thiophenol 68 (270 mg, 0.6 mmol, 1 eqv) 
was dissolved in anhydrous methanol (5 ml). NaOCH3 (25% wt, 2 drops, 0.1 eqv) 
was added and the reaction mixture was stirred at room temperature for 2 hours. 
The reaction mixture was neutralised by adding Dowex H+, filtered, and concentrated in vacuo. 
Product 50 was obtained in quantitative yield. 1H NMR (400 MHz, CD3OD) δ 7.49 – 7.35 (2H, m, CHar), 
7.28 – 7.10 (2H, m, CHar), 4.73-4.70 (1H, d, J = 12, C-1), 3.82 – 3.78 (1H, m, C-3), 3.70-3.66 (1H, m, C-5), 
3.63-3.59 (1H, m, C-4) 3.42-3.37 (1H, m, C-2), 3.30-3.25 (2H, m, C-6) 1.92 (3H, s, CH3).
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2-(Dimethoxymethyl)naphthalene 2-Naphtylaldehyde (1 g, 6 mmol) was 
dissolved in anhydrous methanol (10 ml) and stirred at room temperature. 
Trimethylorthoformate (770 μl, 7 mmol, 1.1 eqv) and camphor sulfonic acid (0.01 
eq, 1-10 mg) were added before the reaction was stirred for 15 minutes. The 
reaction mixture was quenched with Et3N and concentrated in vacuo to give 
dimethylnaphtylacetal 66 in quantitative yield (1.21 gram). 1H NMR (400 MHz, CDCl3) δ; 8.00 – 7.78 
(4H, m, CHar), 7.64 – 7.41 (3H, m, CHar), 5.56 (1H, s, CH), 3.38 (6H, s, 2 × CH3).
N - ( ( 2 S , 4 a R , 6 S , 7 R , 8 R , 8 a S ) - 8 - H y d r o x y - 2 - p h e n y l - 6 - ( p h e n y l t h i o )
hexahydropyrano[3,2-d][1,3]dioxin-7-yl)acetamide Diol 50 (3.72 mg, 11.87 mmol, 
1 eqv) was dissolved in anhydrous acetonitrile (2 ml). Dimethylbenzaldehyde acetal 
(2.15 ml, 14.25 mmol, 1.2 eqv) and coppertriflate (214 mg, 0.59 mmol, 0.05 eqv) 
were added, and the reaction mixture was sonicated for 60 minutes. The reaction 
mixture was concentrated in vacuo and purified by column chromatography (5% 
CH3OH in CH2Cl2) to obtain the 3-OH product 51 (4.40 g, 94%). 1H NMR (400 MHz, CDCl3) δ; 7.51-7.22 
(10H, m, CHar), 5.10 (1H, d, J = 2, CH), 4.80-4.77 (1H, d, J = 12, C-1), 3.91-3.66 (3H, m, C-3, C-5, C-4), 
3.58-3.35 (3H, m, C-2, C-6), 2.00 (3H, s, CH3). The naphtyl acetal 70 was installed by the same procedure.
(2S,4aR,6S,7R,8R,8aS)-7-Acetamido-2-phenyl-6-(phenylthio)hexahydropyrano 
[3,2-d][1,3] dioxin-8-yl benzoate 3-OH Thiophenol glycoside 51 (70 mg, 0.17 mmol, 
1 eqv) was suspended in anhydous CH2Cl2. Benzoylchloride (22 μl, 0.19 mmol, 1.1 
eqv) and pyridine (28 μl, 0.35 mmol, 2 eqv) were added and the reaction mixture 
was stirred overnight at room temperature. The reaction mixture was diluted with 
CH2Cl2 (5 ml) and washed with brine (3 × 5 ml). The organic layer was dried over Na2SO4 and 
concentrated in vacuo. The product was purified by column chromatography (EtOAc in heptane) to 
give traces of product 52. 1H NMR (400 MHz, CDCl3) δ 8.06 – 7.87 (2H, m, 2 × CHar), 7.67 – 7.30 (3H, m, 
3 × CHar), 5.69 (1H, d, J = 9.5, C-1), 5.61 – 5.45 (3H, m, CCHO and C-5), 4.59 – 4.27 (2H, m, CH2), 3.89 
(2H, m, C-3 and C-4), 3.66 (1H, m, C-2), 1.91 (3H, s, NHAc). 13C NMR (100 MHz, CDCl3) δ 169.7 (C=O), 
165.3 (C=O), 137.3 (Cq), 129.0 (CHar), 128.8 (CHar), 128.4 (CHar), 128.1 (CHar), 126.0 (CHar), 100.4 (C-1), 
78.0 (C-4), 73.6 (C-5), 72.1 (C
q
CO), 69.8 (C-2), 67.6 (C-3), 52.4 (CH2). MS: found 528.33 [M+Na
+], 
calculated for [C
28
H
27
NO
6
S + Na+] 528.15.
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(2S,3R,4R,5S,6R)-3-Acetamido-5-(benzyloxy)-6-(hydroxymethyl)-2-
(phenylthio)tetrahydro-2H-pyran-4-yl benzoate 
Thiophenolglycoside 52 (32 mg, 0.06 mmol, 1 eqv) was suspended in 
borane.THF (0.1 ml, 1 M). The reaction mixture was cooled to 0 °C 
before TMSOTf (16 μl, 0.08 mmol, 1.4 eqv) was added slowly. The 
reaction mixture was quenched with CH3OH (0.5 ml) and Et3N (0.1 ml) and concentrated in vacuo. 
Flash column chromatography was performed to give the opened 4-OH 53 and 6-OH 71 products.  1H 
NMR (400 MHz, CDCl3) δ 7.38 – 7.18 (6H, m, 6 × CHar), 6.88 – 6.76 (3H, m, 3 × CHar), 6.76 – 6.63 (6H, m, 
6 × CHar), 5.11 (1H, dd, J = 15.1, 9.1 Hz, CH), 4.58 (2H, m, CH2), 4.77 – 4.61 (1H, m, αH), 4.00 – 3.69 (3H, 
m, C-3, C-5, C-4), 3.66 – 3.50 (3H, m, C-2, C-6). 13C NMR (100 MHz, CDCl3) δ 170.0 (C=O), 167.0 (C=O), 
137.1 (Ar-C
q
), 133.6 (Ar-C
q
), 133.2 (Ar-C
q
), 131.7 (Ar-C
q
), 129.8 (CHar), 129.1 (CHar), 129.0 (CHar), 128.6 
(CHar), 128.5 (CHar), 128.4 (CHar), 128.1 (CHar), 128.0 (CHar), 127.8 (CHar), 87.2 (α-CH), 79.4 (CH2), 77.3 
(C-3), 77.2 (C-5), 76.8 (C-4), 74.9 (CH2), 53.3 (C-2), 23.2 (CH3).
(2S,3R,4R,5S,6R)-3-Acetamido-5-hydroxy-6-(hydroxymethyl)-2-(phenylthio)
tetrahydro-2H-pyran-4-yl benzoate Acetal 52 (50 mg, 0.09 mmol, 1 eqv) was 
suspended in 60% AcOH (1 ml) in H2O (5 ml) and stirred for three hours at room 
temperature. The reaction mixture was concentrated in vacuo and purified by 
column chromatography (5% CH3OH in CH2Cl2) to give the desired product 72 (35 mg, 98% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.08 – 7.78 (2H, m, CHar), 7.67 – 7.23 (8H, m, CHar), 5.64 (1H, d, J = 9.5 Hz, C-1), 
5.55 – 5.36 (2H, m, CH2), 4.85 (1H, d, J = 10.5, C-3), 4.43 – 4.07 (2H, m, C-4 and C-5), 3.85-3.75 (2H, m, 
J = 15.2, 9.9, C-6), 3.58 (1H, m, C-2), 1.82 (3H, s, CH3).
(2S,3R,4R,5S,6R)-3-Acetamido-5-(benzyloxy)-2-(phenylthio)-6-((tosyloxy)
methyl)tetrahydro -2H-pyran-4-yl benzoate 6-OH Thiophenol glycoside 53 (11.30 
mg, 0.02 mmol, 1 eqv) was dissolved in anhydrous CH2Cl2. Tosylchloride (4.61 mg, 
0.02 mmol,  1.1 eqv) and pyridine (18 μl, 0.22 mmol, 10 eqv) were added and the 
reaction mixture was stirred at room temperature overnight. The reaction mixture 
was concentrated in vacuo. Analysis by mass spectrometry showed traces of the 
desired product 73.  1H NMR (400 MHz, CDCl3) δ 7.99 (2H, d, J = 7.9 Hz, 2 × CHar), 7.81 (2H, d, J = 8.4 
Hz, 2 × CHar), 7.58 (2H, m, J = 16.1, 11.8 Hz, 2 × CHar), 7.49 – 7.35 (4H, m, 4 × CHar), 7.35 – 7.28 (4H, m, 
4 × CHar), 7.18 (3H, m, 3 × CHar), 7.11 – 6.97 (2H, m, 2 × CHar), 5.61 (1H, d, J = 9.5 Hz, C-1), 5.31 (2H, s, 
CH2), 4.70 (1H, d, J = 10.5, C-3), 4.43 – 4.11 (2H, m, C-4 and C-5), 3.98 – 3.66 (2H, m, C-6), 3.61 (1H, d, 
J = 9.6, C-2), 2.41 (3H, s, CH3), 1.87 (3H, m, CH3). MS: found 684.25 [M+Na+], calculated for [C
35
H
35
NO
8
S2 
+ Na+] 684.77
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(2S,3R,4R,5S,6S)-3-Acetamido-5-hydroxy-6-(iodomethyl)-2-(phenylthio)
tetrahydro-2H-pyran-4-yl benzoate Tosyl alcohol 73 (150 mg, 0.26 mmol, 1 eqv) was 
dissolved in anhydrous DMF. Sodiumiodine (87 mg, 0.58 mmol, 2.2 mg) was added 
and the reaction mixture was stirred for 3 hours at 100 °C. The reaction mixture was 
cooled to r.t. before it was diluted with toluene and concentrated in vacuo. Column 
chromatography was performed with 5% CH3OH in CH2Cl2 to give the product 54 with minor impurities. 
1H NMR (400 MHz, CD3OD) δ 8.03 – 7.88 (1H, m, CHar), 7.69 – 7.60 (1H, m, CHar), 7.60 – 7.50 (1H, m, 
CHar), 7.50 – 7.43 (2H, m, 2 × CHar), 7.40 (2H, m, 2 × CHar), 7.33 – 7.10 (3H, m, 3 × CHar), 5.29 – 5.16 (1H, 
t, J = 8 and 20, C-3), 4.90 (1H, d, J = 10.4, C-1), 4.15-4.07 (1H, m, C-4), 3.85-3.82 (1H, m, C-5), 3.72 – 3.57 
(1H, m, C-2), 3.45-3.40 (2H, m, CH2) 2.64 (3H, s, NHAc).
(3R,4R,5S,6R)-3-Azido-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol 
d-Glucosamine 48 (1.50 g, 6.96 mmol, 1 eqv) was suspended in CH3OH (30 ml), 
K2CO3 (3.17 g, 23.96 mmol, 3.3 eqv), and CuSO4·5H2O (17.37 mg, 0.07 mmol, 0.01 
eqv). Sulfonyl diazotransfer reagent 56 (2.26 g, 8.35 mmol, 1.2 eqv) was added 
followed by stirring at room temperature overnight. The suspension was filtered 
over celite and concentrated in vacuo. To the crude reaction mixture was added acetic anhydride (0.28 
ml, 31.32 mmol, 4.5 eqv), triethylamine (0.38 ml, 27.84 mmol, 4 eqv) and the reaction mixture was 
stirred for 1.5 hour at room temperature. The reaction mixture was purified by flash column 
chromatography (EtOAc / Heptane) to give β-anomer 58 (600 mg, 41% yield). 1H NMR (400 MHz, 
CDCl3) δ 5.45 (1H, d, J = 8.6, C-1), 5.14 – 4.60 (2H, m, C-3 and C-5), 4.18 (1H, dd, J = 12.5, 4.5, C-4), 3.95 
(1H, dd, J = 12.5, 2.1, C-2), 3.70 (1H, m, C-6a), 3.54 (1H, dd, J = 9.9, 8.5 Hz, C-6b), 2.34 – 1.70 (12H, m, 
4 × CH3).
(2R,3S,4R,5R,6S)-2-(Acetoxymethyl)-5-azido-6-(phenylthio)tetrahydro-2H-pyran-
3,4-diyl diacetate Tetracetate 58 (680 mg, 1.82 mmol) was dissolved in anhydrous 
CH2Cl2 (10 ml) and stirred at room temperature. Thiophenol (224 μl, 2.18 mmol, 1.2 
eqv) was added followed by the addition of SnCl
4 
(1.27 ml, 1 M, 0.7 eqv) over 5 
minutes. The reaction mixture was refluxed overnight. The reaction mixture was 
quenched with NaHCO3 (100 ml) and extracted with CH2Cl2 (3 × 25 ml). The organic layer was washed 
with brine (3 × 20 ml), dried over Na2SO4 and concentrated in vacuo. The reaction mixture was purified 
by flash column chromatography (5% CH3OD in CH2Cl2) to give thioglycoside 59 (400 mg, 52% yield). 1H 
NMR (400 MHz, CDCl3) δ 7.59 – 7.16 (5H, m, 5 × CHar), 5.56 (1H, d, J = 5.6, C-1), 5.26 (1H, t, J = 9.9, C-3), 
5.11 – 4.91 (2H, m, C-4 and C-5), 4.51 (1H, ddd, J = 10.3, 5.2, 2.1, C-2), 4.29 – 3.84 (2H, m, CH2), 2.07 
– 1.85 (9H, m, 3 × CH3).
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(2S ,4aR ,6S ,7R ,8R ,8aS)-7-Azido-2-(naphthalen-2-yl)-6-(phenylthio)
hexahydropyrano[3,2-d][1,3]dioxin-8-ol β-Thiophenol 2-azido triacetate 59 (81 
mg, 0.19 mmol, 1 eqv) was dissolved in anhydrous CH3OH (2 ml) and stirred at 
room temperature. Sodium methoxide (2 drops) were added and the reaction 
mixture was stirred for 1 hour at room temperature. The reaction mixture was 
quenched with Dowex H+, filtered, and concentrated in vacuo to give the de-
acetelated azido sugar 60 in quantitative yield. The crude diol 60 (65 mg, 0.19 mmol, 1 eqv) was 
dissolved in anhydrous DMF (0.5 ml) and stirred at room temperature. Molsieves (3 Å, 3 pcs), 
2-naphtyldimethylacetal (42 mg, 0.21 mmol, 1.1 eqv), and camphor sulfonic acid (cat.) were added, 
followed by stirring at room temperature overnight. The reaction mixture was quenched with Et3N (1 
ml) and concentrated in vacuo to give the desired product (Rf = 0.57 in 10% CH3OH in CH2Cl2, 8 mg, 9% 
yield). No further analysis were performed.
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Chemical procedures
General considerations and materials. All moisture sensitive reactions were carried out under an argon 
atmosphere, using oven-dried glassware and allowed to cool in a dessicator over anhydrous KOH, 
unless otherwise stated. Solvents were either purified over aluminum oxide under argon using a Pure 
Solv 400 solvent purification system (Innovative Technology, Amesbury, USA) (CH2Cl2, Et2O, toluene, 
and THF) or dried over 3Å molecular sieves (CH3CN, CH3OH, Pyridine). Commercially acquired chemicals 
were used without further purification unless stated otherwise. Burgess reagent was purchased from 
VWR. 6-methyl-tetrazine-ATTO-488, 6-methyl-tetrazine-Sulfo-cy3, 6-methyl-tetrazine-Sulfo-cy5, and 
DBCO-cy7 were purchased from Jena Bioscience. Dipyridyl tetrazine, DBCO-PEG4-Fluor 545, DBCO-
cy3, and DBCO-cy5 were purchased from Sigma-Aldrich. All chemicals used for biological experiments 
were dissolved in DMSO (1mM stock solution).
TLC. Analytical TLC was performed using plates of silica gel (Merck 60 F-254 on aluminium) and 
visualised using UV light (254 nm), ninhydrin, or KMnO
4
. Silica gel 60 (70–230 mesh) from Screening 
Devices, Amersfoort was used for flash chromatography.
NMR. 1H NMR and 13C NMR spectra were recorded on a Bruker Avance III 400 spectrometer (observation 
of 1H nucleus 400 MHz, and of 13C nucleus 100 MHz). Chemical shifts are reported in parts per million 
(ppm), calibrated on the residual peak of the solvent, whose values are referred to tetramethylsilane 
(TMS, δTMS = 0), as the internal standard. Coupling constants (J) are reported in Hertz (Hz), rounded to 
the nearest 0.5 Hz. Signal assignment was made from unambiguous chemical shifts and COSY, HSQC, 
HMBC, and DEPT.
ESI. Electrospray ionization (ESI) mass analyses were performed on a Finnigan LXQ, while high-
resolution ESI mass analyses were recorded on a Thermo Scientific Q Exactive High-Resolution mass 
spectrometer.
IR. Infra-red analyses were performed on a Bruker FT-IR spectrometer. 
2. Biological procedures
Bacterial strains and growth conditions. Escherichia coli K12 MG1655 was grown in Lysogeny Broth (LB) 
at 37 °C with aeration. Akkermansia muciniphila MucT (ATTC BAA-835)2 was cultivated anaerobically 
at 37 °C in CP medium supplemented with mucin2 or in CP-PT synthetic medium as described earlier.3 
Specific Growth Rate (SGR, μ) was calculated by measuring OD
600
 over a two hour growth interval 
during exponential growth of the respective bacteria. Colony forming units (CFUs) were determined 
by plating the E. coli on LB agar plates and A. muciniphila on CP-mucin agar plates. 
Application of bioorthogonal probes. PG probes were filter-sterilised before application in 
microbiological experiments. The probes were added in a 50 uM final concentration to early exponential 
bacterial cultures (OD600 = 0.3). The cultures were incubated for 1-2 hours in the presence of the 
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probes. Glycan probes were added at inoculation and left to grow for a maximum of 3 hours in the case 
of E. coli and a maximum of 10 hours for A. muciniphila. After growth in the presence of the probes, 
cells were harvested and washed twice with PBS. Cells were resuspended in click buffer (CuAAC: 100 
uM CuSO
4
, 100 mM ascorbic acid, 5 μl of 1 mM dye dissolved in PBS; SPAAC: 5 μl of 1 mM dye in PBS; 
tetrazine: 5 μl of 1 mM dye in PBS). Cells were incubated for 1 hour at room temperature in the dark 
and then washed three times with PBS. Supernatant was resuspended in PBS prior to confocal or FCM 
analysis. 
Confocal microscopy. Ibidi µ-slide 8 well glass bottom slides were used for confocal microscopy. 
Solutions for CuAAC or SPAAC labelling were freshly prepared with the following concentrations: 
CuSO
4
 (100 mM) and Ascorbic acid (5 mM). Live imaging was performed on a confocal laser scanning 
microscope (Leica TCS SP8X system). Alexa Fluor 488 was excited using an argon laser (488nm), and 
fluorescence emission was detected from 500 to 540 nm. Cy-3, Cy-5, and Cy-7 were excited using 
a white light continuum laser. Images were captured using a 633 water-immersion objective with a 
numeric aperture of 1.2 and a pinhole set to 1 Airy unit. Images were processed by ImageJ or LAS AF 
Lite. 
Flow cytometry. Analysis of isonitrile PG probe 6 and Ac
4
FucAz labelled cells was performed using a 
BD FACSaria III Cell Sorter fitted with BD FACSDIVA 6.1 software. Single cell populations were localised 
using FCS and SSC (488-nm 20 mW laser), gating pulse Area over pulse Width. Furthermore, Syto-9 
(488-nm, 502 LP, 530/30 nm) was used to counterstain and distinguish cells from background. The 
Cy-3 tetrazine labelled PG isonitrile probe was detected using a 561-nm (50 mW) laser including a 582 
nm band pass filter with a bandwidth of 15 nm. Cy-7 DBCO labelled Ac
4
FucAz was identified using a 
633-nm (18 mW) laser using a 755 nm Long Pass filter followed by a 780 nm band pass filter with a 
bandwidth of 60 nm. Data analysis was performed using FlowJo X (Treestar, USA).
Appendix A
171
Supplementary details chemical synthesis
FmocHN-d-Dap-OH
FmocHN-d-Asn-OH (1: 1.00 g, 2.82 mmol) was suspended in a solution of [bis(trifluoroacetoxy)iodo]
benzene (1.82 g, 4.23 mmol) in DMF – H2O (20 ml, 2:1 (v/v/)). After 15 minutes, Pyridine (0.45 ml, 5.64 
mmol) was added and the reaction mixture was stirred at room temperature for 16h. The solvent was 
removed under reduced pressure, and the oily residue was dissolved in H2O (20 ml). Concentrated HCl 
(1 ml) was added, and the acidified solution was washed with Et2O (3 × 10 ml). The aqueous phase was 
adjusted to pH 6 with 2 M NaOH solution, and the resulting precipitate was filtered, washed with H2O 
(3 × 10 ml), ice-cold EtOH (3 × 10 ml), and Et2O (3 × 10 ml). Product (0.92 g, 99%) was obtained after 
drying in vacuo as a beige powder. 1H NMR (400 MHz, DMSO-d6): δ 7.83 (d, J = 7.5, 2H, CHar), 7.64 (d, 
J = 7.4, 2H, CHar), 7.36 (t, J = 7.5, 2H, CHar), 7.28 (t, J = 7.5, 2H, CHar), 6.78 (d, J = 6.7, 1H, CONH), 4.26-
4.16 (m, 3H, Fmoc CH and CH2), 2.98-2.60 (m, 3H, α-H and β-CH2). 
13C NMR (100 MHz, DMSO-d6): δ 
171.1 (C=O), 143.8 (C
q
), 143.7 (C
q
), 140.6 (C
q
), 127.6 (CH aryl), 127.1 (CH aryl), 125.1 (CH aryl), 120.0 
(CH aryl), 99.5 (α-H), 46.6 (CH2), 40.4 (CH), 38.8 (CH2). ESI (+) m/z [M + H] calculated for C18H19N2O4: 
327.135; found: 327.3 IR (FT-ATR) 2948, 1722, 1686, 1636, 1577, 1532, 1491. Reference: Y.H. Lau & D. 
R. Spring, Synlett 2011, 13, 1917-1919.4
FmocHN-d-DapNHBoc-OH
 
FmocHN-d-Dap-OH (1.0 eqv, 0.86 g, 2.64 mmol) was dissolved in CH3OH / H2O (2:1, 10 ml) and NaHCO3 
(1.1 eqv, 0.24 g, 2.89 mmol). A solution of Boc2O (1.1 eqv, 0.63 g, 2.89 mmol) in CH3OH (45 ml) was 
added over 10 minutes. The reaction mixture was stirred and after TLC indicated completion it was 
diluted with aq. Na2CO3 (sat., 30 ml). The aqueous layer is washed with EtOAc (3 × 10 ml) and then 
acidified using 10% NaHSO
4
 solution until pH = 1. The acidified aqueous layer was extracted with 
EtOAc (3 × 10 ml) and the combined organic layers were dried over Na2SO4 and concentrated in vacuo. 
The product was isolated as a white foam in 79% yield that was used without any further purification. 
Rf 0.28 (10% CH3OH in CH2Cl2 (v/v)). 1H NMR (400 MHz, CDCl3): δ 7.76 (d, J = 7.5, 2H, CHar), 7.59 (d, J 
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= 7.5, 2H, CHar), 7.40 (t, J = 7.4, 2H, CHar), 7.30 (t, J = 7.4, 2H, CHar), 6.38 (s, 1H, NH), 5.15 (s, 1H, NH), 
4.37 (m, 3H, CH and CH2 Fmoc), 4.22 (t, J = 6.9, 1H, α-H), 3.59 (d, J = 45.6, 2H, β-CH2), 1.45 (s, 9H, 
3 × CH3). 
13C NMR (100 MHz, CDCl3): δ 173.2 (C=O Fmoc), 157.2 (C=O Boc), 143.8 (CqFmoc), 143.6 
(C
q
Fmoc), 141.3 (C
q
Fmoc), 141.3 (C
q
Fmoc), 127.7 (Ar-CH), 127.1(Ar-CH), 125.2(Ar-CH), 119.9(Ar-CH), 
80.6 (C
q
-Boc), 67.4 (CH2-Fmoc) , 55.4 (CH-Fmoc), 47.1 (α-CH), 42.1 (β-CH2), 28.2 (3 × CH3). For detailed 
experimental analysis see Ichikawa et al.5
FmocHN-d-DapNHBoc-D-Ala-OCH3
FmocHN-d-DapNHBoc-OH (1 eqv, 0.86 g, 2.02 mmol), EDC.HCl (1.1 eqv, 0.43 g, 2.22 mmol), d-Ala-
OCH3.HCl (1 eqv, 0.37 g, 2.02 mmol), HOBt (1.2 eqv, 0.3 g, 2.24 mmol), and DIPEA (3.4 eqv, 1.10 ml, 6.9 
mmol) were charged to a roundbottomflask containing CH2Cl2 (20 ml). The reaction mixture was stirred 
for 16h before it was washed with NH
4
Cl (3 × 10 ml). The organic layer was washed with NaHCO3 (3 × 
10 ml) and brine (3 × 10 ml). The organic layer was dried over Na2SO4 and concentrated in vacuo. The 
product was purified by flash column chromatography with 2.5% CH3OH in CH2Cl2 to afford dipeptide 
3 (0.91 g, 82%). Rf 0.20 (10% CH3OH in CH2Cl2 (v/v)). 1H NMR (400 MHz, CDCl3): δ 7.77 (2H, d, J = 7.4, 
CHar), 7.61 (2H, d, J = 7.4, CHar), 7.40 (2H, t, J = 7.4, CHar), 7.31 (2H, t, J = 7.5, CHar), 6.22 (1H, s, NH), 5.14 
(1H, s, NH), 4.54 – 4.32 (3H, m, FmocCH2 and FmocCH), 4.24 (2H, t, J = 7.2, 2 × α-H), 3.67 (3H, s, OCH3) 
3.54 (2H, d, J = 28.1, CH2), 1.46 (9H, s, BocCH3), 1.38 (3H, d, J = 7.1, CH3). 
13C NMR (100 MHz, CDCl3): δ 
171.1 (4 × C=O), 143.7 (C
q
), 141.3 (C
q
), 127.7 (CHar), 126.6 (CHar), 125.1 (CHar), 120.0 (CHar), 67.6 
(FmocCH2), 52.5 (OCH3), 48.3 (CH), 47.6 (CHCH3), 47.3 (FmocCH), 42.8 (CH2), 28.3 (3 × CH3), 14.1 (CH3). 
HRMS: found 534.2213 [M + Na+], calculated for [C
27
H33N3O7 + Na
+] 534.2216
FmocHN-d-Dap-d-Ala-OH
The protected dipeptide (3: 0.91 g, 0.5 mmol) was dissolved in anhydrous CH2Cl2 (20 ml) and cooled 
in an ice-water bath. TFA (5.0 ml, excess) was added dropwise to the reaction mixture over 5 minutes. 
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The reaction mixture was stirred for 2 h and afterwards concentrated in vacuo to obtain the product 
4 as an oily residue that was used without any further purification. Rf 0.6 (10% CH3OH in CH2Cl2 + Et3N 
(v/v)). 1H NMR (400 MHz, CDCl3): δ 7.94 – 7.80 (2H, d, J = 8.0, CHar), 7.71 (2H, t, J = 7.0, CHar), 7.60 – 7.12 
(4H, m, CHar), 4.45 – 4.07 (3H, m, FmocCH2 and FmocCH), 3.91 (2H, m, 2 × α-H), 3.74 (3H, s, OCH3), 3.13 
– 2.66 (2H, m, CH2), 1.21 (3H, d, J = 7.4 Hz, CH3). 
13C NMR (100 MHz, CDCl3): δ 186.6 (C=O), 170.2 (C=O), 
143.8 (C
q
), 141.3 (C
q
), 127.7 (CHar), 127.1 (CHar), 125.1 (CHar), 120.0 (CHar), 54.3 (CH2), 52.6 (OCH3), 48.4 
(CHCH3), 47.1 (CH), 43.6 (CH2), 28.3 (3 × CH3), 17.6 (CH3). HRMS: found 412.1872 [M + H
+], calculated 
for [C22H26N3O5 + H
+] 412.1872
FmocHN-d-DapNHCOH-d-Ala-OCH3
Amine 4 (1.0 eqv, 1.38 g, 2.62 mmol) was dissolved in a solution of Et3N (1.5 eqv, 0.55 ml, 3.93 mmol) 
and methyl formate (excess, 20 ml). The reaction mixture was refluxed for 16h after which it was 
concentrated in vacuo. The product was purified by column chromatography (5% CH3OH in CH2Cl2) 
to give 124 mg of 5 (11%). Rf 0.46 (10% CH3OH in CH2Cl2 (v/v)). 1H NMR (400 MHz, DMSO-d6): δ 7.87 
(d, J = 7.5, 2H, CHar), 7.70 (d, J = 7.4, 2H, CHar), 7.46 (d, J = 8.4, 2H, CHar), 7.31 (t, J = 7.5, 2, 2H, CHar), 
4.34 – 4.16 (m, 3H, FmocCH, FmocCH2), 3.64 (m, 2H, 2 × α-CH), 3.15 (s, 3H, OCH3), 2.84 (q, J = 7.2, 2H, 
β-CH2), 1.28 (d, J = 7.3, 2.8, 3H, CH3). 
13C NMR (100 MHz, DMSO-d6): δ 172.8 (C=O Fmoc), 162.3 (C=O 
Ester), 161.5 (C=O formamide), 143.7 (Car), 139.4 (Car), 128.8 (Car), 127.6 (Car), 125.2 (Car), 120.0 (Car), 
65.6 (FmocCH2), 48.5 (OCH3), 47.6 (CHCH3), 47.3 (FmocCH), 46.6 (CH2), 45.7 (CH2CH), 45.4 (β-CH2CH) 
16.7 (CH3). HRMS: found 462.1635 [M + Na
+], calculated for [C23H25N3O6 + Na
+] 462.1641
FmocHN-d-DapNC-d-Ala-OCH3
Formamide dipeptide 5 (1 eqv, 124 mg, 0.28 mmol) was co-evaporated three times with toluene before 
it was dissolved in CH2Cl2 (5 ml). Burgess reagent (1.5 eqv, 100 mg, 0.42 mmol) was added and stirring 
was continued for 16h at room temperature. Another 1.5 equivalents of Burgess reagent was added 
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before it was stirred for an additional 16h at room temperature. The reaction mixture was diluted 
with CH2Cl2 (5 ml) and quenched with H2O (5ml). The organic layer was isolated and dried over Na2SO4 
and subsequently concentrated in vacuo. The crude product was purified by column chromatography 
(2.5% CH3OH OH in CH2Cl2) to obtain 26 mg (22% yield) of the isonitrile as a white powder.   Rf 0.30 (5% 
CH3OH in CH2Cl2 (v/v)). 
1H NMR (400 MHz, DMSO-d6): δ 7.77 (d, J = 7.4, 2H, CHar), 7.58 (d, J = 7.4, 2H, 
CHar), 7.41 (t, J = 7.4, 2H, CHar), 7.32 (t, J = 7.4, 1.6, 2H, CHar), 6.91 (d, J = 6.8, 1H, NH), 5.90 – 5.60 (m, 1H, 
NH), 4.72 – 4.30 (m, 2H, FmocCH2), 4.23 (t, J = 6.7, 1H, FmocCH), 3.75 (s, 3H, OCH3), 3.82 – 3.62 (m, 5H, 
CH2CH), 3.44 (q, J = 21.6, 7.3, 1H, CHCH2), 3.14 (q, J = 7.3 Hz, 1H, CHCH3), 1.59 – 1.36 (m, 3H, CH3). 
13C 
NMR (100 MHz, DMSO-d6): δ 170.7 (C=O Fmoc), 165.1 (C=O OCH3), 157.8 (NC) 141.5 (Cq), 139.4(Cq), 
125.9 (CHar), 125.2(CHar), 123.0(CHar), 118.1(CHar), 65.6 (FmocCH2), 51.4 (OCH3), 50.7 (CHCH2), 46.6 
(FmocCH), 46.5 (CHCH3), 44.2 (CH2CH), 16.1 (CH3). HRMS: found 444.1528 [M + Na
+], calculated for 
[C23H23N3O5 + Na
+] 422.1530
H2N-d-DapNC-d-Ala-OCH3
The Fmoc protected starting material (1 eqv, 20 mg, 0.047 mmol) was dissolved in anhydrous DMF 
(0.5 ml). Piperidine (1.1 eqv, 5 µl, 0.052 mmol) was added and the reaction mixture was stirred at 
room temperature for 1 hour. The reaction mixture was transferred to an aqueous layer (10 mL) 
which was washed with diethylether (3 × 5 ml). The aqueous layer was lyophilised overnight to obtain 
the product in quantitative yield as a white solid. IR v
max
 (neat) 2152, 1650 cm-1; 1H NMR (400 MHz, 
DMSO-d6): δ 6.91 (d, J = 6.8, 1H, NH2), 5.90 – 5.60 (m, 1H, NH), 3.75 (s, 3H, OCH3), 3.82 – 3.62 (m, 5H, 
CH2CH), 3.44 (q, J = 21.6, 7.3, 1H, CHCH2), 3.14 (q, J = 7.3, 1H, CHCH3), 1.59 – 1.36 (m, 3H, CH3). MS: 
found 200.19 [M+H+], calculated for [C
8
H13N3O3 + H
+] 200.22 HRMS: found 200.1028 [M+H+], calculated 
for [C
8
H13N3O3 + H
+] 200.1030
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Cyclopropene dipeptide
The p-nitrophenol-activated cyclopropene carbonate was prepared as previously described.6-8
FmocHN-d-cyclopropene-d-Ala-OCH3
FmocHN-amino-d-Ala-OCH3 3 (78 mg, 0.15 mmol, 1 eqv) was dissolved in anhydrous CH2Cl2 (2 ml) and 
triethylamine (52 μl). Cyclopropene carbonate (42 mg, 0.17 mmmol, 1.1 eqv) was slowly added and 
the reaction mixture was stirred overnight at room temperature. The reaction mixture was quenched 
with water and extracted with CH2Cl2 (3 × 5 ml). The organic layer was washed with NH4Cl (3 × 5 ml), 
dried over Na2SO4 and concentrated in vacuo. Column chromatography performed with 2.5% CH3OH 
in CH2Cl2 gave the product (40 mg, 50% yield) as a white solid. 
1H NMR (400 MHz, CDCl3): δ 8.30–8.06 
(1H, m, CH
cyc
), 7.76 (2H, d, J = 7.5, CHar), 7.60 (2H, d, J = 7.6, CHar), 7.40 (2H, t, J = 7.5, CHar), 7.31 (2H, 
d, J = 7.5, CHar), 6.91 (1H, d, J = 8, CH), 6.55 (1H, s, NH), 4.55 (1H, J = 7.2, αHCH3), 4.40 (2H, d, J = 7.2, 
FmocCH2), 4.32 (1H, m, αCH), 4.23 (1H, t, J = 7.2, FmocCH), 4.00 – 3.93 (2H, m, CH2), 3.74 (3H, s, OCH3), 
3.69-3.50 (2H, m, CH2), 3.57 (1H, s, αCH), 2.12 (3H, s, CH3), 1.65 (1H, m, CH) 1.42 (3H, d, J = 7.3, CH3), 
1.26 (1H, s, CH). 13C NMR (100 MHz, CDCl3): δ 205.9 (C=O),172.9 (C=O), 169.8 (C=O), 162.3 (C=O), 
143.7 (C
q
), 141.3 (C
q
), 127.75 (CHar), 127.1 (CHar), 126.2 (Cq), 125.1 (CHar), 119.9 (CHar), 115.6 (CHcyc), 
72.9 (CH2), 67.5 (FmocCH2), 53.4 (OCH3), 52.7 (CHCH2), 48.3 (αHCH3), 47.1 (FmocCH), 43.3 (CH2CH), 
17.9 (CH3), 17.1 (CH), 11.6 (CH3). MS: found 544.61 [M+Na
+], calculated for [C
28
H31N3O7 + Na
+] 544.21 
HRMS: found 544.2041 [M+Na+], calculated for [C
28
H31N3O7 + Na
+] 544.2060
H2N-d-cyclopropene-d-Ala-OCH3
FmocHN-d-cyclopropene-d-Ala-OCH3 (40 mg, 0.07 mmol) was dissolved in anhydrous DMSO (1 ml). 
Piperidine (100 μl) were added and the reaction mixture was stirred at room temperature for 1h. After 
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full conversion the reaction mixture was diluted with water (10 ml) and washed with diethyl ether (3 × 
5 ml). The aqueous phase was lyophilised to give product 4 as a solid (20 mg, 87% yield). The dipeptide 
was dissolved in DMSO (5 mM stock solution), divided over 13 Eppendorf vials and stored at -20 °C. 
MS: found 300.1 [M+H+], calculated for [C13H21N3O5 + H
+] 300.16 1H NMR (400 MHz, D2O): δ 6.58 (1H, 
d, J = 14.3, CH), 4.16 – 4.08 (3H, m, αH and CH2), 3.92-3.51 (3H , m, αH + CH2), 2.67 (3H, s, OCH3), 
1.43 (3H, bd, CH3), 1.41 (3H, s, CH3), 1.31 (1H, d, J = 7.2, CH). 
13C NMR (100 MHz, D2O): δ 174.2 (C=O), 
167.3 (C=O), 162.3 (C=O), 126.7 (C
q
), 116.0(CH
cyc
), 101.6 (αCHCH2), 73.4 (CH2NH), 53.1 (OCH3), 48.9 
(αCHCH3), 44.6 (CH2CH), 22.4 (CH3), 16.6 (CH), 11.1 (CH3). HRMS: found 300.1550 [M+H
+] calculated 
for [C13H21N3O5 + H
+] 300.1554
Scheme S1. The alkyne-dipeptide EDA-DA was synthesised according to the procedure described by Liechti and co-workers.1 The 
dipeptide was filter-sterilised before application in microbiological experiments.
Figure S1. Confocal microscopy images of E. coli with control, cyclopropene, and isonitrile dipeptide PG probe. Cy-3 azide or 
tetrazine dyes were used for staining. Scale bar = 5 μm.
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Figure S2. Flow cytometry analysis of control (red), isonitrile (orange), and cyclopropene (blue) PG dipeptide probes in E. coli.
Figure S3. Overview labelling with control experiments in A. muciniphila. Scale bar = 5 μm.
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Figure S4. Additonal confocal images of PG labelling with cyclopropene and isonitrile PG dipeptide probe. Scale bar = 25 μm.
Figure S5. Overview of labelling with Ac
4
GlcNAz and Ac
4
GalNAz in A. muciniphila. Scale bar = 5 μm.
Figure S6. FCM analysis and confocal microscopy images of alkyne PG probe in A. muciniphila.
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Figure S7. Colony-Forming Units (CFU) of E. coli (C) and A. muciniphila (D) after incubation with PG probes and their click reaction 
(CuAAC with azide for Alkyne PG probe and invDA or [4+1] with tetrazine for cyclopropene or isonitrile probes).
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Summary 
After DNA and proteins, carbohydrates are the third language of life. Chapter 1 introduces the reader 
to this class of biomolecules, also called sugars or glycans, that can be found on the outer surface of 
almost all cells and plays a critical role as the social messengers of a cell. Although our knowledge about 
the role of glycans in eukaryotic cells has increased considerably in recent decades, our understanding 
of the glycan layer on bacterial cells is still very limited. Besides the carbohydrates that are present in 
both eukaryotes and prokaryotes an additional wide range of unique (e.g. microbial sialic acid), often 
very complex (e.g. pseudaminic acid), carbohydrates are present in prokaryotes. This chapter briefly 
introduces two research fields, carbohydrate chemistry and chemical biology, that when combined 
provide a powerful way to investigate the biological role of these unique bacterial carbohydrates 
at the molecular level. This chemistry-based approach, termed chemical microbiology, often starts 
with the development of a chemical synthesis for a target bacterial carbohydrate. Subsequently, the 
synthetic route towards this target allows for the introduction of unnatural functional groups, like 
chemical reporters, that result in the molecular tools needed to study their biological function. The 
studies described in this thesis, focus on developing such molecular tools to study the role of glycans 
and glycoconjugates in human gut bacteria and human-associated bacteria.
Chapter 2 provides an overview of metabolic oligosaccharide engineering (MOE) a popular chemical 
biology technique to label glycans in living cells. In MOE, carbohydrates derivatives are synthesised 
with unnatural chemical reporters and used to study their incorporation in glycans of eukaryote to 
prokaryote species. The progress in this field over the last 6 years is reviewed in detail with a special 
emphasis on the synthesis of the unnatural carbohydrates from commercially available sources. The 
principle behind MOE is that these unnatural carbohydrates with e.g. azide, alkyne, cyclopropene, 
or isonitrile chemical reporter groups, are still recognised by the endogenous enzymes in the cell 
that salvage this new carbohydrate. In this way they can enter the associated biochemical pathways 
and end up in newly biosynthesised cellular glycans. Subsequent labelling techniques, such as 
strain promoted azide alkyne cycloaddition or tetrazine ligation, enable the visualisation of these 
incorporated unnatural carbohydrates with for instance fluorescence microscopy. 
Metabolic labelling is further explored in chapter 3. Key cell envelope glycoconjugates in the mucin-
degrading gut microbiota member, Akkermansia muciniphila, were subjected to chemistry-based 
functional analysis, with Escherichia coli being used as a control species. Two novel non-toxic 
peptidoglycan (PG) probes were designed and synthesised to investigate the presence of PG in this 
species. Their design was based on the natural d-alanine dipeptide motif found in PG. Inspired by 
the fact that d-alanine dipeptide-derivatives were previously reported to be incorporated in newly 
synthesised PG, we synthesised a cyclopropene and isonitrile d-alanine dipeptide. Our probes proved to 
be non-toxic, as shown by growth and viable count analysis, and were therefore superior over existing 
PG probes. Another beneficial property was that the probes also did not influence the specific growth 
rate of A. muciniphila or E. coli. The PG probes were successfully incorporated into the peptidoglycan 
layer of A. muciniphila and visualised using a tetrazine click-ligation with a fluorophore. Our analysis 
proved for the first time that A. muciniphila has a PG layer. Besides PG labelling, we also investigated 
metabolic labelling of other glycoconjugates on the outer surface of A. muciniphila. This part of the 
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study showed that azido-monosaccharide derivatives of N-acetylglucosamine, N-acetylgalactosamine, 
and fucose are successfully processed by A. muciniphila salvage pathways and incorporated into its 
surface glycoconjugates. Especially Ac
4
FucAz was readily processed by the recently discovered l-fucose 
salvage pathway of A. muciniphila. The two compatible labelling techniques were next combined in a 
dual labelling experiment. Our isonitrile dipeptide peptidoglycan probe and Ac
4
FucAz were successfully 
incorporated into A. muciniphila. Subsequent fluorescent labelling with bio-orthogonal techniques 
resulted in dual labelling of peptidoglycan and fucose-containing glycans in live A. muciniphila cells.
With the positive results of MOE in A. muciniphila in hand, chapter 4 describes the further investigation 
of MOE. After successful validation of our Ac
4
FucAz probe for MOE in Bacteroides fragilis we continued 
their application in other human gut microbiota members, including the butyrate-producing 
Anaerostipes rhamnosivorans, Intestimonas butyriciproducens, and Eubacterium hallii. Labelling of 
these human gut microbes proved to be rather challenging with a-specific cellular labelling with the 
fluorophore being the major problem. Initial results, however, did show that a 6-azido-l-rhamnose 
probe resulted in fluorescent labelling of A. rhamnosivorans, which provides initial evidence for the 
existence of an as of yet undocumented salvage pathway. In this species the 6-azido-fucose probe 
was not salvaged. Via confocal microscopy and flow cytometry analysis we observed that the 6-azido-
rhamnose probe was selective for A. rhamnosivorans in the presence of A. muciniphila. Such a co-
culture experiment is a first step in mimicking the complex human gut microbiome. For E. hallii 
Ac
4
GalNAz gave clear metabolic labelling and the majority of the cell population could be labelled 
with the fluorescent dye after a strain-promoted azide alkyne cycloaddition. Other glycan probes 
(Ac
4
GlcNAz, Ac
4
FucAz, and Neu5Az) also resulted in labelling, but not as prominent as Ac
4
GalNAz. 
Surprisingly, MOE has never been reported for the common lab strain Escherichia coli MG1655. 
Curious to investigate this in more detail we started MOE in E. coli. However, no labelling was obtained 
when Ac
4
GlcNAz probe was added to E. coli, most likely due to the fast growth, metabolism and 
turnover. Only, when fresh Ac
4
GlcNAz probe was added every 30 minutes, metabolic labelling in E. 
coli was observed. To further investigate the influence of GlcNAc metabolism in E. coli on MOE, single-
gene knock-outs of E. coli GlcNAc metabolism from the Keio collection were investigated. Labelling 
was observed for NagA (N-acetyl glucosamine 6 P deacetylase) and NagK (N-acetyl-d-glucosamine 
kinase) E. coli mutants. Both enzymes are involved in the last step of the biosynthesis towards UDP-N-
acetylglucosamine. When the overall E. coli metabolism was inhibited, after addition of the respiration 
inhibitor sodium azide, no metabolic labelling was observed. These results indicate that MOE in E. coli 
is possible, but challenging and can only be performed under specific circumstances. 
An investigation into the total synthesis of pseudaminic acid, a sialic acid produced by specific human-
associated prokaryotes, is described in chapter 5. Sialic acids are typically found at the terminal 
positions of surface glycoconjugates in both eukaryotes and prokaryotes. Other related microbial 
sialic acids are legionaminic and acinetaminic acid. The total synthesis of these microbial sialic acids is 
notoriously difficult, as exemplified by the fact that only a few chemical synthesis routes towards them 
are currently known. Our total synthesis of pseudaminic acid started from the readily available amino 
acid l-threonine that was transformed into a key versatile Garner aldehyde derivative intermediate. 
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With this aldehyde in hand, the Henry nitro-aldol condensation reaction was investigated. After 
studying numerous conditions, such as asymmetric catalysis or elongated reaction times, and extensive 
optimisation efforts we were never able to obtain the Henry reaction product to continue with this 
route. As an alternative, a tethered aminohydroxylation was investigated for its ability to introduce the 
key functional group and stereochemistry onto an intermediate obtained from the Garner aldehyde 
derivative. This reaction indeed gave the desired amino-alcohol motif in the correct stereochemistry, 
but another diastereomer proved very difficult to separate from the desired product. After some 
additional transformations and protection steps we obtained a derivative in which the primary 
alcohol could be oxidised to provide a hexose intermediate that resembles the hexose intermediate 
present in pseudaminic acid biosynthesis. This key hexose intermediate will likely enable a subsequent 
Barbier reaction, a chain elongation step, in future studies. With most of the key transformations 
accomplished, the completion of a pseudaminic total synthesis based on l-threonine should soon be 
possible. Besides finishing the total synthesis, future work should also focus on adapting this synthesis 
route to allow installation of chemical reporter groups on pseudaminic acid for its application in MOE. 
Chapter 6 is the general discussion about all the work mentioned in the other chapters. It also contains 
additional information and suggestions for further research in the field of chemical microbiology.
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DNA, eiwitten, lipiden en suikers zijn de bouwstenen van het leven. Deze thesis gaat specifiek in op 
de laatste klasse van biomoleculen: suikers, ook wel koolhydraten of glycanen genoemd. Suikers 
komen onder andere voor op de buitenkant van cellen waar ze een belangrijke rol vervullen als 
boodschapper van de cel. De laatste 10-tallen jaren is er veel bekend geworden over de rol van 
suikers in eukaryoten cellen, hoe anders is dat in prokaryoten cellen waar de rol van suikers nog niet 
is verklaard. Prokaryoten, zoals bacteriën, hebben naast suikers die ook voorkomen in eukaryoten 
cellen een eigen klasse van suikers. Deze suikers zijn vaak zeer complex (e.g. pseudamine zuur) en 
vormen dan ook de aanleiding tot het onderzoek beschreven in deze thesis. In Hoofdstuk 1 worden er 
twee vakgebieden naarder verklaard: suiker chemie en chemische biologie. Technieken en kennis uit 
deze twee vakgebieden kunnen samen de biologische rol van deze unieke suikers in bacteriën nader 
bestuderen en verklaren. Deze chemische aanpak van het bestuderen van biologische processen, 
ook wel chemische microbiologie genoemd, start vaak met de organische synthese van zo’n complex 
bacteriële suiker. Door middel van organische synthese kunnen er onnatuurlijke chemische groepen 
aan het suiker gezet worden, moleculair gereedschap, die het mogelijk maken om de suikers te 
bestuderen in bacteriën. In deze thesis wordt de synthese van dit moleculair gereedschap en suikers 
nader beschreven waarna er wordt gekeken hoe suikers zich gedragen in menselijke darmbacteriën.
In Hoofdstuk 2 wordt er een overzicht gegeven van een populaire chemische biologische techniek die 
het mogelijk maakt om suikers te labelen in levende cellen: metabool oligosacharide architectuur. In 
deze techniek worden suiker derivaten gesynthetiseerd met onnatuurlijke chemische handvaten die 
het mogelijk maken om glycanen te bestuderen in eukaryoten of prokaryoten cellen. Een overzicht 
van de afgelopen zes jaar zijn in dit hoofdstuk uiteengezet. De focus van dit overzicht is de beschrijving 
van de synthese van de onnatuurlijke suikers en het moleculaire gereedschap vanuit commercieel 
verkrijgbare bouwstenen. Voorbeelden van moleculair gereedschap zijn azide, alkyn, cyclopropeen, 
of isocyanide groepen. Dit moleculair gereedschap wordt volgens de standaard biochemische 
routes ingebouwd door de aanwezige enzymen ondanks de chemische aanpassingen aan de suikers. 
Na inbouw in de glycanen kan het moleculair gereedschap gelabeld worden met bijvoorbeeld 
fluorescerende groepen zodat dit bekeken kan worden onder fluorescentie microscopie. Voor deze 
laatste stap maakte we gebruik van een tweetal chemische reacties: de spanning gestuurde azide 
alkyne cycloadditie of de tetrazine ligatie.
Metabool labelen wordt ook toegepast in Hoofdstuk 3. Essentiele glycaan conjugaten in de belangrijke 
darmbacterië Akkermansia muciniphila werden nader onderzocht en geanalyseerd vanuit een 
chemische invalshoek. Als controle organisme werd Escherichia coli gebruikt. Twee nieuwe niet-
toxische peptidoglycaan (PG) probes zijn ontwikkeld en gesynthetiseerd om PG aan te tonen in deze 
soorten. Het ontwerp was gebaseerd op het natuurlijke aminozuur d-alanine dipeptide wat aanwezig 
is in natuurlijk PG. In de literatuur waren al voorbeelden aanwezig van d-alanine dipeptide probes 
om PG aan te tonen. Als moleculair gereedschap hebben wij isocyanide en cyclopropeen groepen op 
het d-alanine dipeptide probe geplaatst. Na inbouw in PG is aangetoond dat onze probes niet toxisch 
waren en dus een verbetering zijn op de bestaande probes. Verder werd de groei van de bacteriën 
niet aangetast door de aanwezigheid van onze probes. De inbouw van de d-alanine dipeptide 
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probes werd aangetoond met de tetrazine ligatie met een fluorescerende groep aan het tetrazine 
conjugaat. Hiermee toonde we voor het eerst aan dat A. muciniphila een PG laag heeft. Naast de 
PG labelen hebben we ook andere suiker conjugaten gelabeld op de buitenkant van A. muciniphila. 
Verschillende monosaccharide met azide als moleculair gereedschap, gebaseerd op de natuurlijke 
suikers N-acetylglucosamine, N-acetylgalactosamine, en fucose, werden succesvol ingebouwd in A. 
muciniphila. Met name azide-fucose werd goed ingebouwd wat de recent ontdekte fucose recycling 
synthese in A. muciniphila verder onderbouwd. Tot slot werden beide label technieken tegelijk 
toegepast in A. muciniphila. Zowel het isocyanide d-alanine dipeptide probe als de azide fucose 
werden ingebouwd in A. muciniphila en daarna met behulp van fluorescentie zichtbaar gemaakt.
De positieve resultaten van metabool labelen in A. muciniphila gaven aanleiding om dit verder door te 
zetten in andere darm-bacteriën in Hoofdstuk 4. Na validatie van de fucose azide probe in Bacteroides 
fragilis hebben we een selectie gemaakt van andere relevante darmbacteriën om metabool te labelen: 
Anaerostipes rhamnosivorans, Intestimonas butyriciproducens, en Eubacterium hallii. Het labelen van 
deze bacteriën was zeer problematisch gezien het hoge achtergrond signaal wat we vaak kregen. 
De eerste resultaten laten echter zien dat de 6-azide rhamnose probe opgenomen werd door A. 
rhamnosivorans en succesvol werd ingebouwd wat duidt op de aanwezigheid van een  rhamnose 
recycling synthese. Ter vergelijking, 6-azide fucose werd niet ingebouwd in A. rhamnosivorans. 
Bovendien konden we aantonen dat de 6-azide rhamnose probe selectief was voor A. rhamnosivorans 
in een mengsel met A. muciniphila. Dit resultaat zet een eerste stap in het nabootsen van ons 
complexe darmsysteem. In E. halliii metabool labelen met azido-N-acetylgalactosamine gaf duidelijk 
fluorescente gelabeld bacteriën na een spanning gestuurde azide alkyn cycloadditie. Andere azide 
probes (Ac
4
GlcNAz, Ac
4
FucAz, and Neu5Az) gaven minder labelling vergeleken met Ac
4
GalNAz. 
Metabool labelen in Escherichia coli MG1655 was, tot onze verbazing, nog nooit aangetoond. 
Daarvoor ondernamen we verder proeven om dit nader te bestuderen. De snelle groei, een hoog 
metabolisme, en de duplicatiesnelheid waren echter waarschijnlijke oorzaken waarom metabool 
labelen met Ac
4
GlcNAz niet lukte. Alleen bij toevoeging van Ac
4
GlcNAz probe elke 30 minuten was er 
labeling te zien in E. coli. Voor nader onderzoek hebben we ons gericht op mutanten van E. coli waarbij 
belangrijke metabole routes waren uitgeschakeld. Hierbij was labeling te zien voor NagA (N-acetyl 
glucosamine 6 P deacetylase) en NagK (N-acetyl-d-glucosamine kinase) E. coli mutanten. Wanneer 
het metabolisme volledig werd platgelegd, door toevoeging van natriumazide, was er geen metabool 
labeling te zien. Deze resultaten laten zien dat metabool labelen mogelijk is in E. coli maar dat het zeer 
uitdagend is en alleen onder specifieke niet natuurlijke condities werkt.
In Hoofdstuk 5 komt de totaal synthese van pseudamine zuur aan bod. Dit is een suiker behorende 
bij de klasse van siaalzuren. Pseudamine zuur is een microbiële siaalzuur wat alleen gemaakt wordt 
door bacteriën die in contact staan met de mens. Siaalzuren zijn vaak te vinden op de uiteinden van 
glycoconjugaten in eukaryoten of prokaryoten. Naast pseudamine zuur is er ook legionamine en 
acinetamine zuur recentelijk ontdekt in bacteriën. De totaal synthese van deze microbiële siaalzuren 
is niet triviaal, desondanks zijn er enkele synthese routes bekend naar de siaalzuren. Onze route naar 
pseudamine zuur begon vanaf het commercieel verkrijgbare aminozuur l-threonine. Na enkele stappen 
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was een belangrijk veelzijdig Garner aldehyde derivaat bereikt. Vanuit hier werd er een Henry reactie, 
een nitro-aldol condensatie, geprobeerd. Na verscheidene pogingen, zoals asymmetrische katalyse 
of lange reactie tijden, werd het product van deze reactie nooit volledig gevormd. Op zoek naar een 
alternatief om het amino-alcohol motief in het molecuul in te bouwen hebben we de gestuurde 
aminohydroxylatie geprobeerd. Tijdens deze reactie werd er een diastereomeer gevormd die lastig te 
scheiden bleek. Na enkele reactie waren we aangekomen bij de oxidatie van een primair alcohol. Na 
oxidatie zou dit product een precursor opleveren voor pseudamine zuur. Door tijdsgebrek zijn deze 
transformaties helaas niet voltooid en konden we de totaal synthese van pseudamine zuur tot op 
heden niet voltooien. Bij een succesvolle totaal synthese zou de volgende stap zijn het inbouwen van 
het moleculair gereedschap wat metabool labelen mogelijk moet maken.
Hoofdstuk 6 is een algemene discussie naar aanleiding van alle hoofdstukken. Verder geeft het 
aanvullende informatie en toekomst perspectieven in het vakgebied chemische microbiologie. 
“Hey you”
The Wall, Pink Floyd
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